In silico Investigation of Chromatin Organisation in Splicing, Ageing, and Histone Mark Propagation along DNA-Loops by Ruiz Velasco Leyva, Mariana
  
Dissertation 
submitted to the 
Combined Faculties for the Natural Sciences and for Mathematics 
of the Ruperto-Carola University of Heidelberg, Germany 
for the degree of 
Doctor of Natural Sciences 
 
 
 
    
     
 
      
 
 
Presented by 
Mariana del Rosario Ruiz Velasco Leyva, M.Sc. 
born in Mexico City, Mexico 
Oral-examination: September 18th, 2018 
  
  
  
  
In silico Investigation of Chromatin Organisation in 
Splicing, Ageing, and Histone Mark Propagation along 
DNA-Loops 
 
 
 
 
 
 
 
 
 
 
 
Referees: 
Dr. Jan Korbel 
Prof. Dr. Benedikt Brors 
  
  
 
  
  
 
In silico Investigation of Chromatin Organisation in 
Splicing, Ageing, and Histone Mark Propagation along 
DNA-Loops 
 
 
 
 
 
 
 
 
 
 
 
 
Mariana Ruiz Velasco Leyva, M.Sc. 
 
 
 
 
 
 
 
 
 
 
Supervised by Dr. Judith B. Zaugg 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Learning is a treasure that will follow its owner everywhere.” 
Chinese proverb  
 Acknowledgements 
Terminar el doctorado implica llegar a la cumbre de mi formación académica y poder por 
fin comenzar a descubrir un mundo de posibilidades en donde aplicar todos los 
conocimientos que he aprendido de tantas personas en estos años. Mi primer 
agradecimiento lo dedico a mi familia, quien una vez más valoró y confió en mi decisión 
de viajar al otro lado del mundo para poder seguir mis sueños. A pesar de la distancia, a 
pesar de los sacrificios que implica estar lejos de mi tierra, todo ha valido la pena. Muchas 
gracias por siempre respetar e impulsar mis decisiones y por siempre encontrar la forma de 
estar presentes en los momentos importantes. Los amo.  
Finishing the PhD implies getting to the summit of my studies and opens an 
exciting world of possibilities for professionally applying the knowledge that I gained in 
these years. I owe this knowledge to several tutors and colleagues that throughout my 
studies invested hours of their time to teach me concepts, methods, or skills. My PhD 
would not be possible without the excellent mentorship that I received from my advisor, 
Judith Zaugg, who taught me valuable lessons and concepts from literally day one of the 
Zaugg group and during these four years. She prepared me for the next steps by trusting 
me and motivating me to always do my best and she showed me that working hard, having 
a positive attitude, and loving what you do is the key to success. I will always be grateful 
for her advice and her support. 
I also want to thank my TAC members: Jan Korbel, Benedikt Brors, and Kiran 
Patil. I am thankful for the exciting discussions that happened during my TAC meetings, 
for your feedback and for your time. Thank you Marina Lusic for agreeing to be part of my 
thesis defence and for the nice conversations that we have shared in the past. Besides them, 
I want to thank Toby Gibson, Kyung-Min Noh, and Anne-Claude Gavin, who also shared 
their time, experience, and expertise to shape the projects that I had worked in during these 
 years. Thank you Manjeet Kumar, Alejandro Reyes, Ximing Ding, Brian Lai, Marco 
Hennrich, Esa Pitkänen, Armando Reyes, Ignacio Ibarra, and Vasavi Sundaram for the 
exciting discussions and your willingness to collaborate with me. 
 During my time at the Zaugg group, I was able to work side by side with many 
amazing colleagues and to receive their feedback. I thank you all -current members and 
alumni- because besides working together we shared everyday experiences, worries, good, 
and bad times. First of all, I especially want to thank Armando, Christian, Pooja, Ignacio, 
Ece, Ana Belén, and Ivan, whom I consider to be the ‘pioneers’ of the Zaugg group with 
me, we should consider writing the Memoirs of the group some day! Together we 
experienced many nice moments, trips, coffee breaks, and talks; perhaps also because I 
shared office with the majority of them. I also want to thank Olga, Irene, Brian, Daria, 
Giovanni, Raphael, Rocio, and all the other alumni from the group for continuing what I 
described above. Valuable times came from coffee breaks, informal talks, and group 
activities. I cannot thank you all enough for all your efforts, your feedback and for igniting 
so many exciting discussions that make me love biology. 
 My time at the PhD wouldn’t have been half as fun if it wasn’t for my friends from 
EMBL class of 2014: Jessica, Sourabh, Joergen, Sascha, Nade, Marvin, and Lukas. It was 
always a journey with you, thank you for literally being my crew and for being in my life. I 
also thank you for extending the group with your amazing families; your friendship is 
something that I cherish. 
Last but never least, I want to thank Alexander. Thanks to you I am able to see this 
day. Throughout this journey you were my rock, my teammate, and my love. I am also 
grateful to your family for their continuous support. Vielen Dank für Alles.  
 Table of Contents 
 
Summary 12 
Zusammenfassung 14 
List of Figures 15 
Abbreviations 16 
1. Introduction: Lnterplay between chromatin organisation and functionality in the 
mammalian nucleus 21 
1.1 Chromatin organisation at different scales 22 
1.1.1 Large-scale organisation: topologically associated domains and subcompartments 23 
1.1.2 Intermediate scale organisation: Enhancer-promoter interactions 25 
1.1.3 Intragenic organisation: gene promoter-terminator loops 26 
1.2 Mechanisms needed to shape and maintain the nuclear architecture 27 
1.2.1 CTCF and its binding grammar 27 
1.2.2 Structural Maintenance of Chromosomes protein complexes 28 
1.2.3 Loop extrusion 29 
1.3 Elucidating the function of 3D-chromatin architecture 32 
1.3.1 Functional impact of TAD rearrangements 32 
1.3.2 Distribution of functional genetic variants at TADs and loop boundaries 33 
1.3.3 Influence of chromatin architecture in cancer genomes 34 
1.4 Understanding how the 3D architecture conveys its functional impact 34 
1.5 Chromatin organisation is affected with age 35 
1.6 Using 3D-architecture to understand human variation and disease 37 
2. CTCF-mediated intragenic chromatin loops between promoter and gene body regulate 
alternative splicing across individuals 39 
2.1 Introduction 40 
2.2 Results 40 
2.2.1 Intragenic CTCF motif orientation suggests pervasive promoter-exon looping 41 
2.2.2 CTCF-mediated intragenic chromatin loops regulate alternative exon usage 45 
2.2.3 Allele-specific analysis confirms the model of CTCF-dependent alternative exon 
usage mediated by DNA interactions 48 
2.2.4 Functional consequences of genes and exons with predicted intragenic loops 50 
2.3 Discussion 54 
2.4 Methods 57 
2.4.1 Annotation of Intragenic Loops 57 
2.4.2 Overlap with chromatin conformation data and splicing QTLs 58 
2.4.3 Annotation of Differentially Used Exons 58 
 2.4.4 CTCF correlation with DUEs 60 
2.4.5 Allele specific analysis of CTCF binding 61 
2.4.6 Protocol and processing of 4C-seq experiments 62 
2.4.7 Functional analyses 68 
3. Intragenic CTCF-mediated loops regulate alternative splicing across cell types, are 
involved in neural differentiation, and misregulated in cancer 69 
3.1 Introduction 70 
3.2 Results 71 
3.2.1 Intragenic loops affect splicing decisions across tissues 71 
3.2.2 Evidence for CTCF-loop regulated exon usage in cellular differentiation 73 
3.2.3 Frequently mutated regions in cancer are enriched at CTCF motifs that anchor 
intragenic interactions 76 
3.3 Discussion 81 
3.4 Methods 83 
3.4.1 Annotation of Intragenic Loops 84 
3.4.2 Identification of Differentially Used Exons 85 
3.4.3 Correlating exon usage and interaction strength 85 
3.4.4 Enrichment of somatic mutations at intragenic interactions 86 
4. Studying the mechanisms of histone mark propagation along DNA-loops 87 
4.1 Introduction 88 
4.2 Results 89 
4.2.1 Characterisation of inter-individual variation at different architectural sites 89 
4.2.2 Architectural and functional loops are likely to be affected by distal genetic variants 
through the disruption of combinatorial protein binding 93 
4.2.3 Proposing possible mechanisms in which 3D-structure conveys functionality 97 
4.3 Discussion 98 
4.4 Methods 101 
4.4.1 Overview of the samples and datasets used 102 
4.4.2 Defining loop-QTLs 102 
4.4.3 Co-enrichment of TFs at loop-QTLs 102 
4.4.4 Identification of allele-specific genomic factors 103 
4.4.5 Classifying loop-QTLs into models 103 
5. Global chromatin changes alter regulatory landscape in ageing stem cells 105 
5.1 Introduction 106 
5.2 Results 107 
5.2.1 Establishment of a bone-marrow mesenchymal stem cell dataset to assess age-related 
changes in chromatin 108 
5.2.2 Integration of transcriptomics and proteomics data reveal global changes in 
chromatin related proteins upon ageing 110 
 5.2.3 A global chromatin rearrangement is observed with age 114 
5.2.4 Specific changes in accessibility are observed with age mostly at heterochromatin, 
enhancer, promoter, and bivalent chromatin states and correlate with DNA methylation 116 
5.2.5 Altered transcription factor landscape recapitulate changes in the differentiation fate 
with age 122 
5.2.6 Multi-omic integration shows corresponding patterns across different layers of 
organisation 125 
5.2.7 Extensive changes in splicing regulation are observed with age 128 
5.3 Discussion 131 
5.4 Methods 135 
5.4.1 Overview of the samples and datasets used 136 
5.4.2 Culture, isolation, and construction of ATAC-seq libraries for MSCs 136 
5.4.3 ATAC-seq data analysis and identification of CARs 137 
5.4.4 Assessing changes in the shape of the peaks 139 
5.4.5 Analysis of chromatin states in the accessibility regions 139 
5.4.6 Differential expression and exon usage analyses 140 
5.4.7 Identification of a changing transcription factor landscape 141 
5.4.8 Integration of the ATAC-seq, RNA-seq, and proteomics datasets 141 
6. Conclusions and perspectives 143 
6.1. Chromatin organisation at the gene level conveys functionality by affecting alternative 
exon usage 143 
6.2 Chromatin architecture is misregulated at all levels and through multiple mechanisms 
during human ageing in stem cells 146 
6.2 Concluding remarks 148 
Appendix 149 
A. Supplementary information for chapter 2 151 
B. Supplementary information for chapter 3 156 
C. Supplementary information for chapter 4 159 
D. Supplementary information for chapter 5 162 
Bibliography 171 
 
  
 Summary 
A long-standing aim in biology is to elucidate how the genome is tightly compacted inside 
the eukaryotic nucleus while still retaining its capacity to orchestrate the correct 
functionality of the cell. While years of research have revealed that this three-dimensional 
structuring of DNA plays a major role in the transcriptional regulation, most of the existing 
studies have focused on long-range chromatin interactions, which are mainly established 
by the CCCTC-binding factor (CTCF), rarely centring at the gene level. Furthermore, our 
current knowledge on the interplay between structure and function remains largely 
descriptive with little mechanistic insight.  In this dissertation I present three distinct 
computational studies which integrate multiple levels of molecular phenotype data in an 
attempt to gain further insights into the influence of chromatin organisation in (i) splicing 
regulation, (ii) in how distal genetic variants convey their signal, (iii) and an overall view 
of the misregulation of chromatin compaction in ageing stem cells. 
 Firstly, I describe a novel splicing mechanism whereby CTCF-mediated DNA-
loops that are formed within genes facilitate exon inclusion. My results provide substantial 
evidence that intragenic loops regulate exon usage and that CTCF binding can be affected 
either by genetic variation across individuals or by the epigenomic landscape in different 
cell lines. Those exons being CTCF-regulated frequently overlap annotated protein 
domains and are enriched for being involved in cellular stress-response and signalling 
pathways. In summary, this study provides strong evidence for alternative exon usage 
being regulated by chromatin structure, and thus increases our understanding of functional 
consequences underlying variation in chromatin architecture. 
In a second study, I show initial efforts to unravel the mechanisms that allow a 
genetic variant (distal-QTL) to confer its effect at distant regions through long-range 
interactions. By measuring allele-specific biases of various molecular phenotypes 
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 occurring along chromatin interactions, I propose two models that intend to explain the 
propagation of this signal. In the “touch-and-act model” functionality is transmitted 
through the physical contact of both anchors, independent of the region inside the loop, 
while in the “spreading model” the function is propagated along the entire loop resulting in 
a coordinated activation or repression of the whole local neighbourhood. There is evidence 
for both models occurring at varying proportions, which are partially explained by 
transcription factor co-enrichments. 
Finally, I present a study on how chromatin accessibility impacts the transcriptome 
and the proteome in mesenchymal stem cells (MSC) from human donors of multiple ages. 
I also observed a profound misregulation of chromatin organisation occurring with age, 
possibly due to a decrease in chromatin-related proteins such as histones, CTCF, CENPB, 
and lamins, which ultimately affect heterochromatin at centromeres and telomeres 
contributing to genomic instability. By subtle but significant changes in the transcription 
factor landscape of young and old MSCs, I observe a bias in the differentiation potential. 
Additionally, I show a loss of bivalent modifications at enhancer and promoter regions that 
correlate with DNA methylation changes and that could possibly contribute to a decrease 
in stemness with age. 
In summary, I describe a novel splicing mechanism mediated by chromatin 
intragenic interactions, propose models of how distal-QTLs propagate histone marks, and 
advance the understanding of chromatin accessibility changes occurring with age in stem 
cells. 
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 Zusammenfassung 
Ein seit langem bestehendes Ziel in der Biologie ist es aufzuklären, wie das Genom innerhalb des 
eukaryotischen lang-distanzige kompaktiert ist, während es immer noch seine Fähigkeit beibehält, 
die korrekte Funktionalität der Zelle zu koordinieren. Während Jahre der Forschung gezeigt haben, 
dass diese dreidimensionale Strukturierung der DNA eine wichtige Rolle bei der 
Transkriptionsregulation spielt, konzentrierten sich die meisten der vorliegenden Studien auf 
langreichweitige Chromatininteraktionen, die hauptsächlich durch den CCCTC-Bindungsfaktor 
(CTCF) erzeugt werden, was nur selten zentriert auf der Genebene ist. Darüber hinaus bleibt unser 
derzeitiges Wissen über das Zusammenspiel von Struktur und Funktion weitgehend deskriptiv mit 
wenig mechanistischen Einsichten. In dieser Dissertation präsentiere ich drei verschiedene 
Computerstudien, die mehrere Ebenen von molekularen Phänotypdaten integrieren, um weitere 
Einblicke in den Einfluss der Chromatinorganisation zu erhalten bezüglich der (i) Spleißregulation, 
(ii) Art und Weise, wie distale genetische Varianten ihr Signal übermitteln und (iii) Gesamtansicht 
der Fehlregulation der Chromatinveraenderung in alternden Stammzellen. 
Zunächst beschreibe ich einen neuartigen Spleißmechanismus, bei dem CTCF-regulierte 
DNA-Schleifen, die in Genen entstehen, die Exon-Inklusion erleichtern. Meine Ergebnisse liefern 
einen substanziellen Evidenz dafür, dass intragene Schleifen die Exon-Nutzung regulieren und dass 
die CTCF-Bindung entweder durch genetische Variation über Individuen oder durch die 
epigenomische Landschaft in verschiedenen Zelllinien beeinflusst werden kann. Diese Exone sind 
häufig CTCF-reguliert, überlappen häufig mit annotierten Proteindomänen und sind angereichert 
für Funktionen der zellulären Antwort auf Stress und Signalwegen. Zusammengefasst liefert diese 
Studie einen starken Evidenz dafür, dass die alternative Exon-Nutzung durch die Chromatinstruktur 
reguliert wird, und erhöht somit unser Verständnis der funktionellen Konsequenzen, die der 
Variation in der Chromatinarchitektur zugrunde liegen. 
In einer zweiten Studie zeige ich ersten Bemühungen, die Mechanismen zu entschlüsseln, 
die es einer genetischen Variante (distal-QTL) ermöglichen, ihre Wirkung in distalen Regionen 
durch weitreichende Interaktionen zu erzielen. Durch die Messung allelsspezifischer Ausprägung 
14
 verschiedener molekularer Phänotypen bezüglich Chromatin-Wechselwirkungen schlage ich zwei 
Modelle vor, die die Ausbreitung dieses Signals erklären können. Im "Touch-and-Act-Modell" 
wird die Funktionalität durch den physischen Kontakt beider Interaktionsanker unabhängig von der 
Region innerhalb der Schleife übertragen, während sich die Funktion im "Ausbreitungsmodell" 
entlang der gesamten Schleife ausbreitet, was zu einer koordinierten Aktivierung der gesamten 
lokalen Nachbarschaft führt. Ich habe Evidenz für beide Modelle beobachtet, die in variierenden 
Anteilen auftreten und teilweise durch Cofaktoren der Transkriptionsfaktoren erklärt werden 
können. 
Schließlich stelle ich eine Studie vor, in der beschrieben wird, wie die Zugänglichkeit von 
Chromatin das Transkriptom und das Proteom in mesenchymalen Stammzellen (MSC) von 
menschlichen Spendern mehrerer Altersgruppen beeinflusst. Ich beobachtete eine tiefgreifende 
Fehlregulation der Chromatinorganisation mit zunehmendem Alter, möglicherweise aufgrund einer 
Abnahme von Chromatin-verwandten Proteinen wie Histonen, CTCF, CENPB und Laminen, die 
letztlich Heterochromatin in Zentromeren und Telomeren beeinflussen, was zur genomischen 
Instabilität beiträgt. Durch subtile, aber signifikante Veränderungen in der Transkriptionsfaktor-
Landschaft von jungen und alten MSCs beobachte ich eine Verzerrung des 
Differenzierungspotentials. Zusätzlich habe ich einen Verlust an bivalenten Modifikationen in 
Enhancer- und Promotorregionen, die mit der DNA-Methylierung korrelieren und möglicherweise 
zu einer Abnahme der Stammzellfähigkeit mit dem Alter beitragen könnten. 
Zusammenfassend beschreibe ich einen neuartigen Spleißmechanismus, der durch 
Chromatin-Interaktionen vermittelt wird, schlage Modelle vor, wie distal-QTL Histone markieren, 
und verbessere das Verständnis von altersbedingten Zugänglichkeitsveränderungen von Chromatin 
in Stammzellen. 
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 1. Introduction: interplay between chromatin 
organisation and functionality in the mammalian nucleus 
 
This chapter shows an overview of the current knowledge in the fast-paced field of 
chromatin organisation. Most of the text has been directly taken from a literature review 
that has been originally written by me: 
Mariana Ruiz-Velasco and Judith B. Zaugg (2017) Structure meet function: How 
chromatin structure conveys functionality. Current Opinions in Systems Biology 1, 129-
136. 
This article is open access and is available under the terms of the Creative Commons 
Attribution 4.0 License (CC BY). Parts of the text were also extended to include the 
literature following its publication. It also includes additional sections that summarise how 
chromatin organisation is destabilised with age.  
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 The eukaryotic nucleus is the brain of a cell. This organelle is able to store the genetic 
information by compressing it to fit into a microscopic compartment, while preserving its 
capacity of dictating the functionality of the cell. Understanding how this compaction 
occurs, which mechanisms drive this organisation, and how in spite of the intricate 
condensation there is still order and an accurate molecular regulation, has led to decades of 
research. In the past years, however, major progress has been accomplished thanks to 
global consortia which have begun to elucidate and map chromatin interactions in several 
tissues and across dynamic biological processes. The same interest in gaining additional 
knowledge about chromatin structure, its relation to function, and how it is affected by 
dynamic biological processes like ageing or cancer has motivated this doctoral thesis. 
 
1.1 Chromatin organisation at different scales 
Chromatin is the physiological structure composed of DNA and histone proteins (Hake and 
David Allis, 2006). Depending on the cell cycle stage, chromatin is able to linearly 
compact in the mammalian nucleus about 200-1,000-fold during interphase (Lawrence et 
al., 1990) and up to about 10,000- to 20,000-fold in the mitotic state to form the 30nm fiber 
(Swedlow and Hirano, 2003). While this compression is tremendous chromatin 3D-
organisation is not random. Years of research in this field have demonstrated that certain 
genomic locations show a preferential physical interaction with others, as I will discuss 
below. Therefore, understanding how the genome is compacted in a highly ordered 
structure that fits in the eukaryotic nucleus, while keeping its capacity of orchestrating the 
functionality of the cell, is one of the long-standing questions in biology.  
Three dimensional chromatin organisation has been extensively studied at multiple 
scales, ranging from whole chromosome structures to interactions across a few kilobases. 
In our review (Ruiz-Velasco and Zaugg, 2017), we summarized our current knowledge of 
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 3D-organisation, the mechanisms of how it is established and maintained, and the 
functional impact it has on gene regulation and complex phenotypes. We also described the 
various levels of genome architecture by grouping them into (i) large-scale chromatin 
domains, (ii) intermediate-scale (enhancer-promoter) loops, and (iii) intragenic interactions 
(Figure 1.1). These three levels are classified by the length of the interaction and 
encompass various well-described structures in the nucleus, where each level comprises 
specific characteristics. 
Figure 1.1. Schematic about our current knowledge across the different scales of chromatin organisation for both 
structure and function. While we know much about the structure of the highest levels and little as we zoom in, the 
opposite is true for our knowledge about the functional impact of chromatin architecture. The technologies with which 
each level is typically investigated are mentioned in the middle. This figure was previously published (Ruiz-Velasco and 
Zaugg, 2017). 
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 1.1.1 Large-scale organisation: topologically associated domains and subcompartments 
On the most coarse level genomes are organised into structures known as chromosome 
territories (Cremer and Cremer, 2001), which separate euchromatic (“active” and “open”) 
from heterochromatic (“repressed” and “closed”) regions. While this sub-chromosomal 
structures were described in the 80s (Cremer and Cremer, 2001), these 
compartmentalisation was also observed using high-throughput chromosome conformation 
capture technologies (C-technologies). Euchromatin and heterochromatin domains 
coincide with the recently termed ‘A’ and ‘B’ subcompartments (Lieberman-Aiden et al., 
2009). The former is associated to active histone modifications, presence of genes, and 
higher expression, while the latter pertains to repressive compartments, closed spatial 
locations, and nuclear lamina (Lieberman-Aiden et al., 2009). These compartments can be 
further subdivided into A1-A2 and B1-B4 according to their chromatin signature and 
replication time (Rao et al., 2014).  
Chromatin is organised in an almost fractal structure within the chromosome 
territories (Bancaud et al., 2012) with megabase-sized domains being partitioned into 
smaller and smaller sub-domains that are currently known as topologically associated 
domains (TADs) (Dixon et al., 2012; Rao et al., 2014). TADs, were originally proposed 
based on C-technologies and defined as linear regions that display a high number of 
physical interactions within and little contact with regions outside (Dixon et al., 2012). 
TADs seem to behave as “units”, both in terms of regulation, as they typically belong to 
only one compartment (either A or B) in a given cell type (Dixon et al., 2015), and in 
replication, as they share a near one-to-one correspondence with replication domains (Pope 
et al., 2014).  
Interestingly, whereas TAD boundaries tend to be stable over many cell divisions, 
invariant across cell types, and conserved across species (Dixon et al., 2016; Melé and 
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 Rinn, 2016; Vietri Rudan et al., 2015), their association with either A or B compartment is 
highly plastic across cell types (Dixon et al., 2015) and development (Dixon et al., 2015; 
Pękowska et al., 2014). However, even though it is helpful for data visualisation and 
interpretation to demarcate chromatin regions into TADs, pinpointing their precise 
boundaries has proven difficult. This is due to the fractal organisation of chromatin 
structure, which makes the definition of boundaries highly dependent on arbitrary 
thresholds and the choice of parameters (Kruse et al., 2016) (Figure 1.2).  
    
 
 
    
Figure 1.2. The definition of domain boundaries by binning 
algorithms creates the triangular pattern typical of TADs. 
However, the precise boundaries are often hard to delimit. 
       
 
 
An additional complication is that 
high-throughput experiments typically pool cells across all cell cycle stages. Since TADs 
are only being established at early G1, visible during interphase and G2, and lost during 
mitosis (Dileep et al., 2015) they are thus inferred by averaging across a heterogeneous 
population of TAD maturation. Despite these difficulties, one general signature of TAD 
boundaries has emerged: they are strongly bound by cohesin and CTCF (Dixon et al., 
2015; Rao et al., 2014), which I will further discuss in this text. Indeed, the nested sets of 
cohesin-associated CTCF-CTCF loops (recently termed ‘insulated neighborhoods’ (Dowen 
et al., 2014; Ji et al., 2016)) can be considered as TADs with well demarcated boundaries.  
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 1.1.2 Intermediate scale organisation: Enhancer-promoter interactions 
One of the best studied classes of intra-TAD contacts are enhancer-promoter loops that are 
typically facilitated by CTCF and cohesin, which enable the interaction of enhancer- and 
promoter-bound transcription factors (TFs) (Dowen et al., 2014; Hnisz et al., 2016). 
Enhancer-promoter interactions play an essential role in orchestrating the lineage-specific 
gene expression programs that underlie cellular identity, recently reviewed in (Gorkin et 
al., 2014). Interestingly, the physical contacts sometimes precede the activation of the 
target gene during the developmental process (Ghavi-Helm et al., 2014). 
Even though enhancers have the ability to function in either direction and over long 
distances, their activity is typically restricted to gene targets within the same TAD, as 
shown by single-loci studies (Lupiáñez et al., 2015; Tsujimura et al., 2015). This has been 
reproduced in a genome-wide study that identified genetic variants that regulate histone 
marks (hQTLs) over long distances to reside within the same TAD as their target 
regulatory elements (Grubert et al., 2015), and in a transposon based screen that measured 
transcriptional activity at random genomic locations and found enhancers to activate genes 
pervasively within but very rarely across TADs (Symmons et al., 2014). TADs may thus 
explain how enhancers are prevented from establishing ectopic interactions. 
1.1.3 Intragenic organisation: gene promoter-terminator loops 
The chromatin architecture within a single gene represents the smallest level of 
organisation which, due to limitations in resolution, is difficult to study using an unbiased 
genome-wide approach. Therefore, insights come mainly from single-locus studies using 
3C, 4C, or from factor-specific ChIA-PET experiments. ChIA-PET on CTCF and on Pol II 
have revealed ubiquitous chromatin looping within genes, in particular between promoters 
and intronic regions (Mercer et al., 2013). Together with the fact that CTCF is highly 
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 prevalent at transcription start sites (Bornelöv et al., 2015; Ruiz-Velasco et al., 2017; Wang 
et al., 2012), this suggests a role of CTCF in intragenic gene regulation. In particular, this 
is where I centered a big fraction of my research during the PhD and which I describe in 
detail in chapters 2 and 3, by describing how intragenic interactions have an effect on 
alternative splicing, therefore linking structure with function. 
  
1.2 Mechanisms needed to shape and maintain the nuclear architecture 
Even though the precise mechanisms of chromatin structure formation are not fully 
understood, two of the most important players, cohesin and CTCF, are well known.  
 
1.2.1 CTCF and its binding grammar 
CTCF is a ubiquitously expressed and embryonic lethal protein that encodes 11 zinc 
fingers (ZF) and which binds a well-defined core motif of 15 base pairs (Moore et al., 
2012; Nakahashi et al., 2013). CTCF-mediated loop formation requires two CTCFs, each 
bound at one end of the chromatin loop to dimerize, which is only possible if they are 
facing each other in a convergent orientation (de Wit et al., 2015; Guo et al., 2015; Rao et 
al., 2014). Interestingly the use of diverse combinations of its ZFs as binding sub-domains 
has been shown to allow CTCF to interact with a number of diverse DNA sequences, 
mostly comprising the core motif and either upstream or downstream sub-motifs, in which 
has been described as the ‘CTCF-binding code’ (Nakahashi et al., 2013). 
Importantly the disruption of CTCF can unravel several consequences and 
ultimately has been linked with disease states and cancer (Norton and Phillips-Cremins, 
2017). On the one hand mutations affecting the core motif at the DNA sequence level - 
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 which is recognised by ZF3-ZF7 in human (Hashimoto et al., 2017) - show the most 
dramatic reductions in CTCF binding, while disruption of sites recognised by ZF9-11 
decrease its binding but to a different extent. On the other hand the binding of CTCF can 
be regulated through epigenetic modifications, in particular through DNA methylation. Of 
relevance, a recent crystallographic study demonstrated an existing bias for the effect of 
DNA methylation within the core motif, with CpGs reducing CTCF binding affinity when 
they occur at position 2, but increasing its association if they fall at position 12 (Hashimoto 
et al., 2017). 
Ultimately the role of CTCF has shown to be at the center of chromatin 
organisation helping to set up the specific loops which then define chromatin structure 
from small-scale loops to TAD boundaries, and in particular in the loop extrusion process 
as evidenced by its preferential location to TAD boundaries (Dixon et al., 2012) and by 
loss-of-function experiments that demonstrate its involvement in loop anchoring through 
convergent interactions (de Wit et al., 2015; Guo et al., 2015). 
 
1.2.2 Structural Maintenance of Chromosomes protein complexes 
Structural Maintenance of Chromosomes (SMC) complexes comprise multiple subunits 
that form a ring-like structure and which include cohesin and condensins (Yuen and 
Gerton, 2018). Cohesin forms and stabilises unspecific chromatin interactions (Zuin et al., 
2014) and it typically interacts with CTCF. This interaction is primarily driven through the 
CTCFs C-terminal tail (Xiao et al., 2011), which may allow it to place cohesin on a 
particular side of the chromosomal domain and thereby anchor and stabilize the chromatin 
loop (Vietri Rudan et al., 2015).  
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 Besides cohesin, recent evidence has shown that condensin plays a major role in 
organising chromatin by serving as a molecular motor for loop extrusion (Ganji et al., 
2018). However, major differences exists between cohesin and condensin which makes it 
necessary to have additional and substantial evidence to proof that cohesin is also capable 
of functioning as a motor in the loop extrusion process.  
Condensin is able to load and unload intrinsically by encircling DNA double helix 
and securing it with a ‘safety belt’ mechanism to prevent its dissociation in mitotic 
chromosomes (Kschonsak et al., 2017). Meanwhile, cohesin is loaded onto DNA by the 
SCC2/SCC4 complex (also known as NIPBL and MAU2), and to released from DNA by 
WAPL (Haarhuis et al., 2017). Another factor to consider is that interphase, where most 
cohesin-based assumptions are based, and mitosis, where condensin has been shown to be 
crucial, are two stages which account for very different fractions of the cell-cycle. 
Therefore, condensin processivity during loop extrusion must require a faster speed than 
the one needed for cohesin, as recently discussed by Prof. T. Hirano in a seminar. 
 
1.2.3 Loop extrusion 
The most convincing model of chromatin structure formation proposed to date is the “loop 
extrusion model” (Fudenberg et al., 2016; Sanborn et al., 2015). This model initially stated 
that an “extrusion complex” - of unknown structure but which contains two tethered DNA-
binding subunits - is loaded onto chromatin in close proximity to form a tiny chromatin 
loop. DNA sliding in opposite directions would make the loop grow bigger until it hits 
appropriately oriented CTCF motifs where it binds tightly and halts the extrusion complex. 
The speculated extrusion complex includes a cohesin-CTCF pair that is either loaded 
simultaneously, or sequentially to slide in opposite directions simultaneously.  
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  Various studies trying to further understand this mechanism and to validate the 
model have recently emerged. The most conclusive proof to date is a study using real-time 
imaging in which they visualise the formation of DNA-loops with condensins (Ganji et al., 
2018). Here they observe that an “extrusion complex” consisting of condensin, ATP, 
Mg2+, and DNA, which is stably anchored in one extreme, is asymmetrically translocated 
by the motor site of condensin, forming a loop that can extend up to several kilobases. The 
chromatin loop will continue extruding until it hypothetically encounters appropriately 
oriented CTCF motifs (in a convergent orientation) where it binds tightly and halts the 
extrusion complex (Fudenberg et al., 2016) or when condensin spontaneously releases the 
extruded loop (Ganji et al., 2018).  
The previous study was able to demonstrate that loop extrusion can occur upon a 
single condensin complex, which anchors DNA through a charged groove formed by the 
Ycg1 HEAT-repeat and Brn1 kleinsin subunits as a safety belt to start translocating the 
DNA at an in vitro rate of up to ~1.5kb/s (Ganji et al., 2018; Kschonsak et al., 2017). 
While additional studies have proposed that other SMC proteins could potential have 
extruding capacity, like cohesin or the Smc5/6 complexes (Yuen and Gerton, 2018), the 
most conclusive evidence that relates cohesins to loop extrusion comes from HiC 
experiments done in HAP1 cells for wild-type, WAPL-mutants, and SCC4-mutants, which 
demonstrate that loop size results from the dynamics of loading/unloading cohesin into 
chromatin (Haarhuis et al., 2017). Therefore further studies need to be done to validate that 
cohesin is also a loop extrusion motor in interphase chromosomes.  
In addition to cohesin and CTCF, other proteins, repetitive elements, and histone 
marks associated with transcription are enriched at TAD boundaries although cause and 
effect of these associations often remain speculative. Co-binding of CTCF with YYI 
(Moore et al., 2015; Schwalie et al., 2013), ZNF143 and Polycomb group proteins (Mourad 
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 and Cuvier, 2016) may contribute in the establishment of TAD boundaries. Repetitive 
elements could act as specific anchor points that spatially organize chromosomes (Cournac 
et al., 2016; Darrow et al., 2016; Giorgetti et al., 2016). The enrichment for the 
transcription marks H3K4me3 and H3K36me3 in TAD boundaries suggests an association 
with highly expressed regions (Moore et al., 2015) and transcription itself has been 
suggested to play a role in TAD organisation as reviewed in (Melé and Rinn, 2016). One 
well studied example is the Xist RNA, whose transcriptional induction initiates the 
formation of TAD boundaries and the loss of DNA accessibility in the inactive X 
chromosome (Giorgetti et al., 2016). 
Another mechanistic question is how individual TADs switch between 
compartments as observed in cellular differentiation processes. One possibility is that 
chromatin domains get repositioned with respect to chromosome surfaces, with an overall 
tendency of active genomic regions involved in inter-chromosomal contacts (Osborne et 
al., 2004; Pękowska et al., 2014) and heterochromatic regions to localise to the nuclear 
periphery in structures known as ‘lamina associated domains’ (LADs) (Peric-Hupkes et al., 
2010). The direction and degree of repositioning of chromatin domains appears to be 
determined by associated trans-acting factors and is suggested to depend on the 
surrounding genomic context, as demonstrated by the repositioning of sub-TADs into 
different nuclear compartments depending on the recruiting factor (either NANOG, EZH2, 
or SUV39H1) (Wijchers et al., 2016). Interestingly, establishing cell-type specific 
chromatin interactions seems to require cell division (Neems et al., 2016). Unsurprisingly, 
given its prominent role in chromatin structure organisation, CTCF is likely involved in the 
process of compartment switching, as shown for circadian loci where PARP1 interacts 
with CTCF to regulate dynamic chromatin interactions with LADs, which promotes 
transcriptional oscillations (Zhao et al., 2015). 
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 In mammals around 15% of CTCF-binding sites are located at TAD boundaries. 
The remaining 85% that reside within TADs are equally frequently located in intragenic 
and intergenic regions. This distribution suggests that CTCF plays an important role in 
nuclear organisation at all levels of chromatin organisation, and that changes in its binding 
pattern are likely to contribute to the regulatory programs that control the differences 
across tissues, species, and developmental stages. Interestingly, we have recently observed 
that CTCF binding is much more variable between individuals within TADs than at TAD 
boundaries (Chapter 4, Figure 4.1). 
This suggests that the regulation of the highest level of chromatin organisation is 
less dependent on CTCF binding than on the different factors described above, while intra-
TAD interactions are more likely regulated by mechanisms that directly affect CTCF 
binding affinity, such as DNA methylation. This is supported by the fact that methylation-
sensitive CTCF sites are mostly within TADs (Maurano et al., 2015; Wang et al., 2012). 
 
1.3 Elucidating the function of 3D-chromatin architecture 
The robust evidence that chromatin topology is pervading cellular function comes from a 
few recent studies that linked DNA mutations at TAD and loop boundaries to dramatic 
phenotypic changes. However, overall we know much less about the functional impact of 
chromatin architecture than what we know about its structure. 
 
1.3.1 Functional impact of TAD rearrangements 
As described above, TADs tend to act as regulatory units, either belonging to compartment 
A (active) or B (inactive); it is thus a tempting hypothesis that genes involved in a specific 
process might be contained within a single TAD to allow smooth switching between 
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 cellular programs. Indeed, some TADs are enriched for lineage-specific genes (Neems et 
al., 2016) thus potentially facilitating the regulation of cell differentiation. Similarly, poor 
reconfiguration of specific chromatin contacts was identified as a potentially rate-limiting 
step in reprogramming of neural progenitor to induced pluripotent stem cells (Beagan et 
al., 2016). 
In addition to these descriptive studies, the recent progress in genetic engineering 
with the CRISPR/Cas9 system allowed to assess the consequences of removing individual 
contacts or entire TAD boundaries at specific loci, which revealed that disrupting TAD 
boundaries can result in aberrant chromatin domain topology. The effects of these 
disruptions range from transcriptional misregulation (Narendra et al., 2015; Nora et al., 
2012; Tsujimura et al., 2015) to whole-organism pathogenic phenotypes, such as 
polydactyly (Lupiáñez et al., 2015). In fact, already the disruption of specific single intra-
TAD interactions has functional consequences on gene expression (de Wit et al., 2015; 
Guo et al., 2015). Similarly, the disruption of the cohesin complex led to deregulation of 
gene expression at the Cd3 super-enhancer region as a result of partial dispersal of 
enhancer elements (Ing-Simmons et al., 2015). 
1.3.2 Distribution of functional genetic variants at TADs and loop boundaries 
Genome-wide association studies (GWAS) have identified thousands of single nucleotide 
polymorphisms (SNPs) associated with diseases (Hindorff et al., 2009). GWAS SNPs, 
most of which lie in the non-coding genome, are highly enriched for quantitative trait loci 
(QTLs) for molecular phenotypes such as gene expression, histone marks, or DNA 
methylation ((Grubert et al., 2015; GTEx Consortium, 2015; Karczewski et al., 2013; 
Lappalainen et al., 2013; Maurano et al., 2012; Waszak et al., 2015), among others). Many 
of these molecular QTLs, often being far from gene promoters, affect the activity of distal 
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 genes and other regulatory elements with which they are physically interacting (Grubert et 
al., 2015). 
A tempting explanation of how GWAS SNPs distal to any gene may affect 
complex phenotypes is by disrupting either CTCF or cohesin binding sites that are 
anchoring DNA-loops, which in turn may lead to mis-regulation of various molecular, and, 
ultimately, complex phenotypes. In support of this hypothesis CTCF and cohesin sites that 
are variable across individuals (Kasowski et al., 2013), regulated by a QTL (Ding et al., 
2014), or physically interacting with promoters (Mifsud et al., 2015) are significantly 
enriched for GWAS SNPs. 
 
1.3.3 Influence of chromatin architecture in cancer genomes 
In addition to common diseases, CTCF binding sites have also been identified as major 
mutational hotspots in the noncoding cancer genome (Katainen et al., 2015) with recurrent 
mutations in CTCF sites occurring most frequently at TAD boundaries (Hnisz et al., 2016). 
Strikingly, in T-cell acute lymphoblastic leukemia, such perturbations have been shown to 
activate proto-oncogenes due to inappropriate enhancer-promoter interactions (Hnisz et al., 
2016). I will further discuss the impact of somatic mutations affecting CTCF motifs and 
therefore potentially disrupting intragenic loops in chapter 3. 
  
1.4 Understanding how the 3D architecture conveys its functional impact 
The general mechanisms of how chromatin architecture impacts on downstream molecular 
processes, as in the examples cited above, are often still poorly understood. Here we 
review the current understanding and propose two potential models that could be useful for 
further studying the mechanism of how chromatin structure exerts its function. 
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 The interplay of CTCF with general transcription factors is one mechanism of how 
chromatin structure may regulate transcription, as evidenced by the observation that TFII-I 
is responsible for targeting CTCF to the promoter of metabolic genes, which in turn 
triggered their expression and altered the cells response to metabolic stress (Peña-
Hernández et al., 2015). Another mechanism, as proposed for the SMAD4A locus, is a 
CTCF-dependent promoter-gene body loop that accelerates transcriptional activation e.g. 
upon stimulation (Larkin et al., 2012). 
Apart from isolated examples like these, however, it often remains unclear whether 
structure precedes function or vice versa. While most observations are consistent with an 
interdependence of structure and function, a recent study suggested that the picture is even 
more complex by finding that the transcriptional status of a region and its compartment 
membership are not always causally related (Wijchers et al., 2016). 
On a genome-wide level we and others have recently shown that chromatin 
variation across individuals, often caused by a genetic perturbation of single TF-DNA 
interactions, can act as a seed for coordinated regulatory changes mediated largely by long-
range chromatin contacts (Grubert et al., 2015; Waszak et al., 2015). In chapter 4 we 
propose two models that could explain these observations: the “touch-and-act” and the 
“spreading model”. We also test potential mechanisms that could be affected by distal-
QTLs like CTCF dimerisation or protein-protein interactions involved in transcriptional 
activation. 
 
1.5 Chromatin organisation is affected with age 
Ageing is characterized by the progressive functional decline at all organismal levels 
(Booth and Brunet, 2016). The time-dependent accumulation of cellular damage is widely 
considered to be the general cause of ageing (López-Otín et al., 2013). Multiple years of 
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 research aiming to understand the precise cellular and molecular causes of ageing at 
multiple biological scales can be summarised in a series of common processes that has 
ultimately been named as the ‘hallmarks of ageing’ (Booth and Brunet, 2016; López-Otín 
et al., 2013). Of important notice, genomic instability, stem cell exhaustion, and telomere 
attrition are some of these hallmarks, which we will bring back in detail in Chapter 5. 
 Although many studies have tried to identify genes that confer longevity or 
robustness in various organisms, some theories on the etiology of ageing challenge this 
view mainly by arguing that natural causes would eliminate most animals before they grow 
old and if there are such ‘beneficial’ genes, they should be pleiotropic and confer 
additional advantages early in life (Yuen and Gerton, 2018). Consequently, ageing should 
comprise mostly epigenomic changes and it should be subjected to a great influence from 
the environment and lifestyle of the organism. In this line, changes occurring at all levels 
of chromatin organisation have been reported, involving major rearrangements of LADs, 
changes in the transcriptional regulatory landscape, and even alternative splicing changes 
within genes, which we discuss in chapter 5.  
Firstly, the implication of nuclear lamins in the ageing process came from the 
Hutchinson-Gilford Progeria Syndrome (HGPS), characterised by the constitutive 
production of progerin, a mutant form of lamin A, that causes premature ageing (Scaffidi 
and Misteli, 2006, 2008). HGPS affects several tissues, particularly those of mesenchymal 
origin and causes changes in the differentiation potential, with enhanced osteogenesis and 
decreased adipogenesis (Scaffidi and Misteli, 2008). Moreover, the same molecular 
mechanism responsible for HGPS act at a low level in healthy cells (Scaffidi and Misteli, 
2006), implicating lamins in the normal physiological ageing. Loss of lamin B1 has also 
been shown to decrease with age and proposed as a marker for cellular senescence in vitro 
and in vivo (Dreesen et al., 2013).  
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 The transcriptional regulation is also affected by age in multiple ways. For 
example, DNA methylation has also a profound contribution in ageing, as has been 
described extensively by (Horvath, 2013). Additionally, we know that some TFs show 
changing levels like FOXO3, which is linked to metabolism and for which a genetic 
variant is commonly found in centenarian humans (Willcox 2008) or affecting NRF, which 
causes the activation of genes involved in cellular protection (Booth and Brunet, 2016). 
Interestingly NRF is affected by DNA methylation (Domcke et al., 2015) and some TFs in 
this family (NRF2) can bind SWI/SNF nucleosome remodelling complexes (Booth and 
Brunet, 2016).  
Finally specific reports of changing isoforms with age exists for genes such as 
TP53 (von Muhlinen et al., 2018) or mTOR kinase (Razquin Navas and Thedieck, 2017). 
However the knowledge of the extent to which alternative splicing is altered with age is 
still under investigation, some of these findings are described in this dissertation. 
 
1.6 Using 3D-architecture to understand human variation and disease 
We predict that unraveling how chromatin structure is formed and maintained, and how it 
affects downstream molecular processes - either through genetic or epigenetic variation - 
will provide important insights for understanding common genetic diseases. Towards this 
end, studying the effect on intermediate molecular phenotypes will be key to understand 
the consequences of perturbing the 3D architecture on organismal traits and diseases. 
Fortunately, the increasing availability of chromatin conformation data along with 
transcriptome, ChIP-seq, and genotype data will provide a vast repertoire of information to 
answer the questions posed here. The implications of such research will be relevant to 
study changes in the nuclear organisation not only during development and differentiation, 
but also in pathogenic cellular processes like cancer, aging, and complex diseases. 
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 2. CTCF-mediated intragenic chromatin loops between 
promoter and gene body regulate alternative splicing 
across individuals 
 
This chapter discusses my main project during the PhD and details how we identified, 
characterised, and explored a new transcriptional regulatory mechanism, where CTCF-
mediated interactions within genes are able to affect splicing decisions. The text of the 
following chapter has been originally written by myself and was taken and adapted from: 
 
Mariana Ruiz-Velasco, Manjeet Kumar, Mang-Ching Lai, Pooja Bhat, Ana-Belén Solís-
Pinson, Alejandro Reyes, Stefan Kleinsorg, Kyung-Min Noh, Toby J. Gibson, and Judith B. 
Zaugg (2017). CTCF-Mediated Chromatin Loops between Promoter and Gene Body 
Regulate Alternative Splicing across Individuals. Cell Systems 5, 628-637. e6. 
The sections including results from collaborators are explicitly stated and mostly involve 
Dr. Manjeet Kumar and Dr. Mang Ching Lai with advice from Dr. Toby Gibson and Dr. 
Kyung-Min Noh (all from EMBL). Additionally, I received support for the analyses from 
Dr. Alejandro Reyes, Pooja Bhat, Ana-Belén Pinson Solís, and Stefan Kleinsorg. Cell 
Systems, as part of Elsevier, states that I retain the right to include text and figures in my 
thesis, provided it is not published commercially and that the reference is present. 
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 2.1 Introduction 
As discussed in the first chapter, it has become evident that the 3D-organisation of 
chromatin is highly regulated and is thus likely to have a functional role in downstream 
cellular processes, such as gene regulation (Neems et al., 2016; Nora et al., 2012). 
However, our knowledge about the functional impact of chromatin architecture has largely 
remained descriptive, as most studies have focused on describing long-range enhancer-
promoter interactions or megabase resolution chromatin domain organisation (Beagan et 
al., 2016; de Wit et al., 2015; Dixon et al., 2012; Grubert et al., 2015; Ji et al., 2016; Rao et 
al., 2014), with only a few examples that provide a mechanistic understanding for single 
loci (Monahan et al., 2012; Ruiz-Velasco and Zaugg, 2017; Symmons et al., 2014). 
These studies have revealed an extensive function for CTCF in forming chromatin 
loops (de Wit et al., 2015; Guo et al., 2015; Rao et al., 2014). Therefore, the relative 
convergent orientation of a pair of CTCF binding sites restricts its choice of interacting 
partner and can thus be used to predict whether they can potentially form a chromatin-loop. 
Here we proposed a novel functional role for CTCF-mediated intragenic chromatin 
interactions in regulating alternative exon usage. Overall, by integrating multiple layers of 
genome-wide molecular phenotype data with genotypes, as well as curated genome and 
protein annotations, our study proposes a functional role for CTCF-mediated intragenic 
chromatin looping in alternative splicing, particularly regulating the inclusion of domains 
in modular proteins involved in signalling and cellular stress response. 
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 2.2 Results 
2.2.1 Intragenic CTCF motif orientation suggests pervasive promoter-exon looping 
Here we sought to assess the potential of CTCF-dependent chromatin-looping on the 
intragenic scale. To do so, we first examined the distribution and orientation of CTCF 
motifs within genes. For this purpose we defined four regions of interest (detailed in 
section 2.4.1): 
· promoter window: +/- 1kb from transcription start site (TSS) 
· transcription termination site (TTS) window: +/- 1kb of TTS 
· intronic windows upstream of exons: 2kb intronic regions upstream of exon 5’ 
end 
· intronic windows downstream of exons: 2kb intronic regions downstream of 
exon 3’ end 
First exons, first introns and anything within 5kb from the TSS were filtered out. 
We next scanned for CTCF binding sites within these windows (Methods: 2.4.1), 
and to minimise the number of non-functional CTCF binding sites, we only considered 
sites that overlap with a CTCF peak in Lymphoblastoid cell lines (LCLs) obtained from a 
previous study (Kasowski et al., 2013). Directionality was assigned relative to the gene 
strand defining sense CTCF motifs if both the motif and the gene had the same orientation 
and antisense motifs vice versa. Strikingly, we observe a strong bias for sense CTCF 
motifs at promoters (p-value = 7e-7, binomial test) with a very sharp increase within 500bp 
upstream of the TSS (p-value = 8.3e-11), while the window upstream and, to a much lesser 
extent, downstream of exons contained preferentially antisense motifs (p-value = 2e-5 and 
1e-2, respectively; Figure 2.1A). Consistently, when analysing whole introns (scaled to the 
same length) we find the fraction of antisense motifs to increase with proximity to the 5’ 
exon boundary (Figure 2.1B). TTS windows showed very few CTCF sites overall and no 
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 preference for any motif orientation. Interestingly, we did not find any evidence for such a 
pattern to occur in long noncoding (lnc)RNAs (Figure S2.1A), indicating that the three-
dimensional chromatin structure for lncRNA genes is fundamentally different from protein 
coding genes. The following analyses are therefore based on protein coding genes only. 
The strong enrichment observed for sense CTCF motifs at promoters and antisense 
motifs proximal to exons suggests pairs of convergent CTCF bound sites between 
promoter and exon proximal regions, which in turn would trigger the formation of exon-
promoter chromatin loops. To evaluate this, we grouped motifs into the following pairs 
according to their genic region: promoter exon-upstream, promoter exon-downstream, 
promoter-TTS, exon-upstream TTS, and exon-downstream TTS (schematic in Figure 
2.1B). And indeed, when we classified these CTCF-motif pairs as “convergent”, 
“divergent”, “both sense”, and “both antisense”, we found both classes of promoter-exon 
pairs strongly enriched for the convergent configurations (Odds Ratio (OR) =1.5 and 1.3, 
p-value = 3.4e-4, and 1.4e-2 for exon-upstream and downstream respectively, Fisher’s 
exact test, Figure 2.1C) and significantly depleted for divergent pairs. In line with exons 
containing preferentially antisense motifs, the exon-TTS motif-pairs were enriched for 
divergent pairs (OR=1.5 and 1.8, p-value = 8.3e-3 and 8.6e-5 for exon-upstream and -
downstream) and depleted for convergent pairs, while very few pairs were observed for the 
promoter-TTS configuration. Together, these results provide evidence for CTCF-mediated 
DNA loop formation between promoters and exon proximal regions; overall we identified 
181 promoter exon-upstream loops involving 136 promoters. By considering a less 
stringent threshold (i.e. lowering the motif score and considering a broader promoter 
region of +/- 1kb), the number of potential exon-promoter loops increases to 1,463 
involving 956 promoters (LCL-specific set; Figures S2.1B-C, methods: 2.4.1).  
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Figure 2.1. CTCF motifs show preferential directionality along transcripts 
Distribution of motifs in sense (blue) and antisense (red) orientation for (A) four genic regions (see schematic): 
promoter, upstream of exon, downstream of exon, and TTS, and (B) along introns [%]. (C) Orientation of CTCF 
interactions based on the motif pairs: promoter-exon:upstream, promoter-exon:downstream, promoter:TTS, exon-
upstream:TTS, and exon-downstream:TTS. (D) Number of motif pairs with physical interaction based on ChIA-PET 
data of Rad21, H3K4me3, and CTCF (left), and CHiC (right). (E) Schematic of contingency table for testing the 
association of DUEs and promoter-exon:upstream (left) and promoter-exon:downstream (right) loops. Background color 
represents ratio of observed vs expected. (F) Enrichment of sQTLs (FDR=10%) overlapping with a particularly oriented 
CTCF motif (+/-20bp from midpoint) upstream (left) or downstream (right) of a middle exon (star = p-value < 0.05; 
Fisher’s exact test). This figure was produced by myself and is published in (Ruiz-Velasco et al. 2017).
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 To validate the loops predicted from the motif analysis, we obtained ChIA-PET 
data for the cohesin subunit Rad21 and histone mark H3K4me3 (Grubert et al., 2015), 
ChIA-PET for CTCF (Tang et al., 2015), and promoter capture-HiC (CHiC) data (Mifsud 
et al., 2015). For all datasets, the physical contacts were measured in one of the cell lines 
that was used in the analysis above (GM12878). Using these contact maps, we captured 
57% of our convergent predicted loops, a reasonable number given the high false negative 
rate in ChIA-PET and CHiC data (Phanstiel et al., 2015). In accordance with our 
predictions, we observed that most of the interactions occur between promoters and exon-
proximal regions and that most of these interactions have a convergent orientation 
(OR=7.4 for ChIA-PET and 1.6 for CHiC, p-value = 2.5e-9 and 4e-2, Fisher’s exact test; 
Figure 2.1D). 
 Given this evidence of CTCF-mediated promoter-exon loops along with a previous 
report associating CTCF with alternative splicing at the CD45 locus (Shukla et al., 2011), 
we hypothesised that CTCF might regulate alternative exon usage through the formation of 
intragenic promoter-exon loops. In support of this hypothesis, we found that exons 
involved in a predicted promoter exon-upstream loop (convergent CTCF motifs) are more 
likely to be alternatively used across individuals (OR=1.5, p-value = 5e-2, Fisher’s exact 
test; Figure 2.1E). No such enrichment is observed for promoter exon-downstream loops. 
Interestingly, a recent study found that genetic variants affecting alternative splicing across 
individuals (splicing quantitative trait loci, sQTLs) often coincide with QTLs for CTCF (Li 
et al., 2016), suggesting a genome-wide role of CTCF in alternative splicing. Remarkably, 
when we overlapped the sQTLs with exon-upstream CTCF binding sites forming pairs 
with promoters, we observed a strong enrichment for sQTLs to participate in convergent 
interactions (OR=2.4, p-value = 2e-2, Fisher’s exact test), whereas all other configurations 
- including all of the downstream pairs - were not enriched for sQTLs (Figure 2.1F). 
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 Together, these results suggest a relationship between CTCF-mediated promoter-exon 
looping and alternative exon usage. 
One important prediction of such a mechanism is, that alternative exon usage will 
occur more often for exons that have the potential to form a loop with their promoter, i.e. 
convergent pair of CTCF motifs between exon and promoter, than for any other exon. In 
the following chapter we test this mechanism in the context of human genetic variation and 
explore the functional consequences on the protein isoforms in the human system. 
  
2.2.2 CTCF-mediated intragenic chromatin loops regulate alternative exon usage 
To test the model that CTCF-mediated DNA-loop formation can regulate alternative 
splicing decisions in a genetic context, we derive two hypotheses: (1) we expect that, 
across different individuals, CTCF binding correlates with exon usage for exons that can 
form a loop with their promoters, i.e. where motifs are in a convergent orientation and (2) 
we expect that such a correlation does not exist for other exons. To perform these tests we 
employed the CTCF ChIP-seq data for 18 individuals described above with matching 
RNA-seq data (Kasowski et al., 2013). 
To obtain the variation across individuals on the exonic level, we calculated 
differential exon usage between each individual and the median across all (Figure 2.2A). 
Briefly, we used Gencode v19 to obtain exons from protein-coding, autosomal transcripts 
that were expressed in LCLs (as assessed with kallisto (Bray et al., 2016)), keeping only 
exons whose length was within the expected range of 20-5000nt (Derrien et al., 2012) and 
covered by an average of at least ten reads, leaving 86,285 exons of which 62,663 (73%) 
were middle exons (Methods: 2.4.3). We used DEXSeq (Anders et al., 2012) to calculate 
differential exon usage (defined as the ratio of exon vs gene expression) across the 18 
individuals, testing for the difference between each individual and the median across all 
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 individuals. We identified 3,844 significantly differentially used exons (DUEs; FDR 10%), 
of which 2,081 were middle exons (Figures S2.2A-D for DUE characterisation). The log2 
fold-change values of exon usage for each individual against the median were used for the 
correlation analysis below. 
For the variation on the CTCF level we calculated the differential CTCF binding 
across individuals in a similar way: we averaged the signal of CTCF (extracted with 
SNPhood (Arnold et al., 2016)) within 2kb upstream or downstream of the 5’ and 3’ 
boundaries of the exons respectively, and calculated the log2 fold-change between each 
individual and the median across all individuals (Methods: 2.4.4). 
We calculated the Spearman correlation between the variation in CTCF binding at 
the 5’ and 3’ boundary and the variation in exon usage for all DUEs (Figure 2.2B). The 
correlations were generally not driven by outliers as shown for a few representative 
examples (Figure 2.2C). Importantly, we find that exons with upstream convergent pairs 
show a strong bias towards positive correlations, whereas the correlations of CTCF with 
non-looping exons were distributed similar to empirical correlations obtained from 100 
permutations (Figures 2.2D, S2.2E), thus supporting the predictions from our model. 
In summary, these results based on variation across individuals support the model, 
that CTCF-dependent alternative exon usage is mediated by intragenic promoter-exon 
loops. Notably, we find that the evidence holds only for exons where the looping CTCF 
site is located upstream of its 5’ boundary. 
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 Figure 2.2: Relationship between CTCF and differentially used exons 
Workflows used to (A) identify differentially used exons (DUEs) across individuals and (B) to calculate correlations 
between CTCF binding and exon usage. Three groups: exons-promoter pairs with convergent motifs (red), without motifs 
(blue), and 100 permutations (grey). (C) Examples of the log2 fold-change of CTCF binding and exon usage are shown. 
(D) Distribution of all the Spearman correlations for CTCF bound upstream (left) and downstream (right) of the exon 
grouped into convergent (red), exons without motif pairs (blue) and 100 permutations (grey). Convergently oriented 
upstream-exons show a significant shift towards positive correlations (p-value and N are shown, otherwise stated as N.S.; 
Wilcoxon test). These panels were generated by myself and are published in (Ruiz-Velasco et al. 2017).
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 2.2.3 Allele-specific analysis confirms the model of CTCF-dependent alternative exon 
usage mediated by DNA interactions 
In the previous section we show that exon usage is correlated with CTCF binding only for 
exons predicted to form a loop with their promoter. To directly test the link between 
chromatin-loop formation and exon usage, we sought to make use of genetic variation to 
quantify the allelic fractions of chromatin contact frequencies and exonic expression. 
However, to do so we first had to establish that the correlation of variation in CTCF and 
exon usage is indeed driven by genetic variants. A strong overlap of CTCF-QTLs and 
sQTLs has already been reported earlier (Li et al., 2016) and our results showing a 
significant enrichment for convergent motifs containing sQTLs (Figure 2.1F) provide 
further evidence. 
To obtain direct evidence for or against a genetic basis of CTCF binding and exon 
expression, we checked whether, at heterozygous positions, they show an allelic bias in the 
same direction. Briefly, we selected all CTCF peaks within 2kb upstream or downstream 
of an exon boundary that overlapped with a heterozygous SNP in at least one individual 
and showed an allelic bias at a nominal p-value of 0.05 (Methods: 2.4.5). In line with 
genetic variation in the CTCF peak being the driver for the variation in exon usage, we 
observe a significant positive correlation between the allelic fractions of CTCF and exon 
expression level for upstream and, to a lesser extent, for downstream regions (Pearson’s R 
= 0.5 and 0.3 respectively; top panel Figure 2.3A). As a more robust quantification of the 
correlation we binned the exon allelic fraction by the direction of the CTCF allelic bias 
(allele 1 < allele 2 and vice versa) and assess their difference by a t-test (bottom panel 
Figure 2.3A). In line with the hypothesis of CTCF-mediated looping affecting alternative 
exon usage, we found a stronger association between the allelic fraction of CTCF binding 
and exonic expression for set of exons predicted to form a loop between an upstream 
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 CTCF site and their promoter (Figures 2.3C, S2.3B-C). These findings suggest a 
mechanism where a genetic variant disrupts CTCF binding upstream of an exon, which in 
turn prevents the exon from being included in the transcript. 
To test whether the difference in CTCF binding indeed translates into differences in 
chromatin loop formation, and whether these differences translate into alternative exon 
usage, we performed the same allelic bias associations with exon usage and HiC data for 
one of the individuals in our study (GM12878) (Rao et al., 2014). As expected from 
previous studies we found that the allelic bias in HiC and CTCF is positively correlated 
only when CTCF is in a convergent orientation between the promoter and exon (Figure 
2.3C). Notably, and as a strong line of evidence for our model, we found a positive 
correlation of the allelic bias in exon expression and CTCF binding only for exons in 
predicted promoter exon-upstream loops (Figures 2.3B, S2.3B). This suggests that indeed 
exon usage in those sites is dependent on a mechanism that involves a loop between the 
exon and its promoter. 
To validate these global correlations based on allele-specific analyses, Dr. Mang C. 
Lai and I performed 4C-seq experiments for six individuals in a gene that showed 
differential usage of exon 5 across these individuals (THRAP3; methods: 2.4.6). We found 
extensive chromatin interactions between the THRAP3 promoter and several regions within 
the gene (Figure S2.3C). Importantly, for the differentially used exon 5 we found a 
stronger 4C-seq signal upstream for the individuals that include the exon than for those that 
do not include it (Figure 2.3D). No such difference between 4C-seq count was observed for 
other exons (Figure S2.3D). Together with the global allele-specific results above, this case 
study adds to the evidence that a difference in CTCF binding leads to changes in exon 
inclusion through a mechanism involving an intragenic promoter-exon loop. 
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Figure 2.3. Genetic variants jointly affect CTCF-binding and exon inclusion 
(A) Correlation of allelic fraction estimates of exon counts and CTCF signal for peaks within 2kb of the exon. Plots show 
the percentage [%] of reads mapping to allele1. (B) Summary of the results of the allele-specific analysis. (C) Exon 
allelic fraction stratified by binned CTCF allelic fraction (left) and binned HiC allelic fraction (right) (allele 1 > allele 2 
and vice versa) are shown grouped by the configuration of the exon-promoter motif-pair. (D) 4C-seq signals in 6 
individuals stratified by amount of inclusion of exon 5 for THRAP3 are shown for each CTCF site along the transcript. 
The CTCF peaks predicted to form a loop with the promoter (according to their highest scoring motif) are shown in blue 
for sense and red for antisense. Exon 5 is highlighted in red. (V.P. = viewpoint, star = p-value < 0.05). Panels A-C were 
produced by myself and panel D jointly with Dr. Mang Ching Lai; they are published in (Ruiz-Velasco et al. 2017).
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 2.2.4 Functional consequences of genes and exons with predicted intragenic loops 
Finally, we sought to assess the functional impact of exons, that are potentially regulated 
by a CTCF-loop, on the protein level. These analyses were carried out by Dr. Manjeet 
Kumar for two different sets of exons: (i) those exons belonging to the LCL-specific set 
described in section 2.2.1 and (ii) the unbiased set which comprises all exons with 
convergent interactions that were solely annotated by the presence of CTCF motif-pairs, 
regardless of LCL-specific CTCF binding or on the expression status in LCLs. 
For a large proportion of the loop-regulated exons, a known protein isoform exists 
that lacks the respective exon (Figure 2.4A). Moreover, loop exons are more likely than 
other exons to overlap fully with a missing region of a known alternative protein isoform 
(OR=1.6, p-value = 4.2e-2, Fisher’s exact Test). This provides further evidence that the 
looping exons are indeed alternatively used and likely translated into distinct protein 
isoforms. 
We also found that both the unbiased and the LCL-specific set were more likely to 
overlap with a Pfam protein domain than other exons (OR= 1.8, p-value < 2.2e-16 and 
OR= 3.0, p-value < 2.2e-16 respectively; Fisher’s exact test). Additionally, when 
considering the specific functions of the domains overlapping with the looped exons we 
found a significant enrichment for kinase domains (OR= 2.3-unbiased and 5.1-LCL-
specific; adjusted p-value = 2.2e-6 and 3.0e-4). This indicates that alternative usage of the 
looping exons likely has an impact on the protein function. 
We performed a gene ontology (GO) enrichment analysis on the genes containing 
loop-regulated exons. This revealed a strong enrichment for terms related to signalling and 
response to stimuli in both sets (Figures 2.4B and S2.4A). Consequently, we found that 
such genes are also predominantly associated with membrane, cell-periphery, or cell 
projection structures (Figure S2.4B). 
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 Overall, we identified very interesting examples of well-studied proteins where the 
looped exon is absent from at least one of the known isoforms (Figures 2.4C-E). As a first 
example, we show the DNA damage Checkpoint Kinase 2 (Chk2), an enzyme for which 
over 90 splice variants have been described, 13 of which are annotated in Swiss-
Prot/Uniprot, and for five of which the looping exon is missing (Figure 2.4C). 
As a second example we show the protein kinase Clk3, for which we identified 
exon 4 as looping (Figure 2.4D). This protein is known to have a full-length active isoform 
but also a truncated, catalytically inactive isoform. Active Clk3 regulates alternative 
splicing by phosphorylating SR proteins of the spliceosomal complex. The inactive 
isoform is formed by excluding exon 4, which leads to a translational frameshift that 
induces the formation of a premature stop codon and loss of the kinase domain (Duncan et 
al., 1995; Hanes et al., 1994). Interestingly, the ratio of inclusion of exon 4, and thereby 
catalytically active vs inactive isoform, has been shown to control the differentiation 
process in multiple cell types (murine erythroid cells, neurons and astroglia cells) (García-
Sacristán et al., 2005). 
As a final example, we have the histone-lysine N-methyltransferase 1 (EHMT1) 
protein, which is involved in mono- and dimethylation of histone H3 (Lys-9) in 
euchromatin. Of the four isoforms in Swiss-Prot, two of which involved a loop-regulated 
exon. Isoform 2 lacks the whole EHMT1 protein due to an alternative splice at loop exon 
2, while isoform 4 skips the looping exon 26, thereby removing half of the SET domain 
methyltransferase (Figure 2.4E), presumably eliminating the catalytic activity while 
retaining the chromatin location and histone tail-binding properties of the protein. 
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Figure 2.4. Influence of CTCF-mediated intragenic loop exon on protein function 
(A) The cumulative distribution of overlaps between looping exons and missing regions of known protein isoforms are 
shown (as percentage of the missing region). (B) Treemap representations from Revigo (Supek et al., 2011) showing 
significantly enriched biological processes (top 10) for the genes containing loop exons in the unbiased (upper panel) and 
in the LCL-specific set (bottom panel). (C, D, E) Visualisation of exon structure, primary sequence and 3D-structure for 
selected genes with annotated loopss. Looped-exons (magenta) are shown in the primary and 3D-structure. (C) Chk2 
(UniProt-ACC:O96017, PDB:2YCF) contains a looping-exon in the kinase domain (exon 5). (D) Clk3 kinase (UniProt-
ACC:P49761, PDB:2EU9): The loop exon (exon 4) is alternatively used in protein isoforms that then lack the entire kinase 
domain. (E) EHMT1 (UniProt-ACC:Q9H9B1, PDB:3HNA): Loop exons 2 and 26 produce isoforms that affect protein 
function. This figure was contributed by Dr. Manjeet Kumar and is published in (Ruiz-Velasco et al. 2017).
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 These examples illustrate that CTCF-mediated intragenic loop formation can 
influence the ratio of transcript isoforms in many different contexts, and potentially plays a 
significant role in cellular signalling and decision making, thereby modulating processes 
such as differentiation, cancer or other forms of pathogenesis. 
 
2.3 Discussion 
Chromatin topology and function are tightly linked to ensure proper genomic regulation at 
all organisation scales; however, there are still very few studies that show a direct link 
between chromatin organisation and gene regulation (Ruiz-Velasco and Zaugg, 2017). 
Here we propose a novel functional role of CTCF-mediated intragenic DNA-loops in 
regulating alternative splicing decisions, that likely have a functional impact on cellular 
signalling and decision making. The model is derived from integrating multiple layers of 
genome-scale molecular phenotype data, genetic variation, and functional genome 
annotation, and was validated by experimental 4C-seq assays. 
Individual examples for the involvement of CTCF in alternative exon usage have 
been described before, e.g. in the CD45 locus (Shukla et al., 2011), where it was proposed 
that CTCF promotes inclusion of an alternative exon by binding in its downstream intron 
and creating a ‘roadblock’ for PolII, which in turn allows splicing factors to assemble the 
spliceosome (Shukla et al., 2011). However, this model does not take into account the most 
recent and well studied role of CTCF in chromatin 3D organisation. Furthermore, our data 
suggests that CTCF bound upstream of an exon also triggers its inclusion thus questioning 
whether CTCF acting as a roadblock to PolII downstream of the exon is the only 
mechanism. 
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  The additional mechanism we propose is that CTCF-mediated chromatin loops 
between the promoter and the upstream region of an exon regulate its inclusion (Figure 
2.5). We speculate that the mechanism involves a combination of (i) slowing down PolII 
and (ii) increasing the local concentration of splicing factors at the exon (see below). 
However, we cannot exclude the possibility of CTCF-RNA interactions, which are 
prevalent across the entire transcriptome (Kung et al., 2015; Saldaña-Meyer et al., 2014), 
also playing a role. 
PolII speed has repeatedly been shown to affect splicing decisions (Fong et al., 
2014; Jonkers et al., 2014; Oesterreich et al., 2016; Shukla et al., 2011). A recent study, 
which proposes a link between chromatin loop formation and cohesin pausing at CTCF 
sites (Haarhuis et al., 2017) opens the intriguing possibility that the process of loop 
extrusion could also slow down PolII which in turn provides enough time for the 
spliceosome to include exons that are near to the convergent CTCF sites. Furthermore, 
splicing factors have been reported to localise to promoters via the Mediator complex and 
can regulate alternative splicing decisions far from the promoter in a set of alternatively 
spliced genes (Huang et al., 2012; Kornblihtt et al., 2013; Mikula et al., 2013), it is thus 
tempting to speculate that this distal splicing regulation might act through CTCF-mediated 
intragenic chromatin loops. In such a mechanism a transfer of splicing factors from the 
promoter to the looped exons would make splicing more efficient by increasing their local 
concentration at the exon. 
In support of this we found a correlation between the promoter mark (H3K4me3) at 
the 5’ end of the exon and its inclusion into the transcript only for exons looping to their 
promoter (Figure S2.2F). A similar correlation was observed for active mark (H3K27ac) 
and transcription mark (H3K36me3), but not for the enhancer mark (H3K4me1; Figure 
S2.2F). These associations of splicing with promoter, active and transcription marks at 
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 exons could be explained by the interaction of the exons with their promoter, as in our 
proposed model. 
Several questions remain to be address to better understand the extent of our model. 
Additionally, the former analyses only demonstrated the mechanism occurring within a 
single cell type. In the following chapter evidence of intragenic loops affecting splicing are 
shown during development, across tissues, and briefly for cancer cell lines. 
 
Figure 2.5. CTCF-mediated intragenic loop model 
Schematic of the proposed mechanism: CTCF-mediated intragenic chromatin interactions between promoter and gene 
bodies regulate alternative exon usage by favouring the inclusion of exons, possibly through an increasing concentration 
of splicing factors. Genetic variants can affect this mechanism by disrupting the binding of CTCF and preventing the loop 
formation. This figure was produced by myself and published in (Ruiz-Velasco et al., 2017).  
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 2.4 Methods 
2.4.1 Annotation of Intragenic Loops 
For the identification of CTCF peaks binding along transcripts, we defined four genic 
regions: promoter (+/- 1kb from transcription start site (TSS)), end of transcript (+/- 1kb of 
transcription termination site (TTS)), upstream, and downstream regions of exons (either 2 
kb from outside the exon boundaries - when the intron was longer than 2kb - or the actual 
size of the intron in case it was shorter). We expect all promoters to fall within the TSS 
region and to avoid any overlaps between the promoter and exon regions, we removed any 
region associated with first exons, first introns and anything within 5kb from the TSS from 
the set of exonic regions. Additionally, we filtered out exons intersecting with CAGE 
peaks (FANTOM Consortium and the RIKEN PMI and CLST (DGT) et al., 2014) to 
prevent mis-classifying non-annotated promoters as exons. 
To minimise the number of non-functional CTCF binding sites, we only considered 
sites that overlap with a CTCF peak in LCLs obtained from our previous study (Kasowski 
et al., 2013). We then intersected the CTCF peaks with each of these windows and 
assigned the highest scoring motif (MA0139.1) to each peak by using the PWMScan tool 
(http://ccg.vital-it.ch/pwmtools/pwmscan.php) (cut-off of 93.13% with non-overlapping 
matches). Motifs having a score of >= 500 (LCL-specific set) or >= 1000 (unbiased set) 
were further used. 
Given that CTCF binds to an asymmetric motif, it is possible to assign a 
directionality. We did so by defining directionality relative to the gene strand thus 
rendering sense CTCF motifs if both the motif and the gene lie in the same strand and 
antisense vice versa. We grouped the CTCF motif-pairs according to their genic region 
into: promoter:exon-upstream, promoter:exon-downstream, promoter-TTS, exon-
upstream:TTS, and exon-downstream:TTS (schematic in Figure 2.1). We next classified 
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 the motif pairs based on their relative orientation to each other as “convergent”, 
“divergent”, “both sense”, and “both antisense”. For this analysis, we excluded any pair of 
motifs with a distance smaller than 5kb to allow for potential chromatin looping, and we 
only kept unique pairs. For the list of pairs visit:  
http://www.embl.de/download/zaugg/mariana/intragenic.interactions.unbiased.set.hg19.txt 
 
2.4.2 Overlap with chromatin conformation data and splicing QTLs 
For validation we overlapped the predicted loops with existing chromatin conformation 
data requiring that each motif of a CTCF motif-pair overlapped one side of the same 
interaction. We used cohesin subunit Rad21 and histone mark H3K4me3 ChIA-PET 
(Grubert et al., 2015), and CTCF (Tang et al., 2015) ChIA-PET and Capture-HiC (CHiC) 
data (Mifsud et al., 2015). Briefly, CHiC uses oligonucleotides close to several promoters 
to amplify the reads obtained close to the TSS. 
Based on earlier studies suggesting that CTCF is capable of binding to sequences as 
long as 40-60bp (Li et al., 2013), we intersected a 40bp CTCF motif (+/-20bp from center 
of the canonical motif) with the list of splicing QTLs (sQTLs) (Li et al., 2016). We 
considered all sQTLs above an FDR of 10% as described in their methods. 
 
2.4.3 Annotation of Differentially Used Exons 
We obtained RNA-seq data (strand-specific and paired-end reads) for lymphoblastoid cell 
lines of 18 individuals from (Kasowski et al., 2013). We selected protein coding genes 
using the genome annotation provided in Gencode v19. We first filtered out lowly 
expressed isoforms as described in (Soneson et al., 2016) by applying the kallisto tool to 
all RNA-seq files (Bray et al., 2016), only keeping transcripts which were expressed in at 
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 least 10 out of the 18 individuals. We used custom scripts to generate a set of non-
overlapping exon boundaries. This involved first splitting exons into individual parts (since 
some exons can be part of multiple transcripts and can have several annotated 5’ and 3’ 
boundaries) and then merging them again into units that contain the most 5’ and the most 
3’ annotated boundary for each exon. Chromosomes X, Y and mitochondrial DNA were 
filtered out. 
Based on current knowledge about exon length distribution (Derrien et al., 2012), 
we further removed exons that were less than 20 or more than 5,000bp long. These 
annotation and filtering steps resulted in a set of 109,960 exons. We then used DEXSeq 
(Anders et al., 2012) to count the reads falling into each of these exons for each of the 
replicates of the 18 individuals. As an additional filtering step, we excluded exons with less 
than 10 counts on average, leaving 86,285 exons for further processing (for a total of 9,198 
genes) of which 62,663 (73%) were middle exons. 
Differentially Used Exons (DUEs) as described in (Anders et al., 2012), are defined 
as a change in exon usage whereby exon usage is defined as the ratio of reads mapping to a 
particular exon vs reads mapping anywhere else in a gene. To obtain the DUEs we used 
DEXSeq and compared the exon usage for each individual against the median across all the 
18 individuals (Figure 2.2A). The such obtained log2-FC values were used for the 
correlation between exon and CTCF usage (see CTCF correlation with DUEs below). We 
considered exons to be differentially used when their adjusted p-value was below 0.1 
(Benjamini Hochberg correction), leaving a total of 3,844 DUEs. In order to keep only the 
middle DUEs, exons were intersected with the TSS and TTS from the Gencode v19 
annotation and respectively labelled as first, middle, and last exons. For further analysis, 
we excluded the first and last exons, considering only the 2,081 middle DUEs. 
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 These DUEs cover 14% (1,148) of expressed genes with multiple exons. From 
these 1,148 genes, most have less than 10 DUEs (Figure S2.2A), and no strong correlation 
between the number of middle exons per gene and number of differentially used exons was 
observed (Figure S2.2B). The size distribution of DUEs is similar to that of all exons and 
consistent with previous observations (Derrien et al., 2012) (Figure S2.2C). For the list of 
DUEs visit: https://www.embl.de/download/zaugg/mariana/DUE.annotation.txt 
 
2.4.4 CTCF correlation with DUEs 
To calculate the log2 fold-change per exon in each of the individuals against the median 
expression based on their DEXSeq counts, we estimated the exon fold-changes as 
described above and in (Anders et al., 2012). As a quality control, we checked the 
distribution of fold-changes with respect to the median for each individual and found that it 
shows similar patterns for all of them (Figure S2.2D). 
For the quantification of the ChIP-seq read counts of CTCF and RNA PolII binding 
around the exons, we used SNPhood (Arnold et al., 2016). We extracted the reads of CTCF 
falling within 2kb downstream or upstream of the 5’ and 3’ boundaries of exons 
respectively. We then calculated the log2 fold-change of CTCF counts between each 
individual and the median individual, similar as described for the RNA-seq data. These 
fold-changes were then correlated with the fold-changes of the exon. 
The same procedure was applied to other genomic features (PolII, Sa1, H3K4me1, 
H3K4me3, H3K36me3, and H3K27ac) from paired data (Figure S2.2F). Note that only 
cases where the median factor read counts were 10 or more were considered. For each 
exon, we generated 100 sets of permutations for fold-changes in exon usage between 
individuals, keeping the number of individuals with positive and negative fold-change 
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 constant at each exon. This empirical distribution was then used to assess the significance 
of the correlations by applying Wilcoxon tests. 
 
2.4.5 Allele specific analysis of CTCF binding 
We first extracted all heterozygous SNPs from the genotypes of the 14 individuals from the 
1000 Genomes project (http://www.internationalgenome.org/) (1000 Genomes Project 
Consortium et al., 2015), for which genotypes were available, and intersected them with 
the CTCF peaks from the ChIP-seq data. 80% of all the peaks (158,455) contained 1 or 
more heterozygous SNPs in at least one individual. We then kept the SNPs closest to the 
midpoint of the motif that was predicted to form an intragenic interaction. 
Using SNPhood, we analysed whether there was an allelic bias for the read counts 
extracted in the region of +/-250 bp surrounding the SNP. Briefly, SNPhood performs a 
binomial test to assess whether the allelic fractions are deviating from the expected 0.5. We 
selected all CTCF peaks within 2kb upstream or downstream of an exon boundary that 
overlapped with a heterozygous SNP in at least one individual, calculated the allelic bias 
and filtered the peaks based on a nominal p-value cutoff of 0.05, which resulted in a set of 
9,434 upstream and 7,689 downstream allele-specific bound CTCF peaks. This set of 
peaks served as a basis for the correlation with exon allelic bias. 
To calculate the allelic bias for exons, we split the RNA-seq alignment files by 
allele to which they map (allele information was obtained from (Kasowski et al., 2013)) 
using samtools split and then used bedtools (intersectBed) (Quinlan and Hall, 2010) to 
extract the counts. To assess exon allelic bias we performed a binomial test that resulted in 
1,327 and 664 events upstream and downstream respectively (at nominal p-value < 0.05). 
To avoid low-count artefacts, we only kept SNPs that had at least 5 mean read counts. 
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 To verify whether there was an enrichment of allele specific CTCF binding in the 
2kb upstream or downstream of the exons, we identified middle exons that overlap with 
CTCF peaks using GenomicRanges (Lawrence et al., 2013). Only those cases where the 
individual was heterozygous for the SNP and both CTCF and exon were allele specific 
were taken into account. As described in the main text, to obtain a more robust 
quantification we classified the exons according to the directionality of the allelic bias in 
CTCF binding and assessed differences in exon allelic fractions between the two groups by 
a t-test (bottom panel Figures 2.3A, S2.3A). This revealed a significant association only for 
the CTCF sites upstream of the exon. 
For the genome-wide correlation of HiC signal with CTCF binding in an allele 
specific manner, we used the GM12878 diploid HiC maps at 5kb resolution (Rao et al., 
2014) and the CTCF and exon counts as mentioned above. We calculated normalised 
interaction frequencies with Knight-Ruiz normalisation vectors and we followed the same 
procedure described by the authors in their supplemental methods. We obtained the allelic 
fraction by calculating the ratio of maternal counts with respect to the total counts. Next, 
we selected the CTCF peaks binding in +/-2kb from all middle exons that contained SNPs 
for which GM12878 was heterozygous. We finally stratified either the CTCF or the exon 
allelic fraction based on the HiC allelic fraction as described above (Figure S2.3B). 
 
2.4.6 Protocol and processing of 4C-seq experiments 
4C-seq was performed mostly by Dr. Mang Ching Lai and partially by me in the group of 
Dr. Kyung-Min Noh using 6 human LCLs and a protocol modified from (van de Werken et 
al., 2012). All chemicals and reagents were purchased from Sigma Aldrich unless 
otherwise stated in brackets. To perform crosslinking of chromatin, 10 million cells per 
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 cell line were fixed in 5 mL 2% formaldehyde (VWR) at room temperature for 10 minutes. 
250 µL of 2.5 M glycine was added to quench the crosslinking reaction for 3 minutes at 
room temperature. Cells were washed twice in ice cold PBS and were snap frozen using 
liquid nitrogen prior to 4C experiments. 
To perform in nucleus Dpn II restriction digest of crosslinked genomic DNA, 10 
million cells per cell line were first lysed in 5 mL lysis buffer [10 mM pH 7.5 Tris-HCl, 10 
mM NaCl, 0.2% NP-40, 1X complete EDTA-free protease inhibitor (Roche)] for 30 
minutes on ice. Nuclei were centrifuged at 600 rcf for 6 minutes at 4°C. Supernatant was 
discarded and the nuclei were then resuspended in 1 mL residual supernatant. The samples 
were then centrifuged again at 600 rcf for 6 minutes at 4°C and the supernatant was 
discarded. The nuclei pellets were washed in 200 µL of 1.25X Dpn II Buffer (NEB) 
without resuspension at 600 rcf for 1 minute at 4°C. The nuclei pellets were then 
resuspended gently in 492.5 µL of 1.25X Dpn II Buffer with 0.3% sodium dodecyl sulfate. 
The mixture was incubated at 37°C and 950 rpm in a thermomixer (Eppendorf) with 
heated lid for 1 hour. 50 µL 20% Triton X-100 was then added to the mixture and was 
further incubated for 1 hour at 37°C and 950 rpm. Dpn II restriction digest was then 
performed by the addition of 45 µL nuclease free water (Ambion) and 10 µL DpnII 
enzyme (NEB), and the reaction was incubated at 37°C and 950 rpm for 3 - 5 hours with 
heated lid in the thermomixer. An addition 10 µL of DpnII was added to the mixture and 
was further incubated in the thermomixer overnight. 
To ligate digested DNA for generating a 3C template, the mixture was heat 
inactivated for 20 minutes at 65°C, followed by centrifugation at 600 rcf for 6 minutes at 
4°C. Supernatant was removed, leaving 50 µL. Ligation reaction mixture of 950 µL [50 
mM pH 7.5 Tris-HCl, 10 mM MgCl2, 1 mM ATP (NEB) and 5 mM dithiolthreitol, 0.1 
µg/µL bovine serum albumin (NEB) and 150 U/µL T4 DNase ligase HC (ThermoFisher)] 
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 was added to the samples and was incubated overnight at 16°C and 600 rpm in the 
thermomixer. 
To reverse crosslink, the samples were incubated with 200 mg proteinase K 
(ThermoFisher) and 50 µL 20% sodium dodecyl sulfate at 65°C for 1 hour. The samples 
were then incubated with 100 mg RNase A (Qiagen) for 45 minutes at 37°C. 
To purify the 3C template, a phenol chloroform extraction method was performed 
where 1 volume of phenol:chloroform:isoamyl alcohol 25:24:1 saturated with 10 mM Tris 
pH 8.0, 1 mM EDTA was added to the samples and were mixed thoroughly by vortexing. 
The mixture was transferred to a 2 mL heavy phase lock gel tube (5-Prime) and was 
centrifuged at 16,000 rcf for 5 minutes at room temperature. The top clear aqueous phase 
containing DNA was transferred to a clean eppendorf. NaCl of a final concentration of 200 
mM, together with 1 µL of 20 µg/µL glycogen was added to the aqueous DNA solution, 
followed by the addition of 2 volume of -20°C 100% ethanol. The mixture was incubated 
at -80°C for at least 1 hour and was centrifuged at 15,000 rpm for 1 hour at 4°C. The 
supernatant was removed and 500 µL -20°C 80% ethanol was added to wash the DNA 
pellet at 15,000 rpm for 60 minutes at 4°C. The supernatant was then removed and the 
tubes were centrifuged again for 30 minutes at 15,000 rpm at 4°C. The residual supernatant 
was then removed and the DNA pellet was allowed to be air dried for 5 minutes at room 
temperature. To resuspend DNA, 50 µL 65°C 10 mM pH 7.5 Tris-HCl was added to the 
DNA pellet and the solution was incubated at 65°C for 5 minutes to dissolve the pellet. 
Digestion and ligation efficiencies were determined by agarose gel electrophoresis. 
To perform the 2nd round of restriction digestion with NlaIII enzyme (NEB), 5 µL 
10 U/µL NlaIII and 6 µL 10X NlaIII buffer (NEB) was added to 50 µL 3C template, and 
the reaction was incubated at 37°C overnight. NlaIII was heat inactivated at 65°C for 20 
minutes. 
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 To generate 4C template, 5X ligation buffer [250 mM Tris-HCl, 50 mM MgCl2, 5 
mM ATP, 25 mM dithiolthreitol], 5 µL 10 mg/mL bovine serum albumin (NEB) and 2.5 
µL 150 U/µL T4 DNase ligase HC (ThermoFisher) were added to 50 µL NlaIII digested 
3C template and the reaction was incubated overnight at 16°C. 
To purify 4C DNA template, DNA purification was performed as described above. 
The final 4C template was further purified using the QIAquick PCR purification kit 
(Qiagen) according to the manufacturer’s instruction. Digestion and ligation efficiencies 
were assessed by agarose gel electrophoresis. 
To design primers for performing 4C-PCR, the viewpoint sequence of the THRAP3 
gene was first chosen using THRAP3 sequence obtained from the UCSC genome browser 
(https://genome.ucsc.edu/index.html) on the human GRCh37/hg19 assembly. Restriction 
site identification and THRAP3 sequence were processed using ApE-A plasmid editor 
(http://biologylabs.utah.edu/jorgensen/wayned/ape/). 4C-PCR primers were designed using 
primer3 v. 0.4.0 (http://bioinfo.ut.ee/primer3-0.4.0/). Viewpoint and primer sequences 
were chosen and designed, respectively, according to the guidelines as previously 
published (Splinter et al., 2012.). Viewpoint coordinate correspond to the human 
GRCh37/hg19 assembly chr1:36690087-36690526. The forward and reverse primer 
sequences are 5’ ctaacttccatcagaggcgctcac 3’ and 5’ attggcctggttcggtcttctc 3’ respectively. 
Illumina adapters and indexing sequences were incorporated into the PCR primers. High-
performance liquid chromatography purification was used in the production of primers 
(Eurofins Genomics). The primer sequences (5’ to 3’) are listed here: 
 
Primer: THRAP3 Forward: AATGATACGGCGACCACCGAGATCTctaacttccatcagaggcgctcac  
Primer: THRAP3_i2 Reverse: CAAGCAGAAGACGGCATACGAGATACATCGattggcctggttcggtcttctc 
Primer: THRAP3_i4 Reverse: CAAGCAGAAGACGGCATACGAGATTGGTCAattggcctggttcggtcttctc 
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 Primer: THRAP3_i5 Reverse: CAAGCAGAAGACGGCATACGAGATCACTGTattggcctggttcggtcttctc 
Primer: THRAP3_i6 Reverse: CAAGCAGAAGACGGCATACGAGATATTGGCattggcctggttcggtcttctc 
Primer THRAP3_i7 Reverse: CAAGCAGAAGACGGCATACGAGATGATCTGattggcctggttcggtcttctc 
Primer THRAP3_i12 Reverse: CAAGCAGAAGACGGCATACGAGATTACAAGattggcctggttcggtcttctc 
 
Oligonucleotide sequences © 2016 Illumina, Inc. All rights reserved. Derivative works 
created by Illumina customers are authorised for use with Illumina instruments and 
products only. All other uses are strictly prohibited. 
To perform 4C-PCR, 4C template from each of the 6 individuals were amplified 
using primers above, with each index assigned to 1 individual. 4C-PCR was performed 
with the following condition: 
Temperature (°C) Time (sec) Cycle 
98 30 1 
98 10 30 
68 30 
72 180 
4 30 1 
 
For each individual, two 4C-PCRs were pooled together and the PCR products were 
purified using Agencourt AMPure XP beads (Beckman Coulter) according to the 
manufacturer’s instruction. 4C-seq library was prepared by pooling equimolar amounts of 
the barcoded 4C templates. Sequencing was performed on the MiSeq platform with 75 bp 
read length for single end reads. Custom sequencing [5’ actcacctgggcctaccacagagatc 3’] 
and indexing [5’ gagaagaccgaaccaggccaat 3’] primers were used. Two technical replicates 
were performed for all individuals.  
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 To process raw 4C-seq data, FastQC was used to verify that all libraries passed the 
quality controls (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Adapter 
trimming was not required as sequencing began at the first base after the DpnII site. 
Sequencing reads were aligned to hg19 using Bowtie2 (Langmead and Salzberg, 2012) 
with parameters: -p 8, --very-sensitive, --time. Only reads with a MAPQ score >= 10 were 
used. 
The processed data was then analysed using the bioconductor package Basic4CSeq 
according to the author’s instructions (Walter, C., 2015). Briefly, the restriction fragments 
were simulated in silico and aligned sequencing reads were mapped to the restriction 
fragments. Fragment read count was normalised to reads per million (RPM), and 4C 
interaction was subsequently visualised. We observed a cis (0.2 Mb region adjacent to the 
viewpoint) to overall reads ratio of about 40% in all of the 4C-seq experiments performed. 
A cis to overall ratio of 40% or above is considered as a quality control point for 4C 
experiments (van de Werken et al., 2012), indicating our experiments achieved the 
recommended quality. 4C interactions were visualised as a plot of normalised reads versus 
genomic coordinates. 
To study the relation between 4C signals and DUEs of the 6 individuals, we used 
GenomicRanges to overlap normalised 4C read counts and CTCF peak signals. 4C reads 
mapped to fragment ends that overlap a +/- 1kb region of the mid point of the CTCF peaks 
were considered to be a readout for the CTCF peak’s interaction with the viewpoint CTCF. 
The 4C readout signals was representing CTCF interactions were then stratified by the 
relative inclusion and exclusion of the exon usage to generate the box plot. 
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 2.4.7 Functional analyses 
These analyses were done by Dr. Manjeet Kumar from Dr. Toby J. Gibson’s group. Two 
sets of exons were considered for the analyses: the unbiased and the LCL-specific set of 
looped exons. For the unbiased set the intragenic loops were annotated for cases where the 
CTCF motif score was >= 1000; this set reflects the potential of genes to form promoter- 
exon loops in any given tissue - as the identified loops were based only in the motifs. The 
LCL-specific set is defined above (section 2.4.1) and represents a subset of the unbiased 
set, showing CTCF binding and exon expression in LCLs, along with >= 500 score for the 
motifs and +/- 1kb for the TSS window. 
 All exon coordinates were used to retrieve the protein information from Ensembl 
with the assistance of Perl APIs (Cunningham et al., 2015; Yates et al., 2015). Different 
features on the retrieved protein regions were mapped using the Uniprot features of the 
corresponding protein (UniProt Consortium, 2015). Protein domains on the sequence were 
mapped using a local installation of Pfam (Bateman et al., 2004). 
Gene Ontology (GO) term analysis for looping genes was performed using 
ConsensusPathDB webserver (CPDB) (http://consensuspathdb.org/) (Kamburov et al., 
2013). The top 10 GO terms were visualised using Revigo (Supek et al., 2011) and 
represented as treemaps. All the statistical tests were done in R. The Pfam domain-to-GO 
term analysis was performed with the dcGOR R package (Fang, 2014). Location of exons 
on the primary sequence is based on the protein feature view from RCSB-PDB 
(www.rcsb.org). Domain definitions are based on the Pfam. The structure visualisation and 
rendering was done with the help of the UCSF Chimera package (Berman et al., 2000). 
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 3. Intragenic CTCF-mediated loops regulate alternative 
splicing across cell types, are involved in neural 
differentiation, and misregulated in cancer 
 
The next sections describe follow up analyses performed to better understand the extent to 
which CTCF-mediated intragenic loops regulate splicing decisions. This mechanism has 
been thoroughly described in the previous chapter. All of the analyses here are 
unpublished. The results from section 3.2.1 belong to a collaboration with Dr. Fabian 
Grubert, Dr. Rohith Srivas, and Dr. Damek Spacek from Dr. Michael Snyder’s group at 
Stanford University and the story is currently under revision. Section 3.2.2 was initially 
submitted but left out of the final manuscript. Finally, results from section 3.2.3 are part of 
a collaboration with Dr. Esa Pitkänen and Dr. Jan Korbel and represent an ongoing 
collaboration. 
  
69
 3.1 Introduction 
Our study described in Chapter 2 provides one of the first functional consequences of 
intragenic chromatin architecture by linking CTCF-mediated DNA loops to the regulation 
of alternative splicing, ultimately leading to the transcription of various protein isoforms. 
In addition, the model we propose provides a useful framework for further studying 
alternative isoform usage, e.g. across tissues, in cancer or across development, by 
generating hypotheses about alternative exon usage solely based on the analysis of CTCF 
binding sites, which are easily obtained from the DNA sequence. 
 To better understand what happens at the genes containing intragenic chromatin 
loops across tissues, or even in a dynamic process such as during development, we 
performed various analyses that are described in the next sections. Overall, we followed 
the same workflow as the one described in the previous chapter, which led us to conclude 
that intragenic loops are observed not only in Lymphoblastoid cell lines (LCLs), but also in 
all of the other tissues studied, as well as in mouse.  
 Finally, we wondered whether frequently mutated regions occurring in cancer, 
specifically in the PCAWG dataset, showed any of the intragenic loops described by us. 
The analyses done by our collaborator Dr. Esa Pitkänen showed that convergent 
interactions, which define intragenic loops, are enriched for frequently occurring somatic 
SNVs when compared to the other orientations. These findings indicate that CTCF-
mediated intragenic loops are a conserved feature in mammals and highlight the 
importance of such mechanism in the regulation of alternative splicing, along with its 
misregulation in diseases such as cancer. 
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 3.2 Results 
3.2.1 Intragenic loops affect splicing decisions across tissues 
An ongoing study from the Snyder lab in Stanford University has generated chromatin 
interaction maps for 24 cell lines commonly used in the ENCODE project (Grubert, et al., 
in revision). Briefly, the study generated Rad21 (a cohesin subunit) ChIA-PET datasets 
along with RNA-seq libraries as part of the latest ENCODE release. The main results of 
this study include the identification of a set of constant and variable interactions across cell 
lines and the observation that all cell lines clustered into three main groups based on their 
most variable loops after a principal component analysis (PCA): (i) blood, (ii) stem-cell 
like, and (iii) solid tissues (Figure S3.1A). These results indicate that chromatin 
interactions changing across cell types are more likely to be driven by epigenetic variation, 
rather than genetics. As part of a collaboration, we assessed the extent to which intragenic 
looping affected splicing regulation among these 22 cell lines (for which both loop and 
RNA-seq datasets were available). 
 As a first analysis, we verified which of the chromatin interactions from the pooled 
ChIA-PET dataset (n=124,830) had one anchor within +/-1kb from the TSS (promoter 
window) and the second anchor within -5kb of the 5’-boundary (upstream window). In this 
way, we identified 1,372 loops spanning 1,074 genes. Given that cohesin and CTCF are 
known to physically interact with each other (Xiao et al., 2011), we consistently observed 
that the distribution of the Rad21-loop anchors at the promoter and upstream windows 
recapitulated the observed patterns for CTCF (Figures 3.1A, 2.1A). 
 Once again, we used DEXSeq to identify differentially used exons (DUEs) either 
among a) the 22 cell lines or b) among the three groups defined by the PCA (Methods: 
3.4.2). In this way, we defined a) 95,137 and b) 39,832 DUEs (FDR=10%). We next 
decided to verify the correlation between the normalised exon counts and the interaction 
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 strength of the Rad21 ChIA-PET for the exons next to a loop anchor across the 22 tissues 
(Figure 3.1B). This analysis showed that there was a shift towards positive correlation 
values for the exons that were classified as DUEs that was significantly shifted from the 
distribution observed for the other exons in the same gene (p-value = 9.2x10-3, Wilcoxon 
test) or whenever the exons were permuted 100 times (p-value = 8.9x10-193). 
As a second validation, we compared the exon log2-fold change (log2-FC) against 
the loop-anchor log2-FC between stem-like and blood cell lines and colored the values 
based on whether they represented the real DUE-loop pairs (DUE-real) or all of the other 
exons in the gene with the loops contained for the same gene (DUE-not-real) (Figure 
3.1C). The results suggest that the presence of intragenic loops affect the inclusion of the 
exon next to it, but not the inclusion of other exons in the gene. The same was observed 
when comparing stem-like and solid tissue cell lines although to a smaller extent (Figure 
S3.1B).  
Finally we characterised gene ARHGEF7, where the presence of a loop mostly at 
blood-related cell types showed a high correlation with the abundance of the exon next to 
its intragenic anchor (Figures 3.1D, S3.1C). The exon affected by the intragenic loop in 
ARHGEF7 was including in some cell lines, with variable abundance, while completely 
absent in others and this exon was also previously annotated to belong to some but not all 
isoforms according to ENSEMBL (Figure S3.1D).  
Overall, by analysing chromatin loops and exon usage across 22 cell lines from 
variable tissues, we consistently identified evidence that intragenic interactions affect exon 
inclusion. With these results, we also demonstrate that this mechanism is not only 
susceptible to genetic changes, but rather modulated by epigenetic mechanisms that affects 
the chromatin landscape at a given cell type. 
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Figure 3.1. Intragenic interactions affect alternative exon usage across tissues 
(A) Distribution of the distance (in base pairs) between the center of the anchors and the transcription start site (left) or exons’ 
5’-boundary (right). (B) Pearson correlation of the normalised ChIA-PET anchor counts and the exon counts across 22 cell 
lines for exon-loop pairs (red, n=277), exon-loops pairs of the same gene (blue, n=1347) and 100 permutations of the exon 
associated to the anchor (grey, n=27700) (red vs blue: p=9.2x10-3, red vs grey: p=8.90x10-193). (C) Scatterplots of the 
differentially used exon log2-FC and anchor count log2-FC for the real pairs (blue, n=111) and for the other exon-loop pairs 
within the same gene (pink, n=1347) (Pearson correlation = 0.3 for blue and 0.05 for pink). (D) Example of how a loop affects 
exon usage in the 3 groups for gene ARHGEF7. The presence of an intragenic loop from promoter to upstream of exon 6 
(highlighted in yellow) is evident for group 1 (blood), but not for 2 (stem) or 3 (solid). All panels were produced by myself. 
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 3.2.2 Evidence for CTCF-loop regulated exon usage in cellular differentiation 
While we described intragenic interactions to be a mechanism affecting splicing 
ubiquitously in human tissues, the question of whether this mechanism is also present in 
other species still remained. Moreover, we still lacked a biological process where to test 
our model. 
We reasoned that we could use the process of cellular differentiation of mouse 
embryonic stem cells (ESCs) into neural progenitor cells (NPCs) as a second system to test 
for the presence of promoter-exon loops. Additionally, a handful of studies have started to 
characterise the extensive changes in the 3D-chromatin landscape during this process, 
generating useful datasets and reporting a dynamic change at all chromatin interaction 
levels that encompass the transition from ESC to NPCs (Beagan et al., 2017; Bonev et al., 
2017; Fraser et al., 2015; Pękowska et al., 2014). 
To address our hypothesis that CTCF-intragenic loops contributed to neural 
differentiation, we obtained RNA-seq and CTCF ChIP-seq data for both mESCs and 
mNPCs from (Pękowska et al., 2014) and (de Wit et al., 2015) respectively, and annotated 
intragenic loops according to the same rules as described for the LCLs (Methods: 2.4.1 and 
3.4.1). Intriguingly, we found that CTCF motifs from peaks occurring either in ESC or in 
NPC showed an overall similar pattern as the one described for CTCF-motifs (Figure 
2.1A) and for anchor boundaries in human cell lines (Figure 3.1A), having highly enriched 
sense motifs upstream of the TSS and mostly antisense motifs in the introns (Figures 3.2A, 
S3.2A). Consequently, this pattern could facilitate the formation of convergent interactions 
between promoters and upstream of exons, suggesting that the intragenic chromatin 
architecture is conserved between mouse and human.  
We next identified the differentially used exons between the two conditions 
(Methods: 3.4.2) and obtained 1,946 DUEs at FDR=10%, of which 1,080 were included 
 more in mESCs and 866 in mNPCs. Consistently we found that exons in a predicted loop 
with their promoter are enriched for being differentially used between the two cell types 
(OR= 2.0, p-value = 1.1e-2 Fisher’s exact test). To assessed whether this effect was given 
through condition-specific chromatin loop formation in neural differentiation, we tested 
whether exon usage and CTCF binding are correlated for exons that are looping to their 
promoter. Indeed we found that differential CTCF binding is correlated with differential 
exon usage only in cases where the exon forms a predicted loop with its promoter, i.e. 
convergent interactions (OR=3.3, p-value = 3.6e-5), however these was not the case for 
other configurations (Figure 3.2B, S3.2B). 
Importantly, we were able to confirm the influence of CTCF in affecting the 
splicing decision by calculating DUEs in a dataset which specifically degraded the CTCF 
protein after four days in mESCs (Nora et al., 2017) (Methods: 3.4.2). With this system, 
we were able to observe a strong enrichment for the same exons that are alternatively 
spliced during neural differentiation to also change their inclusion levels upon CTCF 
knock-down in the same direction (OR=11.04, p-value = 2.24e-05, Fisher’s exact test). 
This study also identified a very sharp enrichment of CTCF just upstream of the TSS for 
many genes that were misregulated upon CTCF depletion, in agreement with our analyses. 
Overall, our findings suggest that CTCF-mediated loops are also present in mouse 
genes, affecting the inclusion of a group of exons relevant for neural differentiation. 
Moreover, at least part of the differential exon usage in this process can be explained by 
changes of CTCF-mediated intragenic loops, highlighting the importance of this 
mechanism. 
 
  
Figure 3.2. CTCF intragenic loops are also present in mouse models 
(A) Same as in Figure 2.1A,B distribution of CTCF motifs in sense (blue) and antisense (red) orientation in promoter 
and intron regions are shown for mouse ESC and NPC (left). Predicted CTCF-motif pairs (convergent and divergent 
interactions) are summarised for each cell type (right). (B) Schematic of the contingency table for testing the 
association of changes in exon inclusion and CTCF binding in ESCs vs NPCs for exons that have a promoter-exon-
upstream loop. The background color represents that observed vs expected value for each square. These figures were 
produced by myself in collaboration with Stefan Kleinsorg.
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 3.2.3 Frequently mutated regions in cancer are enriched at CTCF motifs that anchor 
intragenic interactions 
CTCF-mediated intragenic loops were present in various important genes, controlling the 
splicing of exons that in many cases contained complete protein domains. This made us 
speculate that such loops might be under a tight regulation which, if modified, could have 
relevant consequences worth to be explored. 
Our observation of an enrichment of sQTLs only at CTCF convergent motifs 
located upstream of the affected exon supported this idea (Figure 2.1F). In addition, a 
previous report already identified CTCF/cohesin-binding sites to be frequently mutated in 
various types of cancer (Katainen et al., 2015). A suggested model trying to explain how 
this frequently mutated regions arise proposes that the activity of the nucleotide excision 
repair machinery (NER) is affected by the accessibility of DNA around a TF-binding site, 
with lower NER directly at the binding motif and which correlates with nucleosome 
positioning (Sabarinathan et al., 2016), which causes an uneven repair within the CTCF-
motif in melanoma cancers for both studies (Poulos et al., 2016). Finally, another study 
reported chromosome loop anchors bound by CTCF/cohesin to be vulnerable to DNA 
double strand breaks by topoisomerases at a position adjacent to the CTCF loop anchor, 
just outside the loop (Canela et al., 2017). For these reasons, we decided to analyse if the 
intragenic interactions that we identified were misregulated in cancer as part of a 
collaboration with Dr. Esa Pitkänen and Dr. Jan Korbel. The following analyses were 
mostly done by Esa, while I characterised the examples. 
As a first analysis, we used a set of frequent somatic mutations (SNVs and 
insertions/deletions (INDELs)) identified in the 2,779 samples from the PCAWG data 
(Campbell et al., 2017) and verified if any of these mutations overlapped with the CTCF 
motifs that formed the intragenic loops from the unbiased set (based solely on the motifs, 
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 without ChIP-seq evidence, see methods: 2.4.1). Briefly, the 19bp CTCF binding site is 
referred to as CTCF motif while the extension from the motif by +/-100bp is the CTCF 
site, both of which localised either at the promoter or at the intron of the genes. 
Overall, we observed that 2,150 out of the 2,779 tumours (77%) had one or more 
mutated CTCF sites, with 19,501 mutations occurring in total at 14,456 CTCF sites and 
2,048 at the CTCF motif (Figure 3.3A). Importantly, sQTLs were significantly enriched at 
frequently mutated CTCF sites (OR=1.82, p-value = 4.6e-6, Fisher's exact test), which 
suggests once again that these mutations are functional. Moreover, there were individual 
CTCF sites with a high mutation load, highlighting that these motifs were repeatedly 
mutated and pointing to some genes that might be interesting to analyse in depth. 
Next, we verified whether the mutation frequency was the same for all CTCF sites 
or whether there were any changes if the motif participated in a convergent or in any other 
orientation of the interaction (Figure 3.3B). Remarkably, we observed that convergent sites 
showed a larger mutation density (9.22e-5 mutations/sites (mut/site)) than non-convergent 
sites (8.05e-5 mut/site, p-value = 9e-3, U-test). After stratifying by the location of the 
CTCF site within the gene in either being at the promoter or at the intron, we also observed 
that the intronic sites were consistently showing a mutation density of 9.07e-5 mut/site for 
convergent and only of 7.72e-5 mut/site for non-convergent (p-value = 7e-3). Moreover, 
the convergent intronic CTCF sites mutated more frequently when they co-localised with 
cohesin (9.95e-5 mut/site for convergent and 8.02e-5 for other orientations, p-value = 3e-3; 
Figures S3.3A,B). Consistent with these observations, there was a 2.6 fold-enrichment for 
CTCF motifs to overlap cohesin ChIP-seq peaks at both anchors when the interactions 
were convergent (using ReMap peaks (Chèneby et al., 2018), p-value = 4.2e-4). 
We next decided to analyse the splicing patterns of several genes which contained 
intragenic loops and where the motif harboured a frequently mutated site (at least 4 
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 mutations were occurring in the same CTCF site for various tumours). Of relevance, we 
report PFKFB2 which encodes 6-phosphofructo-2-kinase, a central enzyme of glycolysis 
(Figure 3.3C). We observed that the CTCF site within the intronic region of PFKFB2 was 
mutated in 8 tumours from various tissues (esophagus, stomach, and liver) at multiple 
positions, having 6 of these SNVs contained within the CTCF motif. We observed that two 
of the nucleotides in the motif showed two different types of mutations (T > C or T > G), 
which is compatible with the idea of a motif disruption occurring in this position. 
Importantly, by using Rad21 ChIA-PET data from the study of Grubert et al. (see 
section 3.1 above) we validated that there was a chromatin interaction directly anchored by 
the CTCF motif under study. In this case, we observed that the mutated CTCF motif in the 
PFKFB2 gene localised exactly between two exons that served as alternative end sites for 
the various isoforms. Of relevance, it is known that the different PFKFB2 isoenzymes 
display distinct regulatory and kinetic properties and that cells can coexpress several 
isoforms suggesting that different isoenzymes cooperate in the regulation of Fru-2,6-P2 
levels (Ros and Schulze, 2013). 
In addition, we observed that those tumours having the mutated CTCF motif in 
PFKFB2 contained an increasing number of interactions that spanned outside of the gene 
(Figure S3.3C), which made us speculate that perhaps there could be an altered splicing 
landscape in this locus due to the somatic SNVs occurring in this motif. However, further 
analyses and a proper quantification need to be done to completely understand what is 
happening in the samples where the intronic CTCF motif of PFKFB2 is mutated. 
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Figure 3.3. Convergent intragenic interactions are the most affected by frequent somatic mutations in cancer 
(A) Number of mutations occurring at each CTCF site show that ~10,000 sites have 1 mutation, reaching a plateau 
around 10 mutations per site. (B) Distribution of mutation frequency classified by the directionality of the CTCF motif 
shows the highest mutation rates for those involved in convergent interactions. The density plots were created by 
bootstraping the data and plotting the means. (C) Gene PFKFB2 contains a frequently mutated CTCF motif (blue) in its 
last intron (top). The mutations identified in this site are shown according to the color key and the tissues of the 
tumours where the motifs were mutated (right). The validated loop along with the precise location of the motif within 
the gene (red) and the affected exon (yellow) are shown (left). Panels A-C were generated by Dr. Esa Pitkänen, track 
view of PFKFB2 was produced by myself. 
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 In summary, by using the CTCF motifs as a predictor of intragenic loops, we 
decided to analyse if there were observable changes in the mutation frequency at these sites 
whenever the orientation of the annotated interaction was considered. We have observed a 
higher mutation rate at convergent sites, which once more suggests that the CTCF sites that 
anchor intragenic loops are functional, potentially under a tight regulation, and show 
consequences when altered. 
 
3.3 Discussion 
In the previous chapter we have described how we have identified a novel splicing 
mechanism where CTCF-mediated intragenic chromatin interactions affect the inclusion of 
the exon next to the intronic anchor of the loop. Nevertheless, we only described our 
mechanism as occurring in LCLs across individuals, therefore describing inter-individual 
variation rather than changes occurring between two cell types or two conditions. Given 
that alternative splicing contributes to the cellular complexity of higher eukaryotic 
organisms, with nearly 95% of mammalian genes undergoing alternative splicing of pre-
mRNA (Kornblihtt et al., 2013; Shukla et al., 2011), we decided to continue with 
additional studies to find out the extent of our mechanism. 
At the beginning of this chapter we describe how we validated that the presence of 
intragenic loops is ubiquitous across cell types, based on Rad21 ChIA-PET data generated 
by (Grubert et al., in revision). The data produced for this study represents the optimal 
dataset to test our hypothesis, as RNA-seq and ChIA-PET libraries were available for 22 
different cell lines. With both elements we were able to observe an increasing positive 
correlation for loop strength and exon counts across cell lines and to validate clear 
examples of intragenic loop-mediated splicing. The major limitation in this study, 
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 however, was to delimit loop-exon pairs, as it seems that the mere presence of intragenic 
loops may still affect splicing in exons surrounding the contacting regions and that the 
presence of loops could be influenced by gene expression. 
Having found this mechanism in multiple cell types, we speculated that the CTCF-
mediated loops could also be present in mouse, potentially contributing to biological 
processes such as neural differentiation. Some previous literature suggested that CTCF was 
indeed involved in the transition from ESC to NPCs and specific results from these studies 
hint us to analyse the connection with splicing: a first study described a well-positioned 
CTCF binding upstream of the TSS in the sense orientation for genes being downregulated 
upon CTCF degradation (Nora et al., 2017). In agreement with this result, human cells 
targeted for CTCF degradation also showed CTCF sites close to the promoters of genes 
that were misregulated (Zuin et al., 2014). Finally, a third study identified multiple 
interactions going from promoter to gene bodies (although not necessarily mediated by 
CTCF) by producing high-resolution HiC maps (Bonev et al., 2017). By using CTCF 
peaks and RNA-seq data we were able to observe similar results as those obtained in 
human, raising the idea that this mechanism is present in mouse. 
Interestingly, while CTCF RNA and protein levels were reported to decrease during 
mouse neuronal differentiation (Beagan et al., 2017) we observed that the intragenic 
interactions were more abundant in NPCs, which could suggest that the CTCF remaining 
throughout differentiation is still retained at these genes as it aids with the splicing 
transcriptional landscape. Indeed the CTCF motif patterns become sharper and the number 
of loops increases in NPCs according to our results. 
Finally, we decided to investigate if the CTCF-mediated alternative exon usage 
might be affected during a disease state, in particular in cancer and identified an increased 
mutation frequency at CTCF motifs involved in convergent interactions. We were also able 
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 to identify a central enzyme of glycolysis to have several SNVs in the intronic CTCF-
motif, therefore making it an interesting candidate for further studies. It has been shown 
that mutations in CTCF and cohesin binding sites are often mutated in diverse cancer types 
(Katainen et al., 2015) and that CTCF is a haploinsufficient tumor suppressor gene which 
is frequently mutated in several cancer types (Kemp et al., 2014). Furthermore, cancerous 
cells tend to have a very different DNA methylation landscape than their cell types of 
origin (Chen et al., 2016). It will therefore be of great interest to investigate whether some 
of the cancer-driving properties of a cell can be explained by specific transcript isoforms 
that originate due to differentially methylated regions, or mutations in CTCF binding sites, 
as initially evidenced by our analysis. 
While identifying frequently mutated CTCF motifs in various tumours opens up 
many relevant cases for further studies, it is still necessary to study the DNA damage 
pathways that influence such misregulation and the overall consequences of having a 
disrupted intragenic anchor. Furthermore the identification of an example of CTCF-
mediated alternative end usage, rather than the otherwise ‘cassette-exon’ splicing, could 
imply that our described mechanism has a broader regulatory scope than otherwise 
thought, indicating once again that we need to investigate this mechanism in further detail. 
In summary the mechanism that we have identified, where intragenic CTCF-
mediated loops can be found in human and mouse cells, correlates with alternative 
splicing, and can be regulated either by genetic variants or by the epigenomic landscape 
therefore influencing the transcriptional landscape of cells. 
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 3.4 Methods  
3.4.1 Annotation of Intragenic Loops 
The approach described in the previous chapters to identify CTCF-mediated chromatin 
interactions was used with slight modifications for the analyses done in this chapter: 
For the analyses across 22 tissues, we used the Gencode annotation (Release 25; 
lifted to GRCh37 coordinates), and only kept protein coding genes with at least 1 middle 
exon. Based on visual inspection, we defined the promoter window as +/- 1kb from the 
transcription start site and the upstream window as -5kb from the 5’-exon boundary. We 
then identified intragenic loops as those loops for which one anchor fell in the promoter 
and the second in the upstream window of the same gene. In this way, we identified 1,372 
loops within 1,074 genes. From this set, we identified exon-loop pairs (real pairs) by 
associating an exon with an anchor of an intragenic loop within 5kb of their 5’-boundaries. 
In the case of the mouse data, we followed the exact same approach, leaving +/- 
1kb from the TSS and -5kb from upstream regions. We used CTCF ChIP-seq peaks (de 
Wit et al., 2015) to validated the CTCF motifs calculated with PWM Scan tool (only using 
those motifs with a score >= 200) (http://ccg.vital-it.ch/pwmtools/pwmscan.php). We once 
again used CAGE peaks from the FANTOM consortium for mm9 to diminish the 
alternative start sites in our analysis (FANTOM Consortium and the RIKEN PMI and 
CLST (DGT) et al., 2014). 
For the cancer section we used the unbiased set of loops, which calculated 
intragenic loops based solely on CTCF motifs (with a score above a 1000) annotated with 
PWMscan (http://ccg.vital-it.ch/pwmtools/pwmscan.php). Overlap with cohesin was based 
on an intersection with SA1 and Rad21 ChIP-seq peaks from ReMap (Chèneby et al., 
2018). 
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 3.4.2 Identification of Differentially Used Exons 
In the case of the analyses across 22 tissues we flattened the Gencode (Release 25; lifted to 
GRCh37 coordinates) file with parameters “-r no” and used a modified script to extract 
counts with subRead (parameters -f -O -s 2 -p -T 40) (Liao et al., 2014) as described in the 
vignette. We classified the RNA-seq libraries a) according to the 3 clusters identified with 
the PCA as described above, or b) by the cell line (n=22). Next we normalised for the 
library size, dispersion, tested for differentially used exons, and estimated the exon log2-
FC between a) solid vs blood and stem cell-like vs blood or b) by cell type vs the median 
exon abundance. In this way, we identified a) 95,137 and b) 39,832 differentially used 
exons (FDR=10%).  
 For the mouse data a similar approach as the one described in the previous chapter 
was used. We used Gencode annotation M1 for mm9 in all cases and the RNA-seq libraries 
produced by (Pękowska et al., 2014). Briefly, expressed isoforms were retrieved with 
kallisto for each cell type, DEXSeq was run with the cell type as a condition (NPC vs 
ESC), and a threshold of FDR=10% was used to annotate as DUE. In the case of the 
CTCF-degron RNA-seq libraries (Nora et al., 2017) we compared all time points of the 
knock-down (1 day, 2 days, 4 days) against the wild-type (WT) and decided to work with 4 
days vs WT, as it maximised the number of DUEs (n=846 at an FDR=10%). 
 
3.4.3 Correlating exon usage and interaction strength 
We kept unique exon-loop pairs and correlated the normalised counts of exon and anchor 
strength across the 22 cell lines. As a control, we permuted all exons 100 times, creating 
new exon-loop pairs. We also accounted for gene expression by correlating all other exons 
within the same ‘looping’ gene and removed any exon within 20kb of the center of the 
anchor (all pairs). Then we performed a pearson correlation for all complete observations 
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 and depicted only the DUEs across the 22 cell lines. For the scatterplot, we used the 3-
group classification specified above and we tested for the correlation between real pairs 
and all pairs of the DUEs. 
 
3.4.4 Enrichment of somatic mutations at intragenic interactions 
Dr. Esa Pitkänen from the Korbel group (EMBL) used a set of high-quality somatic 
mutations (SNVs and INDELs) in cancers (n=2,779) available through the PCAWG 
project (Campbell et al., 2017). He overlapped these mutations with the CTCF motifs and 
sites (extending +/-100bp from the CTCF motif) that formed the intragenic loops from the 
unbiased set (see section 2.4.1). Only those pairs belonging to exactly one orientation were 
used. The mutation frequencies were calculated as the total number of mutations/site and 
differences in number of mutations between sites were tested with the U-test. 
 
  
86
 4. Studying the mechanisms of histone mark propagation 
along DNA-loops 
 
Knowing that 3D-architecture and function are tightly connected inside the nucleus, we 
sought to understand the mechanisms by which a distal genetic variant can affect 
molecular phenotypes which localise megabases away through chromatin contacts in a 
genome wide manner. In this chapter, we explain our initial attempts to solve this question 
and propose two models that could explain these observations and that were previously 
discussed in our review (Ruiz-Velasco and Zaugg, 2017). For this study, we used the data 
and inspired from the work of Dr. Judith Zaugg and Dr. Fabian Grubert (Grubert et al., 
2015). Most of the study was done by me, with analyses of TF co-enrichment and critical 
input from Ignacio Ibarra. While still at a preliminary stage, this work can lead to exciting 
results in the near future. 
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 4.1 Introduction 
Understanding how genotype encodes phenotype and how genetic variation can impact 
human traits and disease is still one of the long-standing question in biology. Years of 
genome-wide association studies (GWAS) have left us with thousands of unique variants 
associated to traits (~62,000 up to May 2018, https://www.ebi.ac.uk/gwas/home) of which 
the vast majority are localised at the non-coding regions of the genome. As a consequence, 
it is now clear that GWAS SNPs frequently affect intermediate molecular phenotypes, 
bearing quantitative trait loci (QTLs) (Ding et al., 2014; Li et al., 2016; Maurano et al., 
2012; Sun et al., 2018). Furthermore, genetic variants can influence distal molecular 
phenotypes occurring at a considerable distance through chromatin interactions (Delaneau 
et al., 2017; Grubert et al., 2015). 
 In particular, a recent study describing the coordinated effect of genetic variation 
through physical interactions identified local (+/-2kb from TSS) and distal (up to 2Mb 
from TSS) QTLs (distal-QTLs) which affect the abundance of histone marks and which are 
abundant and normally contained within topologically associated domains (TADs) 
(Grubert et al., 2015). Similarly, in an attempt to understand how structure relates to 
function through genetic variation, another study identified Cis Regulatory Domains 
(CRDs) which were fully encompassed within TADs, were highly tissue specific, affected 
gene expression, and in some cases reflected how chromatin is packaged into the nucleus 
(Delaneau et al., 2017). 
These and other studies identified that a common way in which genetic variants 
affect molecular phenotypes is through the disruption of TF-binding sites (TFBS). Given 
that CTCF was found to be prevalent at loop boundaries (Rao et al., 2014), we speculated 
that a possible mechanistic explanation of how genetic variants affect faraway elements 
could be through the disruption of CTCF binding and the impairment of the loop 
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 anchoring. Yet combinatorial binding of TFs could also be affected by distal-QTLs 
preventing functional genomic elements to properly activate their targets (Zhang et al., 
2016). 
In this study, we want to understand how distal genetic variants are propagated to 
distant regions through DNA-loops and how this “transmission of signal” affects other 
molecular phenotypes contained within these interactions. We propose two models: one in 
which the close “contact” occurring between the convergent CTCFs anchoring an 
interaction would explain the transmission of signal, such that only the boundaries would 
show a coordinated change based on their physical contact. Alternatively, we propose that 
all elements both within the loop and at its anchors would be affected via “spreading” of 
the signal along the interaction.  
Although the study is still at early stages, preliminary results in a pilot set show that 
both models are occurring, which could reflect that the process is dynamic and that it is 
most likely influenced by loop extrusion. Additionally we have gained insights into how 
the co-abundance of TFs at the anchors of a loop could be disturbed by distal-QTLs and 
speculate on the consequences that such scenario could generate.  
 
4.2 Results 
4.2.1 Characterisation of inter-individual variation at different architectural sites 
A first question that we aimed to answer was whether intermediate molecular phenotypes, 
such as CTCF, cohesin, and histone marks (H3K4me1, H3K4me3, and H3K27ac), would 
show the same levels of inter-individual variation according to the regions where they 
localised in the context of chromatin interactions. For this reason, we used ChIA-PET for 
Rad21 (40,281 loops) and H3K4me3 (10,037 loops) (Grubert et al., 2015) and HiC data 
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 (9,166 loops) (Rao et al., 2014), all of which were done in lymphoblastoid cell lines 
(LCLs). We split the chromatin contacts into three categories that represent the parts of a 
loop, while other regions not contained within the interactions were labelled as “inter-loop 
domains” (schematic on Figure 4.1B):  
● Outer boundaries: regions of the genome that are physically interacting and form 
the outermost loop anchors. 
● Inner boundaries: loop anchors within an outer interaction, that potentially 
represent intermediate maturation states inside a domain or TAD.  
● Inside regions: regions within the boundaries that do not overlap any other anchor.  
 
As a way to verify the type of genomic features that were anchoring or captured by 
the interactions of the different chromatin maps, we visualized the enrichment of 
chromatin states at the various loop regions (Figure 4.1A). In this way we noted that outer 
and inner loop boundaries of HiC and Rad21 ChIA-PET were enriched for CTCF, while 
inside regions were depleted. On the other hand, H3K4me3 ChIA-PET outer and inner 
boundaries showed enrichment for TSS- and enhancer-related states, but inside regions 
were only enriched for the latter. These results showed that according to the dataset used 
we could expect loop populations to capture different interacting functional elements. 
Specifically, H3K4me3 maps should contain more regulatory interactions formed between 
enhancers and promoters, while Rad21 and HiC maps contain more topological-like 
contacts. 
We next obtained CTCF, SA1 (cohesin), H3K4me1, H3K4me3, and H3K27ac 
ChIP-seq peaks from 18 individuals (Kasowski et al., 2013) and we verified the coverage 
of the peaks per megabase (Mb) according to the loop categories described above (Figure 
4.1B, S4.1A). We observed that there are more peaks binding at the loop boundaries when 
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 compared to the inside regions. Furthermore CTCF bound more at outer than at inner 
boundaries, while SA1 showed the opposite pattern. These results are in agreement with a 
report showing that disruption of CTCF has a greater role in spatial segregation, potentially 
due to its enriched presence at TAD boundaries, while cohesin was demonstrated to be 
involved in chromatin interactions within topological domains (Zuin et al., 2014). 
 Additionally, we questioned whether the inter-individual variability and binding 
strength would also be affected by the loop region where the factors bound. For this reason 
we verified the distribution of the median binding strength, as well as the standard 
deviation (SD), for the peaks in each loop category across the 18 individuals (Figure 4.1C, 
S4.1B). Importantly, we observed that smaller SD for CTCF and SA1 peaks at loop 
boundaries which were significantly lower for the outer than for the inner boundaries 
(CTCF: p-value = 5.56e-11, 1.01e-90, 2.98e-161 for HiC, H3K4me3 and Rad21 ChIA-
PET, respectively. SA1: 3.2e-8, 1.01e-90, and 3e-161, Wilcoxon test). Correspondingly, 
we noticed that the binding strength was significantly higher for CTCF and SA1 peaks at 
outer boundaries (CTCF: p-value = N.S., 5.4e-49, and 1.8e-140 for HiC, H3K4me3 and 
Rad21 ChIA-PET, respectively. SA1: 9.5e-3, 3.2e-44, and 9.3e-140, Figure 4.1D). 
However, while the stronger binding at boundaries was still noticeable for some 
histone marks in specific datasets (Figures 4.1D, S4.1B,C), the decrease in SD values at 
loop boundaries was not so striking except for the H3K4me3 histone mark in the 
H3K4me3 ChIA-PET dataset. Moreover, the patterns were almost inverted with stronger 
binding of histone marks at inner boundaries. In agreement with H3K4me3 ChIA-PET 
capturing mostly enhancer-promoter interactions, we also find the lowest variability and 
the strongest binding for all three histone marks here.  
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Figure 4.1. Characterisation of loop regions across individuals 
(A) Enrichment (blue) and depletion (red) of chromatin states at loop regions (outer-, inner-boundaries, inside-regions, 
and inter-loop domains) (Significant p-adjusted values = *). (B) Peak coverage per Mb for CTCF (left) and SA1 
(right) at loop regions of the 3 data sets.  A schematic of the parts of the loop is shown on top of the plots according to 
the color code in the legend. (C) Distribution of peak standard deviation and (D) median binding strengths for CTCF 
(left), SA1 (middle), and H3K27ac (right) across 18 LCLs according to where they bind in the context of loop regions. 
All three maps were visualised and Wilcoxon tests measured differences between outer and inner boundary values (*); 
peak values were asinh-normalised. All panels were done by myself.
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 In summary, by classifying three interaction datasets according to their contacts and 
then verifying the distribution and binding strength of ChIP-seq peaks for various factors 
across individuals, we were able to characterise and validate that CTCF and SA1 
preferentially localise at outer boundaries, possibly serving as TAD boundaries, with a 
strong binding and small standard deviations. Meanwhile histone marks for active genomic 
features behave in a different mode and could potentially show functional loops in charge 
of the transcriptional activation by bridging regulatory elements such as enhancer-promoter 
contacts. 
 
4.2.2 Architectural and functional loops are likely to be affected by distal genetic 
variants through the disruption of combinatorial protein binding 
Recently, it has been shown that 3D-proximity mediates the influence of genetic variants 
on distal gene regulation and that diverse pairs of interacting regulatory elements are 
genetically coordinated (Grubert et al., 2015). In order to better understand how distal-
QTLs affect faraway genomic factors (name hereby used in the text to refer to either 
histone marks, CTCF or cohesin) and the mechanisms that are potentially disrupted, we 
defined a subset of high-confidence distal-QTL-genomic factor pairs that overlapped with 
experimentally determined loop anchors and named them loop-QTLs.  
We required that each side of the interaction intersected either with the distal-QTL 
or with the genomic factor and therefore identified 88 loops from HiC, 143 from 
H3K4me3 ChIA-PET, and 335 for Rad21 ChIA-PET in LCLs (1%, 1.4%, and 0.8% out of 
the complete set of interactions described in 4.2.1, respectively. Figure 4.2A). Most 
anchors of loop-QTLs were annotated as inner loop boundaries (for both sides) and only 
few as outer; this was particularly evident for the Rad21 ChIA-PET loops, where inner 
boundaries were 1.6-fold enriched to also be loop-QTLs (p-value = 5.76e-5, Fisher’s exact 
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 test). This result suggests that loop-QTLs preferentially affect functional interactions but 
not so frequently TAD borders, a result also in line with the reported structural CRD-QTLs 
which are stated to be under a strong selective pressure and affected only by rare genetic 
variants (Delaneau et al., 2017). 
We speculated that two possible mechanisms affected by distal-QTLs involved 
either the disruption of a TFBS, which could potentially also alter functional combinatorial 
binding or alternatively the specific disruption of CTCF which could prevent the formation 
of a loop (Figure 4.2B). In other words, the presence of a SNP would disrupt the binding of 
one TF locally and influence the enrichment of a second TF at the other anchor of the loop. 
We therefore decided to verify if there were any co-abundances of TFs at the boundaries of 
loop-QTLs, an analysis done by Ignacio Ibarra. By using combinatorial pairs of TFs 
supported by ChIP-seq peaks from ReMap (Chèneby et al., 2018) present at each of the 
anchors, we observed that there were various significantly co-enriched pairs for which 
some of the TFs have been described to affect transcriptional activation (Mourad and 
Cuvier, 2016) (Figures 4.2C, S4.2B). 
Importantly, when checking the top 20 significant co-enrichments in loop-QTLs we 
were able to observe many interactions that were recently described in a similar study 
(Zhang et al., 2016). For example, the described DNA-binding protein (DBP) network of 
PML-FOXM1-STAT5A-RUNX3 showed significant co-enrichments in our hands too for 
all of these TF-pairs, some of which have validated biochemical interactions. Moreover, 
the previous study also reported a co-occurrence of PML-STAT5A-CEBPB peaks with cell 
type specific binding of PAX5-BATF-EBF1-BCL11A-FOXM1-NFIC-ATF2-RUNX3. TFs 
such as RXRA, BCL11A, ELK1, and P300 were reported to be involved in activation, 
therefore being depleted for TAD borders (Mourad and Cuvier, 2016).  
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Figure 4.2. Defining loop-QTLs and verifying possible protein co-enrichments 
(A) Schematic of a loop-QTL which contains a distal-QTL-genomic factor pair supported by a physical contact. (B) 
Two of the possible mechanisms disrupted by distal-QTLs are a CTCF-dimer anchoring a chromatin loop or a 
functional interaction of two genomic elements. (C) Co-abundance of combinatorial pairs of top 20 most significant 
TFs occurring at the anchors of a loop-QTL: TF1 at the y-axis and TF2 at the x-axis. The size of the circle shows the 
adjusted p-values (FDR=5%, green circles are significant) and the color indicates the fold enrichment (Fisher's exact 
test). Panels A and B were done by myself, panel C was contributed by Ignacio Ibarra.
A
C
B
xdistal-QTL
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histone
mark/CTCF/
cohesin
CTCF
chromatin loop
Combinatorial
binding of TFs
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 We also observed NFYA to be highly enriched to interact with itself, with PML, 
TAF1, BATF, and RXRA as well as NFYA, PML, and RFX factors, which are known to 
be co-occurring to active the major histocompatibility II genes (Arampatzi et al., 2013). 
Overall, the combinatorial function of these TFs has been implicated with leukocyte and 
lymphocyte activation as well as immune response (Zhang et al., 2016), which could 
explain their prevalence in LCLs. It will be important to have a closer look at the reported 
co-enrichments to verify if there are any novel associations that could be worth following 
up. 
Our second hypothesis was that distal-QTLs could be explained by the disruption 
of CTCF on one side, affecting binding on the other side of the interaction and potentially 
impacting loop formation (Figure 4.2B). This idea is supported by the knowledge that 
CTCF anchors chromatin loops through dimerisation and that loops can be eliminated in 
many cases by removing one of the binding sites (de Wit et al., 2015; Guo et al., 2015). 
With this aim, we retrieved the genotypes of 14 out of the 18 individuals and intersected 
the heterozygous SNPs with all CTCF peaks. To our surprise, most of the peaks (158,455, 
corresponding to 80%) contained 1 or more heterozygous SNPs. We then defined which of 
these were allele-specific CTCF (asCTCF) using SNPhood (Arnold et al., 2016) and 
obtained 93,438 cases (59% of heterozygous peaks).  
In agreement with our hypothesis, we observed an enrichment for asCTCF peaks to 
occur at boundaries of loop-QTLs when compared to the complete set of loops for the 
three interaction maps (OR= 1.76, 1.5, and 1.3, p-values = 3.21e-4, 6.42e-5, 4.61e-2 for 
H3K4me3, HiC, and Rad21 respectively). This result suggest the idea that loop-QTLs 
contain altered levels of CTCF that could explain the disrupted mechanism.  
Overall we defined loop-QTLs to be a high-confidence subset of the distal-QTL 
that have chromatin interaction support and show that they represent mostly inner 
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 boundaries and are enriched for containing asCTCF peaks. We also performed a co-
enrichment TF analysis that shows several TF-pairs which are co-occurring at loop-QTL 
anchors, many for which a previous validation exists, opening up exciting hypothesis of 
the mechanisms disrupted by distal-QTLs. 
 
4.2.3 Proposing possible mechanisms in which 3D-structure conveys functionality 
We decided to further study the mechanism by which a distal-QTL could propagate to the 
other end of a loop and produce a changing phenotype such as a hQTL. We proposed two 
possibilities that could begin to explain the propagation of signal and that were previously 
described in our review (Ruiz-Velasco and Zaugg, 2017) (Figure 4.3A):  
(i) “touch-and-act model”: where the physical contact at the loop anchors would be 
the only affected, without changing the genomic factors within the DNA-loop to convey its 
functionality.  
(ii) “spreading model”: where the complete loop would show an altered function 
and therefore a coordinated activation or repression of the whole local neighbourhood.  
 
We decided to prove our hypothesis by testing the allelic fraction of intermediate 
molecular phenotypes along the loops. If the allelic fraction showed a preference to map to 
one allele only at both boundaries -but not at the inside region- we would predict the touch-
and-act model, while if the allelic fraction showed a constant preference along the loop it 
would be showing the spreading model, which predicts a coordinated activation/repression 
through the entire domain (Figure 4.3B). Yet those interactions where one anchor showed 
an opposite allelic fraction to the other end would indicate that the model cannot be tested 
as the allele-specific events are not linked in the same direction. 
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 Briefly, we followed the same approach as for defining asCTCF by first identifying 
all heterozygous SNPs per individual, overlapping them with the ChIP-seq peaks (SA1, 
H3K4me1, H3K4me3, and H3K27ac), extracting the read counts surrounding the SNP (+/-
250bp) using SNPhood to calculate the allelic fraction and adjusted p-value (Methods: 
4.4.3). We retrieved on average 240,000 unique peaks per individual which contain a 
heterozygous SNP, all of which were pooled and classified according to the loop regions 
(Figure S4.3A,B). By keeping those loops having allele-specific factors at both anchors 
and in total at least ten allele specific events, we were able to obtain 487, 284, and 1909 
loops for HiC, H3K4me3, and Rad21 ChIA-PET, respectively. We then normalised the 
loop length as percentages to visualise all the interactions together and interpolated the 
data to fill in the blanks (Figure 4.3C).  
We decided to check the proportion of loops that fell into each of the models with a 
heatmap and used k-means to cluster each of the datasets into 6 groups. Strikingly, we 
observed evidence for the two models in all three datasets at similar proportions. For the 
HiC data we observed 35% (clusters 5 & 6) of loops to describe the spreading model, 33% 
(clusters 1 & 4) for the touch-and-act, and 32% (clusters 2 & 3) to be not-linked. 
Meanwhile H3K4me3 data had 34% (clusters 1 & 2) for the spreading, 34% (clusters 3 & 
6) for touch-and-act, and 32% (clusters 4 & 5) for each not-linked while the Rad21 dataset 
had 33% (clusters 3 & 6), 33% (clusters 1 & 5), and 34% (clusters 2 & 4) respectively. We 
acknowledge that a major limitation at this point is that the analyses are mostly qualitative 
and not quantitative and that a larger dataset should be used to gain further insights into the 
prevalence of each of the models. 
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Figure 4.3. Models proposing how functionality is conveyed along DNA-loops 
(A) Schematic of the two proposed models for the transmission of signal from a SNP to a distal site. (B) Examples of 
how the two models look like for HiC interactions of one individual when the fraction estimates (y-axis) are visualised 
along the loop-length [%] for heterozygous (grey) and allele-specific (red) factors. (C) Heatmaps grouped with k-
means (6 clusters) provide evidence for the presence of both models (i=spreading, ii=touch-and-act; iii=non-linked) at 
different proportions for the 487, 284, and 1909 loops for HiC, H3K4me3, and Rad21 ChIA-PET respectively. Colour 
key shows allelic fraction, where red shows reads mapping preferentially to one allele, blue to the other allele and 
yellow as the 50% of reads contributed by each allele. Panel A was taken from (Ruiz-Velasco and Zaugg 2017) where 
we briefly mention the models, panels B and C were done by myself and are unpublished.
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 4.3 Discussion  
Multiple studies from the last years have provided us with extensive knowledge and a 
collection of chromatin conformation data, which has increased our knowledge about 
chromatin 3D-organisation. However our understanding of how such architecture influence 
the function of downstream processes, and how structure translates into function, is still 
scarce and just beginning to emerge (Ruiz-Velasco and Zaugg, 2017). One such question is 
to understand how genetic variants can affect distant sites through physical contacts and if 
such transmission of signal would also produce changes in the surrounding intermediate 
molecular phenotypes. 
In this study we took advantage of the prevalent inter-individual variation of 
intermediate molecular phenotypes in LCLs and tried to exploit it to get mechanistic 
insights that explained distal-QTLs in the context of 3D-organisation. We defined loop-
QTLs as those distal-QTL-genomic factor pairs with a validated physical interaction either 
in HiC or in ChIA-PET. The finding that the outer loop boundaries most likely represented 
topological domain boundaries which were less likely to be loop-QTLs could be explained 
by the stronger binding of CTCF, which implies that it is more stable and less variable 
based on its lower SD. While we speculated that CTCF-dimer disruption could begin to 
explain the way in which distal-QTLs exert their function, we did not observe this to occur 
frequently, which is in line with the idea that these interactions should be the most robust 
to safeguard the regulatory domains along the genome. 
On the other hand, we tested whether a loop-QTL could be explained by the 
disruption of a combinatorial binding of two TFs in the 3D-context. These analyses 
provided us with previously described and novel TF pairs which were mostly involved in 
immune response and lymphocyte-leukocyte activation. We speculate that a possibility is 
that even when the physical loop is not affected by the distal-QTL, a functional interaction 
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 could still be disrupted. However further analyses including extensive characterisation of 
the inside regions will need to be done to draw any additional conclusion in this regard. 
We decided to test whether a distal-QTL would affect only those loci in close 
physical interaction or whether it would be propagated along the entire loop, which led us 
to propose two models: the “touch-and-act” and the “spreading” model for the cases just 
described, respectively. We used allelic biases in genomic factors distributed along loops 
to verify both models and the proportions to which they happened. Interestingly there is 
evidence for both of these mechanisms, which could either suggest that there are multiple 
mechanism of how 3D structure conveys its function that depend on the combination of 
loci and regulatory factors (Ruiz-Velasco and Zaugg, 2017) or represent the various 
maturation states during loop extrusion.  
While this study is still at its early stages and more improvements and analyses can 
be done, we are excited about the prevalence of both models and the possibility of gaining 
functional insights to the mechanisms by which genetic variants affect the genome. 
Although a couple of studies with varying approaches have been published since we 
started our study, an advantage in our analyses is that we are using also ChIA-PET data to 
test our models, which should capture more functional interactions given that it filters for 
specific proteins know to be present at loop anchors, and that we plan to extend our study 
to the existing cohorts of LCLs to maximise our results. Finally, we would need to also 
validate that such models apply only when the loop is present and not for peaks outside 
chromatin interactions.  
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 4.4 Methods  
4.4.1 Overview of the samples and datasets used 
We obtained ChIP-seq data (CTCF, SA1, H3K4me1, H3K4me3 and H3K27ac) for LCLs 
of 18 individuals from (Kasowski et al., 2013). We used Rad21 and H3K4me3 ChIA-PET 
(Grubert et al., 2015) and HiC data (Rao et al., 2014). The genotypes of 14 individuals 
were retrieved from the 1000 Genomes project (http://www.internationalgenome.org/) 
(1000 Genomes Project Consortium et al., 2015). Only autosomes were used for all the 
analyses. 
 
4.4.2 Defining loop-QTLs 
We intersected the HiC (boundary width of 5 kb) and ChIA-PET (boundary width of 3 kb) 
loops with the local and distal QTLs pairs defined by (Grubert et al., 2015). We extended a 
window of +/- 5kb from the local and the distal-QTL pairs for the HiC and for the ChIA-
PET loops.  
 
4.4.3 Co-enrichment of TFs at loop-QTLs 
We checked if there were co-enrichments of TF pairs in loop-QTL regions by interrogating 
whether ChIP-seq peaks for both transcription factors are more frequent in both sides of 
the loop, with respect to loops with one or no TF peaks. ChIP-seq peaks were collected 
from ReMap (Chèneby et al., 2018) and a distance of 1kb was defined as a cutoff to define 
if a ChIP-seq peak was overlapping a loop anchor. 
For a pair of TFs named TF1 and TF2, its co-enrichment in loops with anchor sites 
1 and 2 can be interrogated by counting four possible overlaps between ChIP-seq peaks 
and anchors: (a) TF1 in anchor 1 and TF2 in anchor 2, (b) TF1 in anchor 1 and TF2 not in 
anchor 2, (c) TF1 not in anchor 1 and TF2 in anchor 2, (d) TF1 not in anchor 1 and TF2 
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 not in anchor 2. From these numbers, an odds ratio is defined via Fisher’s exact test. Due 
to the dependency of this odds ratio to the assignment of TF pairs in anchor sites 1 or 2, 
reported co-enrichments are the highest observed value between both possible 
assignments. P-values were corrected for multiple testing with Benjamini Hochberg and 
significance was assigned at an FDR=5%. Z-scores were calculated through permuting the 
observed occurrences for both TFs in the interrogated anchor sites 10000 times, and re-
estimation of (a). 
 
4.4.4 Identification of allele-specific genomic factors 
We first identified all heterozygous SNPs per individual and overlapped their coordinates 
with the ChIP-seq peaks, keeping only the SNP closest to the center of the peak. We then 
ran SNPhood (Arnold et al., 2016) to extract the read counts surrounding the SNP (+/-
250bp) for each factor and each of the 14 individuals and calculated the allelic bias 
(binomial test, see methods: 2.4.5), corrected for multiple testing with Benjamini 
Hochberg, and classified as allele specific (FDR=10%).  
For each individual, a table containing the collection of all peaks-SNPs that are 
heterozygous along with the information from SNPhood was created. The peak-SNP pairs 
were also then overlapped with Rad21, H3K4me3 ChIA-PETs and HiC datasets, where 
each peak-SNP event was classified according to whether it overlapped any of the loop 
categories: 'outer/inner_boundary', 'inside_loop', and 'inter-loop-domain'. 
 
4.4.5 Classifying loop-QTLs into models 
Only those loops that have >= 1 heterozygous peak_SNP event in both of the boundaries 
were saved. As in several cases the same SNP was overlapping various genomic features, 
we reduced the points and only retained the SNP that was allele specific or the one with the 
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 lowest p-adjusted value. We applied this function to all loops that had at least one allele 
specific event in each of the boundaries of the interaction.  
We normalised the loop length by using percentages and to allow the visualisation 
in a heatmap, we filled the missing values with a linear interpolation. We next clustered the 
signal along loops to view the extent to which each model is related to using k-means 
(k=6) and used pheatmap for visualisation. 
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 5. Global chromatin changes alter regulatory landscape 
in ageing stem cells 
 
The other chapters have described the intricate link between structure and function in the 
mammalian nucleus of healthy cells. Here we investigate how chromatin structure is 
affected by ageing. This study is a collaborative project with Dr. Anne-Claude Gavin, Dr. 
Mang Ching Lai, and Dr. Ximing Ding (EMBL) and aims to identify chromatin 
accessibility changes occurring with age, which can ultimately be reflected in gene and 
protein abundance changes in mesenchymal stem cells (MSCs). All the computational 
analyses shown here, along with the text and figures, have been done by me unless 
explicitly stated. Experimental work has been done by Dr. Ximing Ding, Dr. Marco 
Hennrich, and Dr. Mang Ching Lai. 
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 5.1 Introduction 
Aging is a gradual process that ultimately ends in the loss of physiological integrity and 
death of an organism (Booth and Brunet, 2016; López-Otín et al., 2013). While several 
years of research have elucidated key features of aging, mostly at the transcriptome and 
proteome level, studies are only starting to assess the contribution of epigenetics in such 
process (Booth and Brunet, 2016; Liu et al., 2013; Sun et al., 2014). Moreover, most of the 
existing reports have studied senescence or replicative-ageing and only a handful have 
focused on healthy human ageing. 
Two of the hallmarks of aging are the decline in the regenerative potential of 
tissues due to stem cell exhaustion, which can lead to malignancies and to an increasing 
genomic instability caused by lesions in DNA and defects in nuclear architecture (López-
Otín et al., 2013). Recently, the SyStemAge consortium generated a valuable cohort across 
59 individuals to study age-related changes occuring at the protein level for the various cell 
types of the bone marrow (BM) niche, including hematopoietic and mesenchymal stem 
cells (HSCs and MSCs) (Hennrich et al., in revision). MSCs have been recognised as a 
critical component for the maintenance of a healthy BM niche (Reagan and Rosen, 2016) 
as they are able to differentiate into various mesenchymal tissues including bone and fat 
throughout life (Scaffidi and Misteli, 2008). While Hennrich’s study have revealed several 
insights about the ageing process, many proteins, and in particular transcription factors 
(TFs), were not abundant enough to be captured by mass spectrometry, resulting in an 
incomplete view and leaving a “blindspot” of the changing regulatory landscape with age.  
In this study we have obtained data for RNA and proteins from the SyStemAge 
project in an attempt to integrate both molecular levels. Surprisingly, we observed that 
chromatin related proteins were significantly downregulated with age, which made us 
wonder whether we could identify major changes in chromatin associated with age in 
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 healthy human MSCs. For this aim and due to the limited amount of available cells, we 
used an assay to profile open chromatin.  
By performing comparisons between older and younger individuals, we were able 
to elucidate global and specific changes occurring in chromatin accessibility, as well as 
changes in gene expression and isoform usage which correlated with age. As a way to fill 
in this “blindspot” of proteomics, we successfully applied a method that verifies the TF 
activity changes between age groups (Berest et al. in revision). By doing such analysis we 
were able to observe that there are changes in the regulatory landscape of MSCs that result 
in a differentiation bias towards bone in younger and fat in older individuals. In addition, 
by looking at the TF activity we were able to identify (i) changes in Polycomb group (PcG) 
proteins that correlated with the down-regulation of accessibility signal at bivalent 
promoters and (ii) changes in centromere-associated proteins, which suggests an increased 
genomic instability with age. 
Through a multi-omic integration approach, our study has validated multiple 
changes observed in human stem cells with age, at the time it has identified new ageing-
associated genes which still need to be studied. Overall these analyses shed some light on 
how time affects chromatin organisation, ultimately leading to changes at other biological 
levels which sum up to the impaired functionality observed in the ageing process. 
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 5.2 Results 
5.2.1 Establishment of a bone-marrow mesenchymal stem cell dataset to assess age-
related changes in chromatin 
The SyStemAge consortium (Hennrich et al. in revision) collected BM from 59 healthy 
donors ranging 20-60 years old (yr), to later study changes at the transcriptomic and 
proteomic level with respect to age in the various cell populations of the BM-niche. While 
valuable insights were obtained from this study, non-targeted proteomic techniques still 
face some limitations, especially when the abundance of the peptides is scarce like for TFs. 
We reasoned that both transcription and chromatin accessibility could help us to fill 
in the “blindspot” of proteomics by providing additional genes that were not captured in 
the proteomics assay and also by showing changes in accessibility that can result from 
preferential TF occupancy at a given condition (Figure 5.1A). Furthermore, a multi-omics 
integration could provide a more solid view of how specific genes are altered during 
human ageing. We then selected a subset of the SyStemAge samples for which proteomics 
(n=45 with MSC data), and in some cases RNA-seq datasets (n=19), were available and 
generated chromatin accessibility with ATAC-seq (n=16) (Figure 5.1B). We centered on 
MSCs as their commitment into adipocytes and osteoblasts has been previously implicated 
in pathological conditions and their differentiation potential can be affected with age 
(Moerman et al., 2004). 
We verified that all the datasets were of good quality by doing Principal 
Component Analyses (PCAs) and additional controls per technique, which left us with 45 
samples for proteomics, 18 for transcriptomics, and 15 for chromatin accessibility (Figures 
5C-F, S5.1A-C).  
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Figure 5.1. Overview and quality control of datasets 
(A) Depiction of the integration analyses for the three datasets: By using RNA-seq and ATAC-seq data we intend to fill 
in the ‘blindspot’ of proteomics and also to gain some knowledge of global changes occurring in chromatin structure 
with age. (B) Summary of the type of data available from each of the MSC donors along with their age and sex. (C) 
Distribution of ATAC-seq peaks [%] per chromatin state (blue) vs the total percentage of each state as the background 
(grey). (D) Distribution of gene expression values (log10) from RNA-seq libraries for all the good quality donors. (E) 
The number of donors where a protein was detected. For most of the analyses only proteins detected in more than 10 
donors were considered. (F) Number of peaks (ATAC-seq), genes (RNA-seq), and proteins (proteomics) defined in our 
study. Panel A was produced in collaboration with Dr. Judith Zaugg, panel B was done in collaboration with Dr. 
Ximing Ding, panels C-F were produced by myself.
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 We required ATAC-seq libraries to have a good TSS-enrichment score (enrichment 
of read counts at +/-2kb from TSS vs 4kb outside of this window, methods 5.4.3, Figure 
S5.1A), which reflected in the majority of peaks occurring at open regions (enhancers and 
promoters), a pattern that is expected and resembles the genomic distribution of DNase 
hypersensitivity (DHS) data (Figures 5.1C, S5.1D). For RNA-seq, we verified that the 
distribution of the gene expression per sample was not highly variable for any given library 
(Figures 5.1D, S5.1B,C) and for proteomics we checked that most of the proteins used 
were detected in a large number of samples (Figure 5.1E). This filtering left us with 
151,615 ATAC-seq consensus peaks, 16,096 expressed genes, and 6509 quantified 
proteins (Figure 5.1F). 
 
5.2.2 Integration of transcriptomics and proteomics data reveal global changes in 
chromatin related proteins upon ageing 
We first identified differentially expressed (DE) genes in the RNA-seq data using DESeq2 
(Love et al., 2014), which rendered 275 genes more abundant in young and 269 in old 
individuals at an FDR=10% (Figure 5.2A, Methods: 5.4.6). We then performed a Gene 
Ontology (GO) enrichment analysis for the two groups with clusterProfiler (Yu et al., 
2012). Interestingly, we observed that the cellular compartments for the genes that were 
downregulated with age related to the nucleus (such as “chromosomal region” or 
“centromeric region”), while the genes that were upregulated related more to the 
“extracellular matrix” (ECM) and the “membrane” (Figure 5.2B). Biological processes 
such as “DNA replication” and “chromosome segregation” were therefore present in the 
younger and “extracellular matrix organisation” in the older samples (Figure S5.2A), 
which is in agreement with previous reports of DE genes in mouse stem cells (Sun et al., 
2014). 
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 Next we verified how the proteomics dataset behaved by visualizing the 
distribution of the spearman correlation for the protein abundance with respect to age 
(Figure 5.2C). This showed that 287 proteins were significantly more abundant in younger 
and 436 in older individuals at a nominal p-value < 0.05.  
One of our first aims was to analyse whether changes in gene expression that are 
observed with age are consistent at the protein level in MSCs. For this we compared the 
log2-fold change (FC) abundance of the genes [old/young] and the spearman correlation 
for their encoded proteins (Figure 5.2D). By doing this comparison, we observed that there 
is an overall positive correlation (R=0.3, pearson correlation) between the level of the gene 
and the protein abundance, and there is an enrichment for a gene to be more expressed if 
there is a larger protein abundance with age (OR=1.95, p-value = 5.0e-39, Fisher’s exact 
test). This trend was even more striking when we only focused on the DE genes (OR=13.4, 
p-value = 4.2e-21, Fisher’s exact test), showing also a strong positive correlation (R=0.61, 
pearson correlation). The correlations further improved when filtering for the number of 
donors where the protein was detected (Figure S5.2B).  
In agreement with previous studies, we observed that histone H1 was more 
abundant in younger individuals (Feser et al., 2010; Funayama et al., 2006), while 
fibronectin in older individuals (Kular et al., 2014). Notably, besides histone H1, we 
observed that most of the histones, lamins, condensins, and nucleoporins, along with many 
other chromatin related proteins annotated with the EpiFactors database (Medvedeva et al., 
2015) (e.g. EZH2, DNMT1, and CTCF) were negatively correlated with age (Figure 5.2D). 
The observed histone loss made us wonder whether this would lead to global chromatin 
changes in ageing. Indeed, when comparing the abundance of chromatin related 
genes/proteins with all other transcripts/proteins quantified they were significantly 
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 downregulated with age at both levels (p-value = 3.3e-5 and 2.2e-16 respectively, t.test) 
(Figure 5.2E).  
To verify that what we were observing was not only due to senescence but rather 
due to ageing, we made a similar comparison for the RNA and the protein levels of HSCs 
from the same study (Hennrich et al. in revision). While the shift of chromatin related 
proteins was still significantly biased towards the younger individuals, it was clear that 
HSCs don’t show such a striking pattern as MSCs especially at the RNA level (p-value = 
0.41 and 2.2e-16, RNA and protein levels, t.test), indicating that a fraction of the chromatin 
factors downregulated with age resulted from ageing and another from senescence (Figures 
S5.2C,D, Table S5.1). However further analyses need to be done to classify the latter 
factors as it has been described that adult stem cells are not subject to replicative 
senescence while they can still accumulate damage with increasing age (Schultz and 
Sinclair, 2016). 
In summary, by comparing RNA log2-FC [old/young] with correlations of protein 
abundance with age, we observed the downregulation of several chromatin-related 
proteins. This finding led us wondering whether we could also observe these regulatory 
changes at the chromatin accessibility level. 
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Figure 5.2. Integration of transcriptome and proteome shows downregulation of chromatin-related proteins 
Volcano plot showing (A) genes that are down- (left, n=275) or up-regulated (right, n=269) according to their log2-FC 
or (C) proteins that are more abundant in younger (left, n=287) or in older (right, n=436) donors based on their 
spearman correlation with age. (B) Gene ontology enrichment analysis of cellular compartments shows terms as 
‘nucleus’ or ‘chromosome’ for down- and ‘ECM’ or ‘membrane’ for up-regulated genes. (D) Scatterplot of log2-FC 
(gene) vs spearman correlation (protein) values coloured by whether they are related to chromatin (Medvedeva et al. 
2015) or not along with their protein type. (E) Distribution of log2-FC and spearman correlation of chromatin-related 
(purple) and other proteins (grey) shows that only the first ones are downregulated with age.  All panels were done by 
myself.
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 5.2.3 A global chromatin rearrangement is observed with age 
We wanted to analyse whether a global rearrangement of chromatin architecture would be 
expected from the downregulation of proteins such as histones, histone remodelers, and by 
the PcG, among other chromatin regulators. Additionally, we asked whether a global 
change would be rather heterogeneous or whether it would be consistently originating at 
specific locations during ageing. 
We generated chromatin accessibility data with ATAC-seq, a method capable of 
capturing open chromatin and nucleosome positioning using as little as 500-50,000 cells. 
The method is reported to allow TF-footprinting in a genome-wide manner at high 
resolution (Tsompana and Buck, 2014). Briefly, MSCs were isolated from healthy donors, 
cultured and ATAC-seq libraries were constructed and sequenced for each individual 
(Methods: 5.4.3). The dataset was processed with an in-house pipeline leaving us with 15 
out of 16 individuals with two replicates each that passed the quality controls (TSS 
enrichment > 7.5 and a good correspondence of age with principal component 1, Figure 
S5.2A). By counting the number of reads per peak per individual, we defined a consensus 
set of autosomal peaks (n=151,615) using DiffBind (Ross-Innes et al., 2012). We kept only 
those peaks that were common in at least 2 different individuals and to ensure that the 
highest signal was extracted, we recentered the summits and extended +/-250bp for the 
consensus peaks (Methods: 5.4.3). 
As a first approach we performed a PCA of the top 500 variable peaks in order to 
understand the impact of ageing on chromatin accessibility. Importantly, we observed that 
PC1 correlated well with the age of donor, showing older individuals to one side of the plot 
and opposite from the younger donors indicating that ageing is a major driver of variation 
(PC1=24.9%) for the ATAC-seq dataset (Figure 5.3A).  
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 We wondered whether peak width contributed to the variability observed with age. 
For this we used the original peak-width of each of the samples and grouped them by age. 
Overall, we observed an increase in the width of the peaks that was proportional with age 
(p-value < 2.2e-16 for youngest vs oldest samples, t.test) (Figure 5.3B). Given that peak 
calling is done based on the read counts accumulating in certain regions and broader peaks 
would indicate an increase in reads, our results suggests that the accessibility of the 
chromatin increased for the older samples. 
As an additional quantification we extracted the normalised signal in a window of 
+/-500bp from the re-centered summit, where a peak is +/-250bp, and we calculated the 
ratio of the sum of signal within the peaks vs the sum of signal in the complete window Σ 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝑟𝑒𝑎𝑑𝑠 𝑖𝑛 𝑝𝑒𝑎𝑘 ÷  Σ 𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝑟𝑒𝑎𝑑𝑠 𝑖𝑛 𝑤𝑖𝑛𝑑𝑜𝑤  per individual. 
Once again, we observed that there was a positive correlation that resulted in higher ratios 
with increasing age (R=0.5, Pearson correlation, Figure 5.3C). With these results we 
noticed that the additional reads were not only occurring inside the peaks, but also in their 
close surroundings suggesting once again a global increase of accessibility with age. 
Given these changes in chromatin accessibility with age, we wondered whether any 
region in the chromosomes would be preferentially enriched for accessibility peaks which 
could serve as “hotspots” for ageing changes. We first visualised the distribution of the 
consensus peakset per chromosome and observed no obvious pattern besides a larger 
fraction of peaks having more accessibility in the younger donors (Figure 5.3D). 
Afterwards we defined a set of changing accessibility regions (CARs, see below and in 
Methods) and visualised the peak distribution in the linear chromosomes. Strikingly, we 
observed that there were loci that contained a cluster of downregulated peaks in very close 
proximity to each other with large log2-FCs at various chromosomes (Figures 5.3E, 
S5.3A). While we don’t know exactly what these regions are, they don't seem to affect 
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 gene levels, but rather to delimit heterochromatin blocks or sometimes to localise next to 
the centromeres, indicating that measurable, sharp signal is present in younger individuals, 
which is not observed for older donors (Figure S5.3B).  
Heterochromatin disorganisation with age has been previously reported for human 
aged MSCs (Ren et al., 2017; Scaffidi and Misteli, 2008). We speculated that one possible 
contributor is CTCF in its role of insulator, preventing heterochromatin variegation 
(Guerrero and Maggert, 2011) as its abundance was diminished with age in our dataset. We 
decided to visualise the peaks containing the CTCF motif in the same way as we did 
before. Notably, we observed that many of the peaks within one of the ‘hotspots’ in 
chromosome 1 contained multiple CTCF motifs (Figure S5.3B). However, other hotspots, 
like the one in chromosome 21, didn’t show this enrichment which suggests that alternative 
explanations exist for the accumulation of significant CARs in a given condition, that are 
only sometimes affected by CTCF binding. 
 In summary, by performing ATAC-seq in MSCs from donors ranging in age (21-59 
yr), we have observed that chromatin accessibility changes throughout time and represents 
a major source of variability. Our initial analyses show that there are global changes 
associated with age, such as increasing width and accessibility signal in older donors and 
specific accessibility hotspots where the changing peaks concentrate. We next decided to 
center in those regions that were significantly changing their accessibility with age and to 
study them in the context of functional genomic annotations, along with their 
consequences in other biological layers. 
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Figure 5.3. ATAC-seq profiling identifies global chromatin accessibility changes with age 
(A) Principal component analysis of top 500 variable peaks in the ATAC-seq datasets shows that PC1 [24.9%] separates 
samples by age. (B) Distribution of original peak width by age shows increasing width with age. (C) Scores showing an 
increase in the overall accessibility with age calculated as (sum(normalised reads in peak) / sum(normalised reads in 
window)). Peak=+/-250bp and window=+/-500bp. (D) Distribution of consensus peaks per chromosome stratified by 
log2-FC as more accessible in younger (red) or in older (blue) samples. (E) Depiction of accessibility peaks along the 
linear chromosomes stratified by log2-FC and coloured by significantly changing with age (red) or not significant 
(grey).  These panels were generated by myself.
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 5.2.4 Specific changes in accessibility are observed with age mostly at 
heterochromatin, enhancer, promoter, and bivalent chromatin states and correlate 
with DNA methylation 
In order to identify relevant changing accessibility regions (CARs) with age, we used two 
approaches: (i) a linear regression of the signal with age and (ii) a log2-fold change of the 
4 youngest and the 4 oldest individuals in our dataset. For both cases we used DESeq2 
(Love et al., 2014); each approach rendered 4,786 and 5,248 CARs respectively, which we 
later combined to have 6,746 peaks at FDR=10% (Methods: 5.4.3). 
We obtained 4,244 peaks down- and 2,477 peaks upregulated with age (Figures 
5.4B, S5.4A). Interestingly, we observed that most of the CARs were decreasing (69% and 
66% in linear and log2FC approach, respectively) rather than increasing their accessibility 
with age (31% and 34%). When plotting the distribution of CARs per chromosomes it was 
also very visible that there were more CARs for younger than for older donors, with only 
chromosome 8 showing the opposite pattern (Figure S5.4B).  
We next clustered the CARs normalised counts based on their accessibility level 
and observed that while the youngest (21-33 yr) and the oldest (56-59 yr) group of 
individuals showed an overall stable signal, a third group of intermediate ages (39-50 yr) 
showed rather a gradient or a “transitioning”, undefined accessibility between being open 
or being closed. This observation may imply that there is a time in life where the changes 
start accumulating before they switch completely, similar to the idea of the “point of no 
return” in ageing described by (Booth and Brunet, 2016). 
To test whether there was a preferential distribution of the CARs with respect to 
genomic features, we used the chromHMM annotation defined in the Roadmap Epigenome 
consortium (Roadmap Epigenomics Consortium et al., 2015) for bone marrow-MSCs. To 
address whether there was an enrichment or depletion of any state for the CARs, we used 
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 the distribution of the consensus peaks per chromatin state as the background and tested 
the distribution of the CARs. We observed that the peaks gaining signal with age were 
enriched at enhancer (Enh, EnhG) regions (Figure 5.4A). Meanwhile, the regions that lose 
signal with age are enriched at active promoters (TssA), heterochromatin (Het, ZNF/Rpts), 
Polycomb-related (ReprPC, ReprPCWK), quiescent (Quies), and bivalent (TssBiv, 
BivFlnk, EnhBiv) states but depleted at enhancers. These findings suggest that changes in 
chromatin accessibility are not homogeneous but rather occurring at specific genomic 
regions that may eventually lead to a misregulated transcriptional landscape. 
We speculate that DNA methylation could be associated to the observed changes in 
accessibility either by increasing (hyper-methylation) and therefore further compacting the 
chromatin or by decreasing (hypo-methylation) and decompacting specific regions. After 
all age has been reported to have a profound effect on DNA methylation and previous 
studies quantified and annotated differentially methylated regions (DMRs) in various 
tissues (Heyn et al., 2012; Rakyan et al., 2010) including MSCs (Fernández et al., 2015). 
We then tested whether the DMRs that were hyper- or hypomethylated with age in MSCs 
preferentially associated with any of the chromatin states from the ATAC-seq data. 
Consistent with previous reports (Wang et al., 2016), we observed that DNA 
hypermethylation occurs predominantly at bivalent chromatin regions, regions repressed 
by PcG, flanking promoters, and at enhancers (Figure 5.4C).  
Importantly we identified some genes (n=30) with bivalent promoters and 
hypermethylated DMRs, of which a couple of them were already validated to be modified 
with age in MSCs (Fernández et al., 2015). For example TBX18 is a known cardiac-
specific developmental TF that is necessary for the formation of the head region that 
generates the electrical impulses that induce heart contraction (Li et al., 2018). In addition 
it has been described to have Mb-hypermethylation immediately upstream of its promoter, 
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 adjacent to repressive PcG-chromatin (Baribault et al., 2018). A second example is the G-
protein coupled receptor 37 (GPR37), a negative regulator of oligodendrocyte 
differentiation and myelination (Yang et al., 2016) that has been associated to Parkinson’s 
disease (Morató et al., 2017), to stem cell maintenance (Choi et al., 2015), and to have age-
related hypermethylation and expression changes (Maegawa et al., 2010). Finally PPM1E 
is a protein phosphatase that inactivates CaM kinases and which has been shown to have 
altered DNA methylation levels in colorectal cancer (Yi et al., 2011), loss of histone 
acetylation levels at its promoter with age, and a lower expression in patients with 
schizophrenia and bipolar disorder (Tang et al., 2011).  
In contrast, hypomethylation was not significantly changing in bivalent regions of 
the genome and it was depleted from heterochromatin and active promoters. All CARs 
gaining and losing signal, hypo-, and hyper-methylated peaks were significantly changing 
with age at enhancer and at repressed by PcG regions, which suggests that these loci are 
subjected to major changes in accessibility throughout life. 
Finally, we reasoned that the impact of CARs would be reflected in the 
transcriptional program of MSCs. To test this idea, we checked for the distribution of the 
log2-FC of CARs vs the log2-FC of the expression of the closest gene within 100kb of 
distance (Figure 5.4D). Overall we observed no global correlation between the 
accessibility of the consensus peaks and the expression of their closest genes (R=0.006). 
However when selecting for specific features where the CARs were significantly 
associated with age (FDR=10%) we observed a better correlation that was most obvious 
for TSS flanking regions (R=0.3) and bivalent promoters (R=0.2) (Figure 5.4E). Two 
potential explanations for the lack of correlation could be (i) the presence of both activator 
and repressor factors that are present in the accessible regions and (ii) the CAR being at 
any chromatin state and not necessarily affecting transcription of its closest gene. 
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Figure 5.4. Changing accessibility regions (CARs) localise differentially across functional states and are 
reflected in transcriptional changes 
(A) Distribution and enrichment [%] of CARs gaining (red) or losing signal with age (blue) per chromatin state with 
respect to that of consensus peaks contained at each region (grey). Only significant odds ratios are shown on top of the 
bars. (B) Heatmap showing the normalised ATAC-seq signal at CARs. (C) Heatmap coloured by log2-FC of 
consensus peaks, CARs, hyper- and hypomethylated regions per chromatin state. Significant values (*). Scatterplot of 
the log2-FC of ATAC-seq vs log2-FC of RNA for the closest gene to each peak (up to 100kb in distance) for (D) all 
ATAC-RNA pairs (black) and pairs with significant accessibility and expression changes (red). (E) Signal showed 
only for pairs where the ATAC-seq peak occurs at a specific chromatin state (Top = active TSS-flanking, bottom, 
bivalent TSS). This figure was produced by myself.
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 By identifying age-related changing accessibility regions and annotating them 
based on where they lie with respect to functional genomic features, we have been able to 
observe that chromatin accessibility is mostly gained at enhancer regions but lost at 
promoters, heterochromatin (both constitutive and facultative), and bivalent states 
throughout life. In particular the observation that bivalent states lose signal with age was in 
line with having enriched hypermethylation and downregulated PcG proteins. This could 
indicate that these regions, which usually are at promoters of genes involved in 
differentiation and are characterised by the presence of both H3K4me3 and H3K27me3, 
are repressed by DNA methylation in later stages of life, potentially decreasing the 
‘stemness’ and thereby differentiation potential of MSCs. 
 
5.2.5 Altered transcription factor landscape recapitulate changes in the 
differentiation fate with age 
One of the advantages of ATAC-seq is that it allows to make inferences about TF-binding 
in a genome-wide manner. For investigating differences in the TF binding activity across 
ageing we used diffTF (Berest, Arnold, et al., in revision), which identifies changes in TF 
usage between two conditions (i.e. young vs old age group) by aggregating the differential 
ATAC-Seq signal across all putative binding sites of each TF. 
We ran this analysis using the 4 youngest and the 4 oldest individuals in our 
ATAC-seq dataset to identify TFs that showed altered activity with age in MSCs. We 
observed that ZEB1 and DLXs TFs, a known adipogenic repressor (Gubelmann et al., 
2014) and distal homeobox genes involved in osteogenesis (Frith and Genever, 2008) 
respectively, to be more active in younger donors. Meanwhile factors from the CEBP 
family, which orchestrate adipogenesis (Gubelmann et al., 2014), were more active in older 
individuals, reinforcing the described observation that the differentiation potential of 
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 MSCs is altered with age from bone (for younger) to fat (for older individuals) (Moerman 
et al., 2004) (Figure 5.5A). Additionally, CENPB and CTCF were more active in the 
young. 
As this analysis only accounted for TF binding sites (TFBS), we decided to verify 
the changes in activity for other factors for which ChIP-seq data exists, such as DNA 
binding proteins or chromatin remodelers. With this aim we used the ReMap database, 
which is a collection of all ChIP-seq experiments done in multiple cell types for various 
factors (Chèneby et al., 2018). We first filtered the 485 factors by gene expression in 
MSCs, leaving us with 407 factors to run in diffTF, many of which were common proteins 
to the previous analysis and some which were additional ones. The results were consistent 
and showed CEBPs and PPARG factors to be more active in the old condition while 
RUNXs (a known osteogenic TF) and HES1, a know repressor of adipogenesis in 
mammals (Lei et al., 2013) were more active in the young (Figure 5.5B). Notably, 
components of the PRC2 complex (EZH2, SUZ12, and EED, part of the PcG) were 
consistently more active in the young condition, in agreement with their higher abundance 
at the transcript and protein level (see above). 
To gain more confidence on our results we checked whether the TF activities were 
supported by significant changes at the RNA and protein abundance. This analysis 
validated that CENPB, ZEB1, CTCF, HES1, EZH2 and DLX2 were downregulated and 
less active, while CEBPs and PPARG were upregulated with age (Figures 5.5C-F). 
Overall, by using a novel approach that identifies genome wide changes in TF binding, we 
have examined how the regulatory landscape of MSCs is altered with age.  
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Figure 5.5. Changes in the TF-regulatory landscape could begin to explain differentiation potential bias and 
loss of stemness with age 
Circular plots showing changing TF activity in younger or older donors (A) using TFBS or (B) ChIP-seq experiments 
(see methods 5.4.7). (C-F) Scatterplots of TF activity vs (C, E) log2-FC of RNA or (D, F) spearman correlation of 
protein and coloured by significant (blue for RNA and green for protein) or none-significant (grey) TF activity 
changes. All figures were done by myself.
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 Our results have been able to validate the known change in differentiation potential 
associated with age described for MSCs (Moerman et al., 2004) as well as to point to 
various other factors that are changing their activity with age, such as CENPB, CTCF, or 
PcG proteins. In addition we found some TFs that have not yet been implicated with any 
ageing phenotype and which might have a relevant function in ageing. 
 
5.2.6 Multi-omic integration shows corresponding patterns across different layers of 
organisation 
As a way to exploit our datasets, along with the novel TF-activity approach, we decided to 
test whether we could fill the “blindspot” of proteomics by integrating proteomics with 
chromatin accessibility as TF-activity. We therefore retrieved the available information on 
protein-protein interactions as collected by STRING (Szklarczyk et al., 2015) and gathered 
each of the quantifications per gene per technique, keeping only those interactions relevant 
to MSCs (where at least one of the quantifications was significantly changing with age). 
As expected, we found that if the activity of a TF was significantly changing with age both 
the transcript abundance (OR=3.82, p-value = 9.5e-109, Fisher’s exact test) and the protein 
levels of the same gene/protein (OR=1.3, p-value = 6.93e-5) were also significantly 
affected. 
Given a TFn-proteinn interaction, where TFn was described by diffTF to 
significantly change its activity with age and proteinn corresponds to a described direct 
interactor, we decided to test whether all proteins interacting with a TF would show a 
significant change at the protein level and in the same direction. For this we subset the 
MSC-specific network of interactions by whether the TF-activity was significantly 
(FDR=1%) changing in young or in old donors.  
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 By doing so we observed a preference for protein levels to be more abundant in 
younger donors if its interacting TF was also more active in the younger group (OR=1.7, p-
value = 6e-3, Fisher’s exact test) and the same hold true for the proteins that were more 
abundant in the older group (OR=1.6, p-value = 6.7e-5). 
 We also decided to visualise the protein-protein interactions’ network of the top 50 
down- and up-regulated genes for which we ranked the genes by the largest or smallest 
log2-FC of the RNA. We observed a highly interacting network for the most 
downregulated genes that was consistent with what we have reported throughout this text 
and with previous reports (Figure 5.6A). Some interactions related to the centromere 
associated proteins (CENPA, NDC80, BUB1), some to the histones and lamin (HIST1Hs, 
LMNB1), and some others with cell cycle progression (AURKA, E2F8). On the contrary, 
genes that were upregulated were not so interacting with each other and participated in 
different processes like immune response and inflammation (IL6, IL32), oxidative 
phosphorylation (SOD2), or were related to the ECM and to collagen (COL8A2, MMP1). 
 Through the integration of various layers of biological quantifications, we have 
been able to take a glimpse at genes that are changing their abundance and activity with 
age. It is from here that we can start to propose which observed changes are relevant to 
continue studying or even to further validate, as to completely understand their 
involvement in the biology of ageing. 
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Figure 5.6. Filling the blindspot of proteomics unravels an increased number of interactions 
STRING interaction networks for the top 50 genes that are (A) downregulated and (B) upregulated with age. This 
figure was done by myself.
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 5.2.7 Extensive changes in splicing regulation are observed with age 
Finally, we decided to investigate whether there were splicing changes related to age 
following the existing reports showing changes in abundance of splicing factors, isoform 
changes in proteins as relevant as p53 (Deschênes and Chabot, 2017), and also based on 
our results showing a downregulation of SF3B3 and SRSF1. For that, we used the same 8 
individuals that served to identify DE genes and followed the DEXSeq workflow that we 
have described in Chapters 2 and 3 (Methods: 2.4.3 and 3.4.2).  
To our surprise, we identified 6,761 differentially used exons (DUEs) in 3,461 
genes (FDR= 10%) of which 3,190 were more abundant in younger and 3,570 in older 
donors. This number was even larger than the DUEs identified across individuals in 
chapter 2, showing that age affects the splicing mechanism too, potentially also increasing 
the inter-individual variation.  
We next checked whether the genes containing DUEs were preferentially enriched 
for any biological processes by doing a gene ontology enrichment analysis. Surprisingly, 
we observed that genes containing exons that were mostly expressed in younger samples 
(n=1897) were enriched for biological processes such as mRNA processing and RNA 
splicing, suggesting that DUEs affecting splicing regulators could also potentially explain 
the big amount of changes observed with age in this process (Figure 5.7A). On the other 
hand, genes containing exons mostly expressed in older individuals (n=2512) were 
enriched for response to oxygen levels and metabolic processes. However, it is important 
to note that a large fraction of the genes contained DUEs from the two classes, which may 
explain the retrieved common terms (n=949). 
 Once again, we wondered whether any of the DUEs could be regulated by CTCF-
mediated intragenic loops based on the consensus peaks containing CTCF-motifs. With 
this aim we annotated the loops in MSCs (see 2.4.1) and identified 488 promoter-upstream 
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 convergent interactions in 305 genes. As an internal validation, we predicted THRAP3, the 
gene that we used as an experimental validation for chapter 2.2.3, to form a loop.  
Some of the intragenic loops were next to a DUE, showing once again that 
chromatin organisation is likely changing and impacting splicing throughout human 
lifetime. As an example we show gene LRIG1, a negative regulator of tyrosine kinase 
receptors involved in accelerated intracellular degradation and which was also reported to 
affect the plasticity of the ageing hippocampus (Trinchero et al., 2017). LRIG1 has two 
DUEs, one of which is next to a convergent interaction (Figure 5.7B). Moreover, 
interactions within this gene are present for the Rad21 ChIA-PET data that we describe in 
3.2.1. While these results seem promising, further analyses and potentially experimental 
validations will need to be done to further understand the extent of the CTCF-loop 
mechanism affecting this gene and the overall ageing splicing landscape. 
 In summary, we were able to observe splicing to be greatly affected with age and 
once again that intragenic loops also relate to alternative splicing in this process. 
Additional analyses need to be done to understand the extent of change of intragenic loops 
and whether DNA methylation could also be responsible for the splicing changes.  
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Figure 5.7. Intragenic loops affecting alternative splicing are also found with age 
(A) Gene ontology enrichment analysis (for biological processes) of the genes containing exons that are included in 
young or in old donors. (B) LRIG1 shows CTCF motif in sense orientation at promoter (blue) and antisense motif in 
the intron (red), both of which are validated by ATAC-seq peaks (left). Exon usage stratified by condition for LRIG1 
shows two DUEs, the one indicated by the arrow coincides in location with the anchor for a predicted intragenic 
CTCF-mediated loop. This figure was produced by myself.
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 5.3 Discussion 
The BM is a multifunctional tissue of crucial importance which sustains the stem cell pool 
of an organism. It contains cells such as HSCs and MSCs, which will differentiate 
throughout the lifetime into mature cells such as haematopoietic elements, osteoblasts, or 
adipocytes (Reagan and Rosen, 2016). With the pass of time multiple types of damages, 
such as genomic instability and epigenetic drift, unfold into stem cell exhaustion which 
likely constitutes one of the ultimate culprits of tissue and organismal aging (López-Otín et 
al., 2013). Given that a tight link exists between age and the onset of several diseases, it is 
necessary to gain more understanding about the underlying changes occurring in BM stem 
cells throughout life with a systemic approach. Such studies will provide a more 
comprehensive view of how the ageing process affects the BM niche from the molecular to 
the cellular level. 
Here we present a study that combines chromatin accessibility, transcriptomic, and 
proteomic data in MSCs from human donors of multiple ages. By integrating the previous 
data we were able to clearly observe that there is profound misregulation of chromatin 
organisation at the long, medium, and short scales with age, which accounts for the largest 
percentage of inter-individual variation, and which ultimately has consequences in a 
variety of processes at the transcriptomic and proteomic level.  
 
Why is chromatin organisation changing with age? 
The notion that chromatin structure is affected with age has been described by the most 
obvious phenotype of premature ageing observed in the Hutchinson-Gilford progeria 
syndrome (HGPS), which is characterised by mutations in the lamin A/C gene (Dreesen et 
al., 2013; Scaffidi and Misteli, 2006, 2008). HGPS affects several tissues, particularly 
those of mesenchymal origin and causes changes in the differentiation potential of MSCs, 
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 with enhanced osteogenesis and decreased adipogenesis. Additionally, it has been 
described that the same molecular mechanism responsible for HGPS acts at a low level in 
healthy cells (Scaffidi and Misteli, 2008).  
One of the most striking results from our study was observing that chromatin 
related proteins were significantly downregulated with age. Among the changing ageing 
proteins we observed a collection of proteins including all the lamins, several histones, 
nucleoporines, chromatin remodelers, and PcG subunits, to name a few. We therefore 
speculate that the changing chromatin structure landscape is a sum of the decrease in 
abundance and activity from all of the previously mentioned factors, along with decreased 
CTCF, methyl-CpG binding proteins, DNA methylation, telomere shortening, and 
centromere associated factors. 
The chromatin changes seem to occur for both senescence and ageing. For 
example, MeCP2 was consistently upregulated with age in HSCs and MSCs. MeCP2 is a 
methyl-CpG binding protein known to repress transcription from methylated promoters 
through its interaction with HDACs (such as SIN3A which was previously implicated with 
ageing) (Fuks et al., 2003). On the contrary, proteins like EED (subunit of the PcG 
complex), splicing factors such as SF3B3 and SRSF1, and TOP2 (DNA topoisomerase) 
were downregulated on HSCs and MSCs. 
In addition, the consistent loss of CTCF at the transcript, protein, and TF-activity 
level in MSCs suggested changes in global chromatin organisation. Most strikingly, 
multiple cohesin subunits were downregulated with age in MSCs as well as condensin in 
both cell types. Given the known roles that the previous proteins play in loop extrusion to 
establish the nuclear architecture, as amply described in chapter 1, it is tempting to 
speculate that there will be differences in chromatin structure occurring with age at high-, 
medium-, and short-range interactions. The only evidence supporting this idea is the study 
132
 done in oncogene-induced senescent cells where HiC maps revealed a loss of within TAD 
interactions and a corresponding gain of cross-boundary interactions (Chandra et al., 
2015). 
 
Where can we observe these age-related changes? 
Reports exists showing heterochromatin disorganisation with age, specifically at 
centromeres, telomeres, and at the nucleolus in human aged MSCs (Ren et al., 2017). The 
centromere is a chromosomal locus that ensures delivery of one copy of each chromosome 
during cell mitosis through a protein complex known as the kinetochore (Cleveland et al., 
2003). In line with these observations, we observed a significant decrease in the TF-
activity and protein abundance of CENPB and a three-fold downregulation of the NDC80 
complex, which is the key site for kinetochore-microtubule attachment in anaphase. A 
significant decrease in TELO2 abundance was also observed in our dataset. 
By looking at the linear distribution of the CARs, we were able to observe some 
‘hotspots’ where multiple peaks were located in close proximity to each other and had high 
log2-FC. These regions were preferentially localised next to heterochromatic blocks or 
close to the centromeres, and they seemed to be present in the younger, but not the older 
individuals. It is important to note that more questions became open after these initial 
analyses and more work needs to be done to completely address what these ‘hotspots’ are 
and the effect that they have on chromatin mis-regulation. Experimental validations may 
also be necessary to have a better understanding of the extent of such changes. 
 We also observed that the CARs localised in diverse chromatin states depending 
on whether they gained or lost signal with age. The upregulated peaks were enriched at 
enhancer regions, while the downregulated regions occurred at active promoters, 
heterochromatin (both facultative and constitutive), and bivalent states. We observed that 
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 some of the changes in these distribution could be attributed to DNA methylation. For 
example, the bivalent enhancer and promoter-flanking regions were enriched for 
downregulated CARs and for hypermethylated CpGs from (Fernández et al., 2015), 
consistent with their report. However, although they also identified hypomethylation 
primarily occurring at repetitive DNA sequences, we couldn’t validate this finding perhaps 
due to the very small number of peaks falling in this state. Finding CARs at quiescent 
regions, which have been shown to be enriched for laminB (Roadmap Epigenomics 
Consortium et al., 2015), could also suggest an altered attachment of the chromatin to the 
nuclear lamina with age. 
Finally, as we were able to identify intragenic loops and abundant alternative 
splicing in the ageing MSCs, it could be possible that CTCF binding changes, reflected as 
changes in chromatin accessibility, also have an effect at the gene level and contribute to 
the ageing phenotype. 
 
What are the consequences of changing chromatin accessibility in the ageing cell? 
We hypothesised that global chromatin changes would impact (i) the transcriptional and 
translational program of MSCs and (ii) the structural organisation of the genome, which we 
already described above. One of the advantages of having such a multi-omics approach is 
that we can have a broader quantification of the thousands of genes and proteins that are 
present at any given condition by filling the “blindspot” of proteomics. 
A first outcome of a changing regulatory landscape with age is the bias in the 
differentiation potential for MSCs, where younger cells will preferentially lead to 
osteogenesis but older to adipogenesis. Although the change has been described (Moerman 
et al., 2004), our study shows the bias from the chromatin landscape to the protein level. 
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 A second possible consequence is the potential loss or slowing of stemness that 
results from repressed bivalent regulatory regions. Bivalent promoters have been described 
to occur only at stem and cancer cells and are characterised by the simultaneous presence 
of activating and repressive histone marks (Liu et al., 2013). In our study we found that 
PRC2, the complex responsible for adding the repressive modifications, was 
downregulated with age. We also observed an enrichment of bivalent chromatin states only 
in younger stages of life. Lastly, hypermethylated DMRs were also enriched at these same 
regions, raising the possibility that later in life the repression of bivalent states becomes 
stronger through DNA methylation. 
Finally, the changing accessibility and abundance of centromeric and telomeric 
regions could lead to a plethora of changes that include increased DNA damage, 
misregulation of cell cycle, aneuploidies, and ultimately diseases like cancer. 
In summary, we have analysed, characterised, and integrated various layers of 
information that made us unravel extensive changes in chromatin structure with age. Some 
of these changes were accompanied by functional consequences. The variety of identified 
changing genes/proteins show that the ageing process is a sum of several mis-regulated 
pathways which contribute to the attrition of cells with time, i.e. through changes in 
chromatin accessibility, differences in splicing, or in proteins that ensure a tight regulation 
of replication. 
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 5.4 Methods  
5.4.1 Overview of the samples and datasets used 
We selected a subset of the SyStemAge samples (Henrrich et al. in revision) with ages 
ranging from 20-60 y.o. for which proteomics (45 samples), and in some cases RNA-seq 
datasets, were available. RNA-seq data consisted of 19 MSCs paired-end libraries with 
donors ranging from 20-59 y.o. (one replicate per donor). ATAC-seq was done for 16 
MSCs donors, most of which had proteomics and some RNA-seq data available (Figure 
5.1B). 
We used the EpiFactors database (http://epifactors.autosome.ru/) (Medvedeva et al., 
2015) to identify chromatin interacting proteins in human. To identify curated ageing 
genes, we used GenAge in the HAGR database (genomics.senescence.info/) (Tacutu et al., 
2018). For the DMRs we used the sites identified by (Fernández et al., 2015) and for the 
genomic annotation we used the chromatin states from BM-MSCs of the Roadmap 
Epigenome Project (Roadmap Epigenomics Consortium et al., 2015). Finally, we used the 
STRING database (Szklarczyk et al., 2015) to verify protein interactions. 
 
5.4.2 Culture, isolation, and construction of ATAC-seq libraries for MSCs 
Bone marrow aspirates from the iliac crest of healthy human subjects were washed with 
phosphate-buffered saline (PBS, Sigma-Aldrich #D8537). The eluates were laid on Ficoll-
Paque (15 mL, Biochrom), centrifuged (800g, 30 minutes) to separate mononuclear cells 
(MNCs). The MNC fraction was seeded in T75 cell culture flasks with Verfaillie medium 
(at a density of ~106 cells/mL), and cultured in fibronectin coated flasks until adherent 
colonies formed (at least 4 days). The adherent colonies were MSCs at passage 0 and for 
expansion of the cells, freshly isolated or thawed MSCs were culture-expanded in VM for 
one passage and then seeded in parallel into VM at 37 °C with 5% CO2. 
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 For library preparation, an aliquot of 50,000 cells in exponential growth phase was 
harvested 48h after the passage. The cells were washed once with 50 µl of cold PBS and 
subsequently lysed (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2 and 0.1% 
IGEPAL CA-630). Immediately after lysis, nuclei were spun at 500g for 10 min. The pellet 
was resuspended in the transposase reaction mix (25µl Transposase Reaction Buffer (TD), 
2.5µl Nextera Tn5 Transposase (TDE1), 22.5µl H2O, and 0.5 µl of 0.1% digitonin) and 
incubated at 37 °C for 30 min. After the tagmentation step, the first 5 cycles of PCR 
amplification were performed using Nextera Barcoded Primer set and NEBNext High 
Fidelity PCR mix as described in the original protocol (Buenrostro et al., 2013). 
In order to avoid the saturation in the amplification of prepared libraries, the 
appropriate number of cycles to amplify the ATAC-seq library was determined based on a 
qPCR test using 5 µl of previously PCR-amplified DNA as template and SYBR Green as 
fluorescent dye. Once the library was additionally PCR-amplified, it was ready to be 
sequenced.  
 
5.4.3 ATAC-seq data analysis and identification of CARs 
Libraries (n=38) for 16 individuals were processed with an in-house pipeline. Briefly, 
adapters were trimmed with Trimmomatic (Bolger et al., 2014) and reads were aligned to 
hg38 using Bowtie2 (Langmead and Salzberg, 2012) with parameters --very-sensitive -X 
2000 and filtered based on good quality (MAPQ>=10). Mitochondrial, duplicated, and 
INDEL-containing reads were removed using samtools (Li et al., 2009) and Picard tools 
(https://broadinstitute.github.io/picard/). Quality controls were carried out at multiple 
stages of the pipeline, ending up with a TSS enrichment score which verifies that the 
majority of ATAC-seq reads fall within +/-2kb from TSS vs 4kb outside of the TSS 
(upstream of the -2kb from TSS). Good TSS enrichments are considered to be above ~7-
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 fold, we decided to use 7.5-fold on both libraries. For peak calling MACS2 was used (--
nolambda --nomodel --qval 0.1 --slocal 10000) and those peaks falling in blacklist regions 
removed. 
In order to identify relevant changing accessibility regions (CARs) with age, we 
used the DiffBind (Ross-Innes et al., 2012) and DESeq2 (Love et al., 2014) bioconductor 
packages. We first defined a consensus set of autosomal peaks (n=151,615) for those peaks 
that were present in at least 2 individuals and counted the number of reads per peak per 
individual. Based on the TSS enrichment we were able to pinpoint some libraries which 
could contain quality issues (both libraries from male-21 yr batch_2, male-22 yr batch_2, 
male-50 yr batch_2). We also identified a donor which behaved as an outlier in the PCA 
(male-22 yr batch_1, Figure S5.1B). After a thorough series of analyses where we 
gradually removed these libraries from the complete dataset, we observed the best results 
by keeping only 15 donors, each with 2 replicates. 
To ensure that the highest signal was extracted, peak-summits were recentered and 
extended +/-250bp. We then followed the DESeq2 workflow. After initial exploratory 
analysis, we decided to identify the differential accessibility regions through two 
approaches: 1) fitting the signal to a linear regression as a function of age and 2) defining 
three age categories and calculating log2 fold-change values.  
For the linear regression approach we used a design = ~ Batch_Sex + Age for the 
15 ATAC-seq libraries of our dataset. After normalising for library size and estimating the 
dispersion, we applied a Likelihood Ratio Test to obtain a set of peaks with increasing or 
decreasing signal as a function of age (4,221 peaks at FDR 10%). Based on an 
unsupervised hierarchical clustering, we observed that samples fell mostly in three age-
groups: 21-33 y.o. (first), 39-50 y.o. (second), and 56-59 y.o. (third). We therefore selected 
four samples from each of these groups and ran DESeq2 with the design = ~ Batch_Sex + 
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 age-group, using the same consensus set of peaks. We identified 5,270 differential peaks 
(FDR 10%) between the first and third groups and labelled all peaks as having differential 
signal with the linear and/or the log2 fold-change approach. In total, we obtained 4,244 
peaks losing and 2,477 peaks gaining signal with age (6,746 peaks FDR 10%) and labelled 
all peaks as being differential with the linear, the log2 fold-change, or both approaches. 
 
5.4.4 Assessing changes in the shape of the peaks 
We measured if there were width changes for those peaks overlapping the consensus peak 
set. For that we used the original peak width of each of the samples and grouped them by 
age. Additionally, we used SNPhood (Arnold et al., 2016) to extract the normalised read 
counts in 50 bins of 20bp, leaving us with +/-500bp surrounding the re-centered peak 
summit of the differential peaks.  
To check the overall changes in chromatin accessibility we calculated a ratio of the 
sum the normalised reads within the peaks vs the total normalised reads in the +/-500bp 
window. Then we visualised the ratios against the age of the donor. 
 
5.4.5 Analysis of chromatin states in the accessibility regions 
To investigate the distribution of accessibility regions in the genome, we used the 
chromHMM annotation defined in the Roadmap Epigenome consortium (Roadmap 
Epigenomics Consortium et al., 2015) for BM-MSCs. To address whether there was an 
enrichment or depletion of such states for the peaks that were significantly changing their 
signal with age, we used the Fisher’s exact test and verified the distribution of the 
consensus peak per chromatin state as the background and that of the differential peaks that 
gained or lost signal with age, correcting for multiple testing with Benjamini-Hochberg.  
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  For testing the distribution of DMRs we applied a similar approach to the MSC 
DNA methylation data from (Fernández et al., 2015). 
 
5.4.6 Differential expression and exon usage analyses 
In order to identify genes that were differentially expressed with age in MSCs, we selected 
the four youngest (20, 20, 23, 32) and the four oldest (50, 55, 57, 60) libraries of the 
dataset, all of which were males. We then ran a DESeq2 (Love et al., 2014) analysis using 
only expressed genes which were previously filtered with kallisto (Bray et al., 2016) using 
Gencode v27 as annotation (https://www.gencodegenes.org/). We also filtered all the 
transcripts for which there were less than 10 total reads. Given that the eight libraries used 
were produced in the same batch, our design only considered the condition (design = ~ 
age-group). We verified that selecting these eight libraries was robust with other DESeq2 
analyses that used different numbers of individuals per group, while maximizing the 
output. With this approach, we identified 544 differentially expressed genes at an 
FDR=10% (275 more abundant in young vs 269 more abundant in old). 
 Gene Ontology over-representation analysis was done with ClusterProfiler (Yu et 
al., 2012), in particular with enrichGO. We tested for ‘Cellular Compartment’, ‘Biological 
Process’, and ‘Molecular Function’ (not shown). 
As a way to identify changes in splicing with age in MSCs, we used DEXSeq 
(Anders et al., 2012) and we followed the standard workflow described in their vignette 
and in detail in chapters 2 and 3. Briefly, after filtering for the used isoforms in MSCs, we 
flattened the Gencode v27 file and extracted the exon counts from the RNA-seq libraries 
using the HT-seq scripts provided with the package. We next compared exon fold change 
between the youngest group and the oldest group of individuals that we used for the DE 
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 analysis above. This rendered 6,761 DUEs at an FDR= 10% of which 3,190 were more 
abundant in younger and 3,570 in older donors.  
5.4.7 Identification of a changing transcription factor landscape 
To identify TFs that are significantly changing with age, we used diffTF (Berest, Arnold, et 
al. in revision) and compared the distribution of TFBS from HOCOMOCO (Kulakovskiy 
et al., 2018) in ATAC-seq peaks for the first and the third group. We use an extension 
window of 100bp and default parameters. We took an FDR= 10% to call significance of 
TF activity. 
As a way to gain insights not only of the TF activity, but also of other factors for 
which ChIP-seq exists, we filtered the 485 ReMap 2018 (Chèneby et al., 2018) 
(http://tagc.univ-mrs.fr/remap/index.php) based on median gene expression, leaving us 
with 407 factors. We then followed the diffTF pipeline with default arguments using the 
three groups defined above to measure old vs young. 
 
5.4.8 Integration of the ATAC-seq, RNA-seq, and proteomics datasets 
To gain further insights into the protein-protein interactions that have been described and 
validated, we used the STRING database v.10 (Szklarczyk et al., 2015). We filtered for 
interactions with a combined score of 400 and above and added the quantifications from 
the diverse layers to the database (TF-activity, accessibility at promoter, transcript, and 
protein abundance). We then filtered to keep only those interactions where at least one of 
the genes was significantly changing with age at any of the layers. We later stratified by 
young and old based on the significant TF-activity as elucidated by diffTF (Berest et al. in 
revision). 
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 6. Conclusions and perspectives 
 
The interplay between chromatin organisation and the correct transcriptional regulation of 
the cell has become evident in the last years. However, studies have majorly focused on 
long-range chromatin interactions and only rarely analysed the 3D-organisation at the gene 
level. Furthermore, mechanistic insights relating chromatin structure and function remain 
scarce, while paradoxically increasing evidence supports a strong link between both levels. 
 In this dissertation I have undertaken a computational investigation to understand 
how nuclear architecture conveys functionality, mainly at the splicing process, but also by 
asking how 3D-organisation allows the propagation of molecular intermediate phenotypes 
- in particular histone marks, CTCF and cohesin - from distal genetic variants. Finally, I 
have also looked at the effects of increasing age in chromatin accessibility and how these 
changes reflect in RNA and protein abundance. While each of the chapters discusses the 
findings and limitations of the separate studies, in the next lines I sum up the major 
conclusions of my thesis regarding chromatin organisation in splicing and ageing, both of 
which were my most advanced projects. I also speculate how these research projects may 
continue in the future. 
 
6.1. Chromatin organisation at the gene level conveys functionality by affecting 
alternative exon usage 
Alternative splicing contributes to the cellular complexity of higher eukaryotic organisms, 
with nearly 95% of mammalian genes undergoing alternative splicing of pre-mRNA 
(Kornblihtt et al., 2013; Shukla et al., 2011). Aberrant splicing has been implicated in a 
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 number of human diseases, thus showing the importance of its correct regulation 
(Blencowe, 2006; Kornblihtt et al., 2013).  
 During my doctoral studies I was able to unravel a new mechanism regulating 
alternative splicing that consists on the formation of a CTCF-mediated chromatin loop, 
from promoter to upstream of the exon to be spliced in, that occurs both in human and in 
mouse cells. By starting with DNA motifs for CTCF and genomic annotations, I was able 
to predict the presence of intragenic loops. In a second phase, I exploited several datasets 
for lymphoblastoid cell lines from diverse biological levels to test the contribution of loops 
in splicing and gained mechanistic insights about this process. Finally, by performing some 
chromatin conformation experiments in collaboration with colleagues from EMBL, we 
were able to validate the presence of these intragenic loops and the correlation in exon and 
CTCF levels across individuals in lymphoblastoid cell lines. Through various 
collaborations, we verified the extent of the identified mechanism and found similar results 
in different cell lines and in mouse. Moreover, by using a list of frequently mutated regions 
in cancerous tumours we were able to observe that the CTCF motifs anchoring intragenic 
interactions bear a higher mutation frequency, particularly at intronic sites overlapping 
cohesin and that significantly overlap with splicing-QTLs. Overall, this mechanism is 
affected by natural genetic variation and changes in the epigenomic landscape. 
I acknowledge that, in spite of the clear evidence for a mechanism where CTCF-
looping affects alternative exon usage, it is still one of the many mechanisms that regulate 
alternative splicing, as also reflected by the overall moderate effect sizes reported in our 
studies. Furthermore, we have not discarded that the gene expression levels affect the 
presence and strength of CTCF-intragenic loops or that these interactions could affect more 
than one exon at a time. In line with this claim, a study describing intragenic loops in 
mouse that were claimed to be independent of CTCF was able to correlate the presence of 
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 loops with increasing number of exons and with the expression levels of the gene itself 
(Bonev et al., 2017). I still speculate that many of the loops identified in the previous study 
could be mediated by CTCF as the quality of the ChIP-seq data was higher in other studies, 
as in the ones used in this dissertation. Furthermore, while we controlled for analysing 
“cassette-exon” splicing, some of my results also hinted to cases where the intragenic loop 
was formed next to transcription start or end site, which suggests that we will need further 
analyses to know to which extent this mechanism is affecting splicing. 
Nevertheless, a mechanism that regulates exon inclusion through intragenic CTCF 
loops offers some intriguing possibilities: since most CTCF binding events are invariant 
across many cell types (Li et al., 2013). A proportion of CTCF binding however, is 
sensitive to DNA methylation (Marina et al., 2016; Maurano et al., 2015), which in turn is 
known to be highly cell-type specific. Thus, one could conceive a mechanism where DNA 
methylation regulated CTCF binding could explain a portion of alternative isoform usage 
observed across different tissues or during development, as we have observed for the 
differentiation of mouse ESCs to NPCs. As a first attempt to start understanding the 
interplay between alternative splicing, CTCF intragenic loops, and DNA methylation, the 
group of Dr. Vessela Kristensen and in particular Dr. Sunniva Stordal from Oslo 
University Hospital in Norway, started to tackle this question. We recently started 
collaborating with them to analyse the ATCG dataset. Finally, we also know that this 
mechanism is affected by genetic variation as shown in section 2.2.4 and by the epigenetic 
landscape across tissues as in section 3.2.1. 
Overall, our study provides one of the first functional interpretations of intragenic 
chromatin architecture by linking CTCF-mediated DNA-loops to the regulation of 
alternative isoform usage and protein isoforms across human tissues, in mouse neural 
differentiation, and in cancer. In addition, the model we propose provides a useful 
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 framework for further studying alternative isoform usage by generating hypotheses about 
exon usage solely based on the analysis of CTCF motif, which are easily obtained from the 
DNA sequence.  
 
6.2 Chromatin architecture is misregulated at all levels and through multiple 
mechanisms during human ageing in stem cells 
Ageing is the progressive physiological deterioration that ultimately ends in the death of an 
organism and that arises through the accumulation of multiple biological misregulated 
processes (Booth and Brunet, 2016; López-Otín et al., 2013). While several studies have 
attempted to understand the molecular causes of ageing, especially at the transcriptome and 
proteome level, the motivation of my study came from the persistent lack of understanding 
about the influence of chromatin accessibility in ageing and ultimately of the consequences 
that such differences would lead to. Moreover, it is known that stem cells are subjected to a 
different ageing influence and that they comprise a very specific niche that when affected 
contributes to the overall organismal decline (Schultz and Sinclair, 2016). 
Although my analyses are still ongoing, preliminary results recapitulate some of the 
hallmarks of ageing (as described by López-Otín et al., 2013) and have resulted in the 
identification of specific chromatin regions affected with age and also in a description of 
global chromatin accessibility differences that are mainly observed at centromeres and 
telomeres for multiple chromosomes. It will be important to establish better quantitative 
metrics to classify those “hotspots” of changing accessibility regions (CARs) and probably 
to also link them with chromatin states or genomic features. For example, given the 
changes in DNA methylation with age and the observed enrichment of CARs that lose 
signal with age in heterochromatin, it would be relevant to check if transposable elements 
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 are significantly affected. This question is currently being addressed by Dr. Vasavi 
Sundaram, a shared postdoc between our group, Dr. Paul Flicek (EMBL-EBI), and Dr. 
Duncan Odom (MRC in the University of Cambridge).  
In addition one of our most relevant results so far is that multiple chromatin related 
proteins are downregulated with age which once more hints to the relevance of the 
epigenome in ageing. The epigenetic regulation has been evidenced to be affected with 
age, for example through DNA methylation changes. Importantly, the environment has a 
strong influence in ageing, which has been demonstrated by altered lifespans as a 
consequence of caloric restriction or exercise (Booth and Brunet, 2016). Now that we have 
identified chromatin-related ageing proteins that occur in both hematopoietic and 
mesenchymal stem cells, it will be crucial to have a closer look at them and to test if they 
can bring some novelty into the ageing field. 
Finally, I am currently assessing the best way to integrate the various layers of 
molecular data that are available in an attempt to have a more systemic view of the ageing 
changes going from chromatin to transcript and to protein. Additionally, as increasing cell-
to-cell variability has been proposed as a consequences of ageing in the transcriptome 
(Martinez-Jimenez et al., 2017), it will be important to assess if such variability already 
comes from chromatin or whether it exists at all at this layer. If it is indeed the case that 
certain accessibility regions in chromatin show increased variability with age, it will be 
relevant to understand the extent to which it can affect the regulation of specific chromatin 
states and possibly if it contributes to disease states. These questions are now being studied 
by Dr. Mang Ching Lai, a postdoc in our group. Ultimately my aim is to have a manuscript 
explaining our findings in the near future, therefore contributing to a deeper understanding 
of the molecular mechanisms misregulated with age. 
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 6.2 Concluding remarks 
With this dissertation I have intended to gain further understanding on the intricate relation 
between chromatin organisation, its mechanisms that convey function, and its influence in 
cellular processes such as in splicing. Furthermore, our results confirm that the 
misregulation of chromatin accessibility also leads to changes at the RNA and protein level 
as a result of ageing. The next years should see an increase in genome-wide high-
throughput datasets and also of an improving biostatistical framework to integrate the 
multiple layers of regulation, such as the application of machine learning approaches and 
reductionality algorithms, among others. The possibility to also integrate phenotypic data 
as measured by microscopy or screening assays with CRISPR-Cas9 should also open an 
exciting path to study the interplay of chromatin structure and function. To conclude, the 
findings that I generated throughout four years of intensive research hopefully add up to 
the increasing research of inter-individual variability, the link between DNA and 
phenotype, and overall represent a grain of sand in the knowledge of human epigenomics. 
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Figure S2.1, related to figure 2.1. CTCF-motif pair pattern is preserved with changing parameters, but absent 
in long noncoding RNAs 
(A) Distribution of motifs, as shown in Figure 2.1A,B for the promoter (top) and TTS (bottom) for coding transcripts 
(left) and lnc-RNAs (right). Note that the sharp peak of sense motifs observed for protein-coding promoters is lost for 
lncRNAs (only transcripts with 2 or more exons were considered). (B) Distribution of motif-pairs for the LCL-
specific set, as in Figure 2.1C.  Note that changing the score of the motifs from 1000 to 500 and broadening the 
promoter window to +/-1kb allowed more CTCF motif-pairs to be annotated. (C) Same as in Figure 2.1D for the 
LCL-specific set. This figure was generated by myself and is published in (Ruiz-Velasco et al. 2017).
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Figure S1, related to Figure 1. CTCF-motif pair pattern is preserved with changing parameters, but absent in long 
noncoding RNAs
(A) Distribution of motifs, as shown in Figure 1A and 1B, for the promoter [top] and transcription termination site [bottom] for 
coding transcripts [left] and long noncoding RNAs (lncRNAs) [right]. Note that the sharp peak of sense motifs observed for 
protein-coding pr moters is lo t for lncRNAs (only transcripts with 2 or more exons were considered).
(B) Distribution of motifs pairs, as shown in Figure 1C for the LCL-specific set. Note that changing the score of the motifs from 
1000 to 500 and broadening the promoter window to +/- 1kb allowed more CTCF-motif pairs to be annotated. The significant 
enrichment for convergent and depletion of divergent pairs in the promoter-exon motif pairs is preserved. 
(C) Similar to Figure 1D, number of motif-pairs with physical interaction but using the LCL-specific set.
A. Supplementary information for chapter 2
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Figure S2.2, related to figure 2.2. Characterisation of differentially used exons and their correlation with diverse 
genomic factors 
(A) Number of genes containing one or more differentially used exons. (B) Scatterplot of the correlation between the 
number of middle exons per gene and number of DUEs in that gene. (C) Distribution of the length of the middle exons. 
Note that most of them fall in a range of 20-200bp. (D) Log2-FCs for middle-exon expression with respect to the median 
for the 18 individuals. (E) Same as in Figure 2.2D, the spearman correlation between exon log2-FC and CTCF log2-FC 
is significantly higher for exons involved in promoter exon-upstream interactions than for those exons in other 
orientations (green) or than for promoter exon-downstream CTCF motif-pairs (numbers and p-values for the other 
categories are reported in Figure 2.2D). (F) Spearman correlation between DUEs and different histone marks, PolII, and 
cohesin (SA1) shows a higher correlation for looping upstream-exon in some (H3K4me3, H3K27ac, H3K36me3) but 
not all (H3K4me1, PolII, SA1) factors. PolII and H3K36me3 also have higher correlation for looping downstream-
exons. Panels A-D were generated by myself in collaboration with Ana Belén Pinson-Solís and Pooja Bhat, panels E and 
F were done by myself and they are published in (Ruiz-Velasco et al. 2017).
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Figure S2.3, related to figure 2.3. Genetic basis of CTCF binding and exon inclusion 
Exon allelic fraction stratified by (A) CTCF or (B) HiC for upstream (left) and downstream (right). Allele 1 > Allele 2 
and vice versa are shown grouped by the configuration of the exon-promoter motif-pair. (C) 4C-seq normalised signal 
(RPM) at the THRAP3 gene showing various interactions within the gene and in particular the predicted promoter exon-
upstream interaction that we predicted. (D) Same as in Figure 2.3D, analysis of 4C-seq signal for exons 7,9, and 11. 
Note that the significant shift for 4C signal is only observed when stratified by exon 5. Panels A and B were generated 
by myself, panels C and D were done in collaboration with Dr. Mang Ching Lai and are published in (Ruiz-Velasco et 
al. 2017).
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Figure S3, related to Figure 3. Genetic basis of CTCF binding and exon inclusion
(A, B) Exon allelic fraction stratified by (A) CTCF or (B) HiC for upstream [left] and downstream [right] (Allele 1> Allele 2 and vice 
versa) are shown grouped by the configuration of the exon-promoter motif-pair.
(C) 4C-seq normalised signal (RPM) at the THRAP3 gene showing various interactions within the gene and in particular the 
predicted promoter-exon upstream interaction that we predicted.
(D) Analysis of 4C-seq signal in the THRAP3 gene as show  in figure 3D for exons 7,9, and 11. Note that the sig ificant shift for 
4C signal is only observed when stratified by exon 5.
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Figure S2.4, related to figure 2.4. Gene ontology (GO) based functional analysis 
Treemap showing the top 10 enriched terms for (A) Molecular Function, (B) Cellular compartment, or (C) Biological 
processes (Pfam protein domains) for the genes with looping exons. Both the unbiased (left) and the LCL-specific 
(right) sets are shown. This figure was contributed by Dr. Manjeet Kumar and is published in (Ruiz-Velasco et al. 
2017).
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Figure S4. Gene ontology (GO) based functional analysis, related to Figure 4
All analyses are shown for the unbiased set [left] and the LCL-specific set [right]. 
(A) Treemap showing enriched molecular functions for the genes with looping exons. Kinase activity and ribonucleoside/ribonu-
cleotide binding are significantly enriched.  
(B) Cellular component enrichment for the looping genes is dominated by the membrane region mainly plasma membrane 
although other areas such as cell periphery and cell projection are also enriched.
(C) GO Biolog cal processes enrichment for the Pfam protein domains, whi h verlap with the looping exons. The terms ass ci-
ated with cellular response to stress and metabolic processes are enriched. The top 10 GO terms derived from Pfam domains to 
GO mapping are displayed.
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Figure S3.1, related to figure 3.1. Intragenic interactions affect alternative exon usage across tissues 
(A) PCA of chromatin loop interaction frequencies across all samples. Colours denote the germ layer origin of each 
sample; x-axis indicates the percentage of variance explained by PC1, and y-axis by PC2. (B) Same as figure 3.1C, 
scatterplots of the differentially used exon and anchor counts for the real pairs (blue) and other exon-loop pairs within 
the same gene (pink) in solid tissues. (C) Normalised counts of exon 6 in ARHGEF7 according to the normalised loop 
strength show a positive correlation (Pearson cor. = 0.5) for all 22 cell lines. The highest exon abundance is for blood 
tissues and a couple of outliers. (D) DEXSeq plot showing the differential exon usage of all exons for gene ARHGEF7, 
highlighting exon 6, which is affected by an intragenic loop. Panel A was taken with permission from Grubert et al. (in 
revision), panels B-D were produced by myself.
B. Supplementary information for chapter 3
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Figure S3.2, related to figure 3.2. Intragenic loops are also prevalent in mouse    
(A) Intragenic interactions predicted for mouse ESC (left) and NPCs (right). (B) Similar to figure 3.2B, the schematic 
shows the test for exons to be included more in ESC or in NPC and to have a stronger CTCF binding in ESC or in 
NPC when the tested exons do not have a promoter-exon-upstream loop. The complete figure was produced by 
myself.
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Figure S3.3, related to figure 3.3. Intronic CTCF sites involved in convergent interactions are frequently 
mutated when overlapping cohesin 
(A, B) Similar to figure 3.3B, intronic CTCF motifs (A) and in particular those overlapping cohesin (B) show an 
increased mutation frequency in convergent interactions. (C) Sashimi plot produced using IGV for PFKFB2 showing 
that mutated tumours have an increased number of reads that span outside of the gene (black arrows), which is rarely 
observed for the non-mutated samples (blue triangle = mutated CTCF). Panels A and B were produced by Dr. Esa 
Pitkänen and panel C by myself.
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Figure S4.1, related to figure 4.1. Characterisation of loop regions across individuals for histone marks 
(A) Same as in figure 4.1B for H3K27ac (left), H3K4me1 (middle), and H3K4me3 (right) at loop regions of the 3 data 
sets. (B, C) Same as in Fig. 4.1C for H3K4me1 (left) and H3K4me3 (right) across 18 LCLs according to where they 
bind in the context of loop regions. All three maps were visualised and Wilcoxon tests measured differences between 
outer and inner boundary values (*). The figure was produced by myself.
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 Figure S4.2, related to figure 4.2. TF-co-enrichments in loopQTLs 
(A) Schematic of how a SNP could affect the binding of the protein on one side and affect the binding of the other side 
of the contact. The concept of a heterozygous SNP is also depicted. (B) Same as in Figure 4.2C but for all significant 
co-enriched pairs. Panel A was done by myself, panel B was contributed by Ignacio Ibarra.
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Figure S4.3, related to figure 4.3. Characterisation of allele-specific factors across individuals 
Number of (A) peaks per genomic factor, (B) unique peaks and SNPs per individual. (C) Average loop length 
for the three datasets. All panels were done by myself.
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Figure S5.1, related to figure 5.1. Overview of quality data and outliers per technique 
(A) PCA of the 38 ATAC-seq libraries coloured by age shows some outliers (black arrows). In addition, based on the 
TSS enrichments we also removed 4 more libraries, leaving us with 30 libraries corresponding to 15 donors. (B) 
Heatmap for the pearson correlation of RNA-seq bam files produced with bamCorrelate from deeptools (Ramírez et 
al. 2014) and (C) distribution of transcripts per million shows one outlier (blue arrows). (D) Distribution of DHS-seq 
peaks (%) per chromatin state (green) vs the total percentage of each state as the background (grey). All panels were 
produced by myself.
D. Supplementary information for chapter 5
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Figure S5.2, related to figure 5.2. Integration of RNA and protein in HSCs 
(A) Gene ontology enrichment analysis of biological processes shows terms as ‘nuclear division’ or ‘chromosome 
segregation’ for down- and ‘ECM organization’ for up-regulated genes. (B, C) Scatterplot of log2-FC (gene) vs 
spearman correlation (protein) values (B) coloured by number of donors where the protein was detected for DEGs in 
MSCs or (C) for all genes with both values in HSCs coloured whether they interact with chromatin. (D) Distribution of 
log2-FC and spearman correlation of chromatin-related (purple) and other proteins (grey) in HSCs shows that the 
chromatin-proteins downregulation with age is not as strong as in MSCs. This figure was done by myself.
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Figure S5.3, related to figure 5.3. Linear visualization of chromatin accessibility changes with age 
(A) Depiction of accessibility peaks along the linear chromosomes stratified by log2-FC and coloured by significantly 
changing with age (red) or not significant (grey). The RNA log2-FC is plotted below and show no specific enrichment 
of misregulated genes in the chromatin hotspots (indicated by the black arrows), (B) CARs containing CTCF motifs are 
coloured (blue) and show accumulation only at certain hotspots. All figures were produced by myself.
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Figure S5.4. Heatmap of CARs according to the 3 groups and distributed by chromosome, related to figure 5.4 
(A) Heatmap showing the normalised ATAC-seq signal at CARs calculated from the comparison of young vs old 
(log2-FC approach). (B) Distribution of CARs per chromosome stratified by log2-FC as more accessible in younger 
(red) or in older (blue) samples. This figure was generated by myself.
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Table S5.1. List of ageing proteins associated to chromatin common for MSCs and HSCs 
Gene name Ensembl_id log2FC RNA 
MSC 
Spearman cor. 
MSC 
log2FC RNA 
HSC 
Spearman cor 
HSC 
APEX1 ENSG00000100823 -0.56 -0.47 -0.04 -0.19 
ATAD2 ENSG00000156802 -1.31 -0.3 -0.22 -0.3 
ATF2 ENSG00000115966 -0.43 -0.34 -0.16 -0.73 
BRD7 ENSG00000166164 -0.32 -0.49 -0.04 -0.19 
BRD8 ENSG00000112983 -0.57 -0.38 -0.06 -0.17 
CBX5 ENSG00000094916 -0.43 -0.36 -0.16 -0.03 
CDK1 ENSG00000170312 -2.61 -0.16 -0.56 -0.32 
CDK2 ENSG00000123374 -0.94 -0.42 -0.41 -0.14 
CHD2 ENSG00000173575 1.06 0.03 0.10 0.20 
DAPK3 ENSG00000167657 0.09 0.12 0.18 0.9 
EED ENSG00000074266 -0.1 -0.10 -0.69 -0.18 
ELP4 ENSG00000109911 -0.23 -0.24 -0.16 -0.04 
H2AFX ENSG00000188486 -1.28 -0.38 -0.30 -0.15 
HDAC1 ENSG00000116478 -0.43 -0.26 -0.11 -0.12 
HDAC3 ENSG00000171720 -0.39 -0.33 -0.09 -0.31 
HELLS ENSG00000119969 -1.57 -0.3 -0.20 -0.17 
HMGN2 ENSG00000198830 -1.05 -0.28 -0.28 -0.34 
HMGN3 ENSG00000118418 -0.25 -0.22 -0.41 -0.10 
HMGN4 ENSG00000182952 -0.09 -0.08 -0.27 -0.09 
LEO1 ENSG00000166477 -0.42 -0.26 -0.07 -0.21 
MAPK3 ENSG00000102882 0.26 0.18 0.24 0.09 
MDC1 ENSG00000137337 -0.33 -0.27 -0.13 -0.16 
MECP2 ENSG00000169057 0.7 0.21 0.44 0.59 
MTA2 ENSG00000149480 -0.47 -0.29 -0.08 -0.002 
NASP ENSG00000132780 -1.03 -0.29 -0.14 -0.37 
NBN ENSG00000104320 -0.46 -0.29 -0.32 -0.11 
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NCAPD2 ENSG00000010292 -1.163 -0.21 -0.24 -0.30 
NCAPG ENSG00000109805 -3.05 -0.15 -0.46 -0.35 
NCAPG2 ENSG00000146918 -2.18 -0.3 -0.03 -0.12 
NCAPH ENSG00000121152 -4.12 -0.22 -0.39 -0.39 
NCAPH2 ENSG00000025770 -1.03 -0.4 -0.18 -0.24 
NDC1 ENSG00000058804 -0.94 -0.11 -0.21 -0.03 
NUP107 ENSG00000111581 -0.32 -0.31 -0.10 -0.16 
NUP35 ENSG00000163002 -1.9 -0.28 -0.23 -0.22 
NUP37 ENSG00000075188 -0.18 -0.4 -0.44 -0.25 
NUP43 ENSG00000120253 -0.39 -0.12 -0.15 -0.12 
NUP50 ENSG00000093000 -0.39 -0.38 -0.12 -0.28 
NUP62 ENSG00000213024 -0.44 -0.12 -0.08 -0.34 
NUP85 ENSG00000125450 -0.57 -0.30 -0.19 -0.03 
NUP88 ENSG00000108559 -0.82 -0.35 -0.01 -0.15 
NUP93 ENSG00000102900 -0.95 -0.28 -0.23 -0.29 
PCNA ENSG00000132646 -1.32 -0.37 -0.31 -0.37 
PPM1G ENSG00000115241 -0.48 -0.28 -0.06 -0.23 
PSIP1 ENSG00000164985 -0.44 -0.23 -0.45 -0.06 
RBBP7 ENSG00000102054 -0.69 -0.19 -0.17 -0.18 
SAP18 ENSG00000150459 -0.16 -0.32 -0.3 -0.25 
SF3B3 ENSG00000189091 -0.27 -0.39 -0.12 -0.13 
SKP1 ENSG00000113558 -0.18 -0.08 -0.12 -0.01 
SRSF1 ENSG00000136450 -0.59 -0.27 -0.42 -0.22 
TFDP1 ENSG00000198176 -1.04 -0.21 -0.13 -0.3 
TOP2A ENSG00000131747 -2.63 -0.11 -0.60 -0.43 
UBE2N ENSG00000177889 -0.49 -0.13 -0.50 -0.06 
UBR7 ENSG00000012963 -1.35 -0.23 -0.32 -0.02 
UHRF1 ENSG00000276043 -1.89 -0.31 -0.59 -0.51 
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